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This dissertation work focused on retinal modifications that are relevant to 
Age-related macular degeneration (AMD) in cholesterol-fed rabbit model of 
Alzheimer’s disease (AD), as AD and AMD share common features. It is unknown 
whether cholesterol-fed rabbit model of AD displays any AMD features in retina. 
Previous research showed 27-hydroxycholesterol (27-OHC) involvement in AD 
like pathology in organotypic hippocampal slices of rabbit brain and human 
SHSY-5Y neuroblastoma cells. The extent to which and the mechanisms by which 
27-OHC may also cause pathological hallmarks related to AMD are not known. 
Various studies suggested estrogen’s (E2) role in AMD development. 27-OHC is a 
ligand for estrogen receptor (ER) and liver X receptor (LXR). 25-
hydroxycholesterol (25-OHC) and 7-ketocholesterol (7-KC) are also implicated in 
AMD development. 25-OHC and 7-KC were shown to be ligands of ER and LXR 
in various cell types. It is unknown whether 27-OHC, 25-OHC and 7-KC influence 
ER and LXR transcriptional activity in ARPE-19 cells, a spontaneously arising 
human RPE cell line with normal karyology.  
ARPE-19 cells and cholesterol-fed rabbit eyes were used for the study. 
Paraffin embedded eye cross sections were used for immunohistochemistry. 
Cholesterol was quantified by cholesterol/cholesteryl ester quantification kit. 
Oxysterols in the rabbit retinas were measured by mass spectrometry. Western 




assay for measuring lactate dehydrogenase from cells, ELISA (Enzyme-linked 
immunosorbent assay) for quantifying amyloid beta (Aβ) 1-42 and Aβ1-40, tumor 
necrosis factor α, DCFH-DA (2’,7’-dichlorfluorescein-diacetate) assay for 
measuring reactive oxygen species (ROS), amplex red hydrogen peroxide / 
peroxidase assay for quantifying hydrogen peroxide and peroxidase activity, JC-1 
(5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbocyanine iodide) assay 
for mitochondrial membrane potential detection, TUNEL (Terminal 
deoxynucleotidyl transferase dUTP nick end labeling) assay for apoptotic cell 
detection, GSH-Glo assay for glutathione (GSH) quantification, calcium imaging, 
immunocytochemistry, immunohistochemistry and H&E (hematoxylin and 
eosin) staining, transfection and dual-luciferase reporter assays were used for 
this work. 
This study showed retinal modifications that are relevant to AMD in 
cholesterol-fed rabbits. Increased Aβ levels, decreased apoptosis regulator Bcl-2 
levels, increased apoptosis regulator BAX and growth arrest and DNA damage-
inducible protein GADD153 proteins, apoptotic cells, and increased generation of 
ROS were found in retinas from cholesterol-fed rabbit retinas. Furthermore, 
astrogliosis, drusen-like debris and cholesterol accumulations in retinas from 
cholesterol-fed rabbits were observed. Oxysterol levels in retinas from 
cholesterol-fed rabbits were increased. 27-OHC increased Aβ peptide production, 
increased caspase 12 and GADD153, reduced mitochondrial membrane potential, 
triggered Ca2+ dyshomeostasis, and increased levels of the nuclear factor NF-
kappa-B p65 subunit (NF-κB p-65) and heme oxygenase 1 (HO-1). Additionally, 




mediated cell death in ARPE-19 cells. ARPE-19 cells express ERα, ERβ, LXRα 
and LXRβ. ER and LXR are transcriptionally active. ER agonist E2 protected cells 
from 25-OHC and 27-OHC induced cytotoxicity. E2 counteracted 27-OHC and 
25-OHC induced mitochondrial membrane potential decline.  
Taken together, data demonstrate that cholesterol-enriched diets induce 
pathological hallmarks suggestive of AMD in rabbit retinas. The cholesterol diet 
substantially increased concentrations of the major oxysterols, accumulation of 
which is toxic to retinal cells. Incubation of cells with oxysterols also reproduced 
the majors effects observed in vivo with the diet rich in cholesterol. These results 
strongly suggest that hypercholesterolemia and subsequent increase in oxysterol 
formation may contribute to the pathogenesis of AMD. Our data also shows that 
ER modulation may play an important role in the cholesterol and oxysterol 
effects. Specifically, ER agonists may provide protection against oxysterol 
deleterious effects on retinas. As well, reduction of cholesterol plasma levels may 
prevent excess conversion of cholesterol to oxysterols and precludes the 






Eyes are windows to the wonders of the world. The reflected light enters 
the eye through the cornea, a transparent dome on the front surface of the eye, 
then travels through the aqueous humor, pupil, lens and vitreous humor to 
project onto photoreceptors of the retina, whose impulses converge on the optic 
nerve and then to the brain to be transfigured into image. 
  
Figure 1: View of the human eye (Webvision, http://webvision.med.utah.edu/) 
 




The pupil is central aperture of the iris that allows light to enter the eye 
(Figure 1). The iris is a colored circular muscle, which controls the size of the 
pupil so that more or less light, depending on conditions is permitted to enter the 
eye. Iris color, generally referred as eye color, is due to variable amounts of 
pigments formed by melanocytes. The sclera also known as white of the eye is the 
opaque, fibrous, protective outer layer of the eye containing collagen and elastic 
fiber, which forms part of the supporting wall of the eyeball. The sclera is 
continuous with the cornea (Figure 2). Furthermore sclera is in continuity with 
the dura of the central nervous system. The cornea is transparent external surface 
of the eye that covers both the pupil and the iris. This is the first and most 
powerful lens of the optical system of the eye and allows, jointly with the 
crystalline lens, the construction of a sharp image at the retinal photoreceptor 
level. 
The retina is an integral part of the brain 
 
Figure 3: The retina is an integral part of the brain (Gilbert SF. Developmental 




The retina is actually a part of central nervous system (Figure 3). It is 
formed as a protrusion of the neuroectoderm, a specialized part of the ectoderm, 
which also develops into the central nervous system (CNS) during embryonic 
development. The retina is an amazing arrangement of cells (Figure 4) that can 
translate light into nerve signals, allowing us to perceive the world. The retina 
comprises intricate neural circuitry that converts the graded electrical activity of 
photoreceptors into action potentials that travel via axons in the optic nerve to 
the brain. The macula is an oval-shaped, highly pigmented yellow spot near the 
center of the retina of human eye. Cones are concentrated in the fovea, which is 
at the center of macula. The macula is essential for central and near vision, and 
when the macula deteriorates, persons are impaired in their driving, reading, and 
other activities of daily living. Because of fewer cell layers, macula is more 
susceptible to environmental stressors. The progressive damage of the macula is 
a disease, known as macular degeneration.  
The mature retina consists of two distinct tissues, the neural retina and the 
retinal pigment epithelium (Figure 5). Neural retina consists of five types of 
neurons, divided into at least 50 subtypes, and glial cells. Five classes of neurons 
are photoreceptors (PR), bipolar cells (BP), ganglion cells (GC), horizontal cells 
(HC), and amacrine cells (AC). All cells of the neural retina derive from 
multipotent progenitor cells. Photoreceptors are capable of phototransduction. 
There are two types of light-receptor cells in the retina-rods (about a billion) and 
cones (about 6 million) (Osterberg, 1935). Rods are responsible for our vision in 
dim light, and cannot discriminate colors. Cones are responsible for color vision, 




with two different cellular compartments: the outer segment (OS) contains 
hundreds of membranous disks, containing rhodopsin, and inner segment 
contains nucleus and mitochondria. Bipolar cells are situated in the inner nuclear 
layer and convey information from the outer plexiform cells to the inner retina. 
They have a cell body from which two sets of processes arise. Dendritic processes 
of bipolar cells make synapses with photoreceptors and horizontal cells in the 
outer plexiform layer and their axon terminals contact with amacrine and 
ganglion cells in the inner plexiform layer. Horizontal cells function in 
modulating signaling between photoreceptors and bipolar cells. Amacrine cells 
modulate 70 % of input to retinal ganglion cells (RGCs). Bipolar cells, which are 
responsible for the other 30 % of input to retinal ganglia, are regulated by 
amacrine cells. Ganglion cells are found in inner most layer of the retina. 
Ganglion cells send messages to the brain in the form of action potentials, which 
are influenced by amacrine cells and bipolar cells. 
Glial cells are non-neuronal cells. Generally, the mammalian retina 
consists of three types of glial cells- microglial cells, astrocytes and Müller (radial 
glial) cells. Microglial cells are the blood-derived resident immune cells in the 
retina that have an essential role in host protection against invading 
microorganisms, launching inflammatory processes, and tissue repair. In species 
with completely or locally vascularized retinae, astrocytes are also situated in 
these innermost retinal layers. The Müller cells are the principal glial cells of the 






Figure 4: Structure of the eye. A a schematic draw of the eye. B a cross section of the whole retina stained with DAPI (4',6-
diamidino-2-phenylindole) to stain the nuclei and viewed under epifluorescence. C a cross retinal section viewed under 







Retinal cells are arranged in precise order, conserved in many species 
(Cepko, 1993). The mature retina is highly organized structure. The 
photoreceptor layer (PRL) consists of the inner and outer segments of rod and 
cone photoreceptors.  
 
Figure 5: Retinal section showing the location of the retinal pigment epithelium 
(RPE) (Simo, 2010) 
The outer nuclear layer (ONL) is made up of the cell bodies of rod and 
cone photoreceptors. The outer plexiform layer (OPL) is composed of axons of 
rod and cones and the dendrites of horizontal and bipolar cells. The inner nuclear 
layer (INL) contains cell bodies of horizontal, bipolar, amacrine, Müller glia and 




and amacrine cells as well as dendrites of ganglion cells. The ganglion cell layer 
(GCL), has cell bodies of ganglion cells and displaced amacrine cells and 
astrocytes. The axons of the ganglion cells form the nerve fiber layer. They pass 
through the retina, collect in a bundle at the optic disc, and leave the eye to form 
the optic nerve. 
The retinal pigment epithelium (RPE) is the outermost monolayer of 
tightly connected hexagonal cells between the light sensitive outer segments and 
the choroid blood supply. RPE plays critical role in the physiology of the 
underlying photoreceptors which include differentiation and survival of 
photoreceptors and a crucial target of injury in AMD (Figure 6).  
 
Figure 6: Summary diagram of the major functions of the RPE (Strauss, 2005) 
 
The RPE is essential for development and maintenance of the neural 
retina (Raymond and Jackson, 1995). RPE participates in the formation of the 
blood retina barrier and controls the transport of ions and metabolites (Miller 
and Steinberg, 1979). RPE cells continuously ingest the shed discs of 
photoreceptor outer segments by phagocytosis. It is believed that a reduced 




initiating the chain of events leading to the onset of A in the older population. 
RPE degeneration is one of the initial events that occur in AMD (Kopitz, 2004; 
Nowak, 2006; Young, 1987). 
Blood supply to the mammalian retina is carried out by the choroidal 
blood vessels and the central retinal artery. The choroid receives the most blood 
flow (65-85 %) (Henkind, 1979) and is vital for the maintenance of the outer 
retina (particularly the photoreceptors). The remaining 20-30 % flows to the 
retina through the central retinal artery from the optic nerve head to nurture the 
inner retinal layers. 
Retinal Diseases  
The retina is vulnerable to a variety of diseases, including AMD, diabetic 
retinopathy (DR), retinitis pigmentosa (RP) and other hereditary retinal 
degenerations, uveitis, retinal detachment, and eye cancers (ocular melanoma 
and retinoblastoma). The leading reason for visual loss among elderly persons is 
AMD, which has an increasingly significant social and economic impact in the 
United States. 
AMD is a retinal degenerative disease associated with aging that 
progressively abolishes sharp, central vision (Figure 7). AMD is a global epidemic 
with an estimated incidence of 30 to 50 million (Kawasaki, 2010; Nirmalan, 
2004; Rein, 2009; Smith, 2001). This disease is characterized by progressive cell 
damage that targets the choroid, RPE and retina. The burden of AMD to 
individuals and society is likely to go up as consequence of increased life 





Figure 7: Normal vision and the same scene as viewed by a person with age-related 
macular degeneration (Courtesy: National Eye Institute, National Institutes of 
Health) 
AMD is the most common cause of irreversible vision loss in elderly 
population (Evans, 2001; Klein, 1998; Mitchell, 1995; VanNewkirk, 2000) and 
accounts for half of all new cases of registered blindness (Evans and Wormald, 
1996). Although AMD is considered as a disease of just the elderly, in fact, even 
middle-aged individuals are at risk. A 50-year-old American woman is four times 
more likely to be diagnosed with AMD than breast cancer before reaching 55 
(Klein, 1997; Rein, 2009). 
Accumulation of extracellular deposits known as drusen (Figure 8), are 
often associated with pigmentary abnormalities (early AMD). Drusen located 
between the RPE and Bruch’s membrane (BM) is considered as a major hallmark 
of AMD (Green and Enger, 1993; Sarks, 1980). Early studies suggested and 
recent studies confirmed that degeneration of the RPE, initiated by membranous 
debris shed from its basal surface leads to drusen formation (Anderson, 2004; 
Anderson, 2002; Burns and Feeney-Burns, 1980; Farkas, 1971; Green and Key, 
III, 2005; Hageman and Mullins, 1999; Ishibashi, 1986a; Kliffen, 1997; Mullins, 





Figure 8: Drusen. H&E stain shows sub-RPE deposition (The University of Iowa 
Department of Ophthalmology & Visual Sciences; Age-Related Macular 
Degeneration/Age-Related Maculopathy: A Histopathologic Analysis. Elizabeth A. 
Faidley, Jessica M. Skeie, and Robert F. Mullins, PhD) 
Drusen may raise the risk of developing AMD (Green, 1999). Drusen are 
composed of acute phase proteins, complement components, apolipoproteins, 
lipids, polysaccharides, cholesterol in unesterified and esterified forms along with 
various other molecules (An, 2006; Curcio, 2005a; Curcio, 2005b; Li, 2007; 
Malek, 2003; Rudolf and Curcio, 2009). Aβ accumulation has also been 
demonstrated to be associated with drusen in eyes from AMD patients (Dentchev, 
2003; Johnson, 2002; Luibl, 2006), mice models for AMD (Malek, 2005) and in 
RPE cells (Yoshida, 2005). Aβ immunization may be a pertinent therapeutic 
approach for both AD and AMD (Ding, 2008; Ding, 2011). 
Advanced AMD includes geographic atrophy (dry AMD) and choroidal 
neovascularization (wet AMD) (Figure 10). Patients complain of distorted vision 




vision, an area of depressed vision corresponding with the point of fixation and 
interfering with central vision (central scotoma). Geographic atrophy is a 
common type of late AMD in the European population, whereas exudative AMD 
is a major type of late AMD in the Asian population. 
 
 
Figure 9: The normal macula compared to wet and dry macular degeneration 








Figure 10: Classification of age-related macular degeneration. (Cook H L Br Med 
Bull 2008; 85:127-149) 
Presently, there are no effective treatments for early AMD. Treatments for 
late-stage disease are limited to photodynamic therapy with benzoporphyrin 
(verteporfin, Visudyne; Novartis, Basel, Switzerland) (Treatment of Age-related 
Macular Degeneration With Photodynamic Therapy Study Group, 1999), macular 
translocation, and antivascular endothelial growth factor drugs such as 
pegaptanib (Macugen; Pfizer, New York, NY),(Gragoudas, 2004). An aptamer 
targeting vascular endothelial growth factor (VEGF)-A; ranibizumab (Lucentis; 
Genentech, South San Francisco, CA), an anti–VEGF-A antibody Fab fragment; 
bevacizumab (Avastin; Genentech), a full-length anti–VEGF-A antibody, have 
essentially changed the clinical management of choroidal neovascularization 




2006; Gragoudas, 2004; Hooper and Guymer, 2003; Mordenti, 1999; Rosenfeld, 
2006; Tufail, 2010). 
AMD’s social and economic factors, unclear pathogenesis and limited 
existing therapies, has driven researchers to carry out studies designed to identify 
risk factors. 
Large epidemiologic studies investigating risk for AMD (Connell, 
2009) 
 
 Beaver Dam Eye Study, USA (1988–2005), Cross-Sectional, Prospective 
(Klein, 2001; Klein, 1997; Klein, 1999; Klein, 2002; Klein, 2007; LeClaire, 
1998) 
 Blue Mountains Eye Study, Australia (1992–2004), Cross-Sectional, 
Prospective (Mitchell, 1995; Mitchell, 2002; Tomany, 2004)  
 Rotterdam Study, Holland (1990–2004), Cross-Sectional, Prospective 
(Klaver, 2001; Smith, 2001; Tomany, 2004; van Leeuwen, 2003)  
 Pathologies Oculaires Liees a L’Age, France (1995–2000), Cross-Sectional, 
Prospective (Delcourt, 1999; Delcourt, 2005) 
 Los Angeles Latino Eye Study, USA (2000–2003), Cross-Sectional 
(Varma, 2004) 
 Melbourne Visual Impairment Project, Australia (1992-1999), Cross-
Sectional, Prospective (McCarty, 2001; Mukesh, 2004) 
 Reykjavik Eye Study, Iceland (1996–2001), Cross-Sectional, Prospective 
(Arnarsson, 2006; Jonasson, 2003; Jonasson, 2005)  




 Copenhagen City Eye Study, Denmark (1986–2002), Cross-Sectional, 
Prospective (Buch, 2001; Buch, 2005a; Buch, 2005b) 
 Andhra Pradesh Eye Disease Study, India (1996–2000), Cross-Sectional 
(Krishnaiah, 2005) 
 Barbados Eye Studies Barbados (1987–2003), Cross-Sectional, 
Prospective (Hyman, 2001) 
 Salisbury Eye Evaluation Project, USA (1993), Cross-Sectional, (Bressler, 
1989) 
 Proyecto VER, USA (1997–1999), Cross-Sectional (Munoz, 2005) 
 Baltimore Eye Survey, USA (1985–1988), Cross-Sectional (Friedman, 
2004) 
 Aravind Comprehensive Eye Survey, India (1995–1997), Cross-Sectional 
(Nirmalan, 2004) 
 European Eye Study, 7 European Countries (2000–2003), Cross-Sectional 
(Augood, 2006) (Chakravarthy, 2007) 
 Hisayama Study, Japan (1998–2003) Cross-Sectional, Prospective 
(Miyazaki, 2003; Miyazaki, 2005) 
 Framingham Eye Study, USA (1973–1975), Cross-Sectional (Kahn, 1977a; 
Kahn, 1977b) 
 National Health and Nutrition Examination Survey I, USA (1971–1972), 
Cross-Sectional (Goldberg, 1988) 
 National Health and Nutrition Examination Survey III, USA (1988–1994), 




 Cardiovascular Health Study USA, (1997–1998), Cross-Sectional (Klein, 
2003a; Robman, 2004) 
 Atherosclerosis Risk in Communities Study, USA (1993–1995), Cross-
Sectional (Cheung, 2007; Grosso, 2007) 
 MRC Trial of Assessment and Management of Older People in the 
Community, UK (1996–2000), Cross-Sectional (Evans, 2001) 
Risk factors examined in the epidemiologic studies 
Genetic predisposition 
 Family history of age related maculopathy (ARM), Complement Factor H 
gene, Apolipoprotein E gene, LOC gene 
Cardiovascular disease 
 Clinical Evidence of Atherosclerosis 
o Angina/Heart attack/Stroke 
 Subclinical evidence of atherosclerosis 
o Carotid atherosclerosis, Aortic atherosclerosis 
 Cigarette smoking 
 Diabetes mellitus 
 Hypertension and associated disease 
 Ischemic cerebral white matter changes, Abnormalities of the retinal 
vasculature 
 Cholesterol 
o Total cholesterol, Low-density Lipoprotein (LDL) cholesterol, High-





 Female sex hormones 
o Endogenous estrogen exposure 
 Age at menarche, Age at menopause, Number of pregnancies 
o Exogenous estrogen exposure 
 Oral contraceptives, Hormone replacement therapy 
 Novel risk factors for atherosclerosis 
o Lipid-related Factors 
 Apolipoproteins, Lipoproteins 
o Inflammatory markers 
 C-reactive protein, Interleukins, Serum Amyloid A, Vascular 
and Cellular Adhesion Molecules, White Blood Cell Count 
o Homocysteine/Folate/Vitamin B12/Vitamin B6 
o Infectious agents 
 Cytomegalovirus, Helicobacter pylori, Chlamydia pneumonia 
Indicators of Inflammation 
 Systemic Diseases with Inflammatory Components 
o Gout, Emphysema 
 Anti-inflammatory Medications 
o Nonsteroidal anti-inflammatory drugs (NSAIDs), Steroids 
 Markers of Systemic Inflammation 
o White Blood Cell Count, Serum Albumin, Plasma Fibrinogen, C-
reactive protein (CRP), Complement Factor H Y402H 





Markers of Endothelial Dysfunction 
 Intercellular Adhesion Molecule-1, E-Selectin 
Indicators of Oxidative Stress 
 Anti-oxidants 
o Vitamin C, Vitamin E, Vitamin A, 
o Carotenoids 
 Lutein, Zeaxanthin, α- and β-Carotene, β–Cryptoxanthin, 
Lycopene 
o Enzymes 
 Plasma Glutathione Peroxidase, Superoxide Dismutase 
o Trace Elements 
 Zinc 
 Pro-oxidant status 
o Dietary fat intake 
 Total fat, Saturated fat, Polyunsaturated fat, Fish/Fish oils 
o Visible Light Exposure 
 Sunlight, Ultraviolet-B 
Ocular Factors 
 Refractive Error 
 Emmetropia, Myopia, Hypermetropia 





o Nuclear Sclerosis, Cortical Lens Opacities, Posterior Subcapsular 
Cataracts 
 Cataract Surgery 
Miscellaneous Factors 
 Alcohol Consumption 
o Beer, Wine, Spirits 
 Medication Use 
o E2, Lipid-lowering agents, CNS medications, NSAIDs, Anti-
hypertensive medications 
 Coffee Consumption 
 Frailty 
 Physical Activity 
This study concentrated on one of the above mentioned risk factor which is 
cholesterol. The pathogenesis of AMD is still not clarified completely. Among 
these factors, cholesterol metabolism is believed to contribute since cholesterol 
accumulation in Bruch's membrane is implicated in the etiology and progression 
of AMD (Chen, 2010; Curcio, 2005a; Curcio and Millican, 1999; Curcio, 2005b; 
Klein, 2003b; Neale, 2010). 
Cholesterol, oxysterols, and Alzheimer’s disease 
Cholesterol is an essential component of cellular membranes of most vertebrates. 
 It is essential for various cellular functions, including the maintenance of 
appropriate membrane permeability and fluidity, as well as the regulation of 




2000). Cholesterol homeostasis is maintained by the interplay between synthesis, 
uptake, and degradation. 
Oxysterols are oxygenated derivatives of cholesterol. Because excess free 
cholesterol is toxic to the cell, maintaining narrow limits of cellular cholesterol 
levels is crucial for cell health (Feng, 2003; Tabas, 2002). Cellular cholesterol 
homeostasis is sensitive to the level of cholesterol and to oxygenated derivatives 
of cholesterol, termed oxysterols. 
Alzheimer’s disease (AD) is one form of dementia that gradually gets 
worse over time. It affects memory, thinking, and behavior. Various studies 
including epidemiological studies showed cholesterol and AD link (Ghribi, 2008; 
Kivipelto and Solomon, 2006; Sparks, 1994; Wolozin, 2004). Studies show that 
increased plasma cholesterol levels are associated with atherosclerosis and 
increased risk of dementia, including AD (Kivipelto and Solomon, 2006; 
Solomon, 2009). Accumulations of Aβ and tau proteins are characterstic of the 
disease.  
Cholesterol-fed rabbit as a model of AD 
Rabbits have been used in atherosclerosis studies because they exhibit 
hypercholesterolemia quickly upon administration of a high-cholesterol diet. 
They are also highly responsive to inducement of atherosclerotic lesions similar 
to human atherosclerosis (Finking and Hanke, 1997; Yanni, 2004). Whereas the 
first indication of association between cholesterol and the accumulation of Aβ 
plaques in the brain came from studies on rabbits fed with 2 % cholesterol- diet 




accumulation of intracellular immunolabelled β-amyloid (Sparks, 1994). Our 
laboratory has been using cholesterol-fed rabbit as a model for studying AD.  
Visual problems in AD 
There is increasing evidence of a link between AD and retinal diseases 
including glaucoma and AMD, as evidenced by the deposition of Aβ peptide in 
both diseases (Guo, 2010). Visual problems have been observed even in the initial 
stages of AD (Katz and Rimmer, 1989; Sadun, 1987). Reduction in the number of 
ganglion cells and in the thickness of the nerve-fiber layer has been observed in 
AD patients (Hinton, 1986). Eyes, in particular retina is affected in AD (Berisha, 
2007; Iseri, 2006; Ning, 2008; Paquet, 2007; Parisi, 2001; Parisi, 2003; 
Shimazawa, 2008). 
AD and AMD share common pathology 
 
Intriguingly, AMD has many pathological features that are common to AD, 
including the deposition of Aβ peptide (Anderson, 2004). Aβ levels are regulated 
by generation from amyloid precursor protein (APP) upon initial cleavage by 
beta-secretase 1 (BACE-1) and degradation by enzymes that include insulin-
degrading enzyme (IDE). Aβ is suggested to play a key role in AD pathogenesis by 
triggering oxidative stress, inflammation and cell death (Querfurth and LaFerla, 
2010). Aβ accumulation has also been demonstrated to be associated with drusen 
in eyes from AMD patients (Dentchev, 2003; Johnson, 2002; Luibl, 2006), mice 
models for AMD (Malek, 2005) and in RPE cells (Yoshida, 2005). In addition to 
drusen deposits, oxidative stress, apoptosis and accumulation of Aβ peptide are 
also hallmarks of AMD (Ding, 2009). Interestingly, these hallmarks are also 




accumulation is the leading neuropathological change that correlates with the 
diagnosis of AD, and is considered a key player in the pathogenesis of AD by 
inducing oxidative stress and apoptotic cell death. The causes of AMD and AD are 
not well defined, but several factors including diet, environment, and genetic 
susceptibility likely contribute to the pathogenesis of these diseases (Ohno-
Matsui, 2011) 
Cholesterol, oxysterols and AMD  
Hypercholesterolemia is one risk factor among others for developing AMD 
(van Leeuwen, 2003). Similar to AD, the causes of AMD are not fully understood. 
The retina synthesizes cholesterol endogenously and also receives from blood 
circulation (Fliesler, 1993; Fliesler and Keller, 1997; Tserentsoodol, 2006b). The 
role of cholesterol metabolism in the pathogenesis of AMD has also been raised 
(Johnson, 2002; Mares-Perlman, 1995). Cholesterol (free and esterified) is highly 
distributed in the macular drusen in humans (Curcio, 2005b; Li, 2007; Rudolf 
and Curcio, 2009). The source of the cholesterol that accumulates in the retina is 
suggested to derive from both local cells and plasma origins (Curcio, 2001; Holz, 
1994; Malek, 2003; Trivino, 2006). The relative contributions of LDL-derived 
cholesterol and endogenously synthesized cholesterol to total retinal cholesterol 
are unknown. 
Epidemiological and animal studies have suggested a link between high 
plasma cholesterol levels and AD (Solomon, 2009). As well, high intake of 
cholesterol and saturated fat have long been suspected to increase the risk for 
AMD (Mares-Perlman, 1995). Because of the putative links between cholesterol 




cholesterol homeostasis in the brain and retina is now drawing more attention. 
Although, there is no consensus on the association of plasma lipid levels and 
AMD, two recent genome wide association studies implicated cholesterol 
metabolism involvement in AMD (Chen, 2010; Neale, 2010). In AMD, drusen 
accumulation on Bruch's membrane exhibit increased deposition of lipids, 
including cholesterol. Drusen contains histochemically detectable lipid (Curcio, 
2001; Curcio, 2005b; Haimovici, 2001; Wang, 2010; Wolter and Falls, 1962) 
including cholesterol in 2 chemical forms, unesterified (UC) and esterified to a 
long chain fatty acid (EC) (Curcio, 2005a). Various laboratories showed changes 
in intraretinal and epiretinal capillary endothelial cells, an increase in lipids, 
ultrastructural changes similar to AMD in the retinas of cholesterol-fed rabbits 
(Miceli, 2000; Ong, 2001; Ramirez, 2006; Salazar, 2007; Trivino, 2006). In one 
study where authors substituted the hyperlipemic diet with standard one 
normalized the blood-lipid levels and decreased ocular lipid build-up. However, 
ocular damage regression was partial (Ramirez, 2006). 
Oxysterols are oxygenated derivatives of cholesterol that have diverse 
physiological and biochemical functions like cholesterol homeostasis, cell 
differentiation, apoptosis, modulation of vesicular movement, regulation of 
nuclear receptors and calcium transport and also involved in many diseases 
because abnormal oxysterol levels can cause oxidative stress, inflammation and 
apoptotic cell death (Ares, 2000; Bjorkhem, 2002; Chen, 2002; Fang, 1996; 








Measure of risk factor Type of ARM 
 
Odds ratio or 
relative risk 
 
95 % confidence 
interval 
Cross-Sectional Studies      
Cardiovascular Health Study 
(Robman, 2004) 
2361 Serum total cholesterol 
(per 10 mg/dL increase) 
ARM 0.95 0.91–0.98 
National Health and Nutrition 
Examination Survey III (Goldberg, 
1988) 
8270 HDL cholesterol (per 
mmol/L) 
Early ARM 1.30 0.99–1.71 
Triglycerides (per mmol/L) Soft drusen 0.88 0.79–0.99 
Pathologies Oculaires Liees a L'Age 
(Delcourt, 2001) 
2584 Cholesterol (per mmol/L) Soft drusen 1.07 0.97–1.17 
Late ARM 0.97 0.71–1.31 
  HDL Cholesterol (per 
mmol/L) 
   







Measure of risk factor Type of ARM 
 
Odds ratio or 
relative risk 
 
95 % confidence 
interval 
2001) Late ARM 1.08 0.92–1.27 
Prospective studies      







Rotterdam Eye Study (van Leeuwen, 
2003; van Leeuwen, 2004) 
4776 Serum Cholesterol (per 10
mg/dL) 
Early ARM 0.96 0.84–1.09 
HDL Cholesterol (per 
mmol/L) 








Ares, 2000; Bjorkhem, 2002; Chen, 2002; Fang, 1996; Hanley, 2000; Hayden, 
2002; Javitt and Javitt, 2009; Joffre, 2007; Komuves, 2002; Ong, 2003; Panini 
and Sinensky, 2001; Riendeau and Garenc, 2009; Smith and Johnson, 1989; 
Vejux, 2008). 
Oxysterols result from either autoxidation or enzymatic oxidation of 
cholesterol (Figure 11). While 7-KC is the major oxysterol generated by 
autoxidation on the B hydrocarbon ring of cholesterol, 24-OHC, 25-OHC and 27- 
27-OHC are major oxysterols produced by enzymatic oxidation on the lateral 
chain of the cholesterol structure. Oxysterols have been implicated in the process 
of aging and degenerative diseases of the human eye (Girao, 1998; Lutjohann, 
2000; van den Kommer, 2009). It was demonstrated that cholesterol oxides are 
toxic to primary cell cultures obtained from rat neuroretinas (Chang and Liu, 
1998). Oxysterols, 25-OHC and 7-KC are shown to induce oxidative stress, 
apoptosis and are cytotoxic to R28 neuroretinal and ARPE-19 retinal pigment 
epithelium cell lines (Ong, 2003).  
Several studies started revealing some aspects of oxysterol formation and 
function in retina and RPE (Joffre, 2007; Moreira, 2009; Rodriguez and Fliesler, 
2009). Currently, the mechanisms by which cholesterol may increase the 
incidence of AMD are not clear. Several lines of evidence suggest that oxidized 
cholesterol metabolites (oxysterols) may be the link by which cholesterol 
contributes to the pathogenesis of AMD. The oxysterol pathway has been 
proposed as a unifying hypothesis for the cause of AMD (Javitt, 2007; Javitt, 
2008; Javitt and Javitt, 2009). 25-OHC and 7-KC are major oxysterols in 




primate retina suggested oxysterol involvement in AMD development (Moreira, 
2009). 7-KC treated ARPE-19 showed some of the characteristics of apoptosis 
(Luthra, 2006). 
 
Figure 11: Cholesterol metabolites. Primary cholesterol oxygenation reactions 
mediated by different cytochrome P-450 species or occurring nonenzymatically in 
the presence of reactive oxygen species (Bjorkhem, 2002) 
Cytotoxicity of oxLDL on RPE cells was shown to be dependent on 7-KC 
formation (Rodriguez, 2004). 7-KC and 25-OHC showed to have cytotoxic, pro-
oxidative, and/or angiogenic activities on ARPE-19 cells (Dugas, 2010). 
Oxysterols, Estrogen Receptor, and Liver X Receptor  
 27-OHC has been demonstrated to bind to both ER and LXR (Fu, 2001; 




endogenous selective ER modulator that has agonist activity in breast cancer cells 
and antagonistic activity in cardiovascular system (DuSell, 2008; Umetani, 
2007). 27-OHC is shown to be an endogenous ligand for LXR in cholesterol-
loaded cells (Fu, 2001). 25-OHC shown to inhibit E2 activation of ER, whereas 
also elicits estrogenic effects in cancer cells and cardiomyocytes (Lappano, 2011). 
25-OHC is revealed to be natural endogenous ligand for LXRs (Chen, 2007; 
Janowski, 1996). Inability of 7-KC to antagonize ERs, and E2 dependent nitric 
oxide synthase (NOS) activity was also shown (Umetani, 2007). 7-KC has been 
described as an LXR agonist (Janowski, 1999). 7-KC mediated induction of VEGF 
was attenuated by an LXR antagonist cholesterol sulfate, suggesting LXR 
involvement (Moreira, 2009).  
Dissertation work 
Previous studies in our laboratory showed that cholesterol-enriched diets 
increase Aβ levels, oxidative stress and cell death in rabbit brains. Since 
cholesterol enriched diet leads to AD like pathology and retinal degeneration is 
widely witnessed in AD, retinal modifications in cholesterol-fed rabbits were 
investigated.  
Our laboratory and others suggested oxysterols may be the link between 
high cholesterol diet and AD like pathology in these cholesterol-fed rabbits. 27-
OHC induces AD-like pathology by increasing Aβ production and triggering 
apoptotic cell death in human neuroblastoma SH-SY5Y cells (Prasanthi, 2009; 
Rantham Prabhakara, 2008) and in organotypic slices from rabbit hippocampus 




As 27-OHC shown to cause AD-like pathology by increasing Aβ production 
and triggering apoptotic cell death in human neuroblastoma SH-SY5Y cells and 
in organotypic slices from rabbit hippocampus, this dissertation work focused on 
influence of 27-OHC on pathological hallmarks that are common to both AMD 
and AD by using the human retinal pigment epithelial cell line, ARPE-19. 
Various studies suggested E2 may play an important role in AMD 
development. 27-OHC is the first identified endogenous selective estrogen 
receptor modulator. LXR, to which 27-OHC is a ligand, is also implicated in AMD 
development. 25-OHC and 7-KC are also implicated in AMD development. 25-
OHC and 7-KC were shown to be ligands of ER and LXR in various cell types. 
The existence of ERα, ERβ, LXRα and LXRβ in ARPE-19 cells was 
investigated. ER and LXR functional activity studied using dual luciferase 
reporter assays. 27-OHC, 25-OHC and 7-KC influence on ER-responsive 
luciferase activity and LXR-responsive luciferase activity was evaluated. Potential 
beneficial or detrimental effects of ER agonist E2, antagonist ICI182780 (ICI), 
LXR agonist GW3965 (GW), and antagonist 5α-6α-epoxycholesterol-3-sulfate 













This chapter lists all chemicals, methods, and instruments for all cell 
culture experiments and animal experiments that were used in the dissertation. 
Material    Company 
25-hydroxycholesterol  Steraloids, Wilton, NH 
27-hydroxycholesterol  Medical Isotopes Inc, Pelham, NH 
7-ketocholesterol   Sigma Aldrich, St Louis, MO 
2-Mercaptoethanol   Bio-Rad, Herculus, CA 
35 mm glass bottom  MatTek Corp, Ashland, MA 
culture dishes    
    
5α-6α-epoxycholesterol-3-sulfate Steraloids, Wilton, NH  
75 cm2 flasks, 6, 96-well plates Corning, Corning, N. Y 
Alcoholic Z-Fixative   Excalibur Pathology, Moore, OK, USA 
Ammonium persulfate  Amresco, Solon, OH 
Amplex Red Hydrogen  Invitrogen, Carlsbad, CA 
Peroxide/ Peroxidase assay  
 
ARPE-19 cell line   ATCC, Manassas, VA 
Aβ1-42 and Aβ1-40 ELISA   Invitrogen, Carlsbad, CA 
BCA assay    Pierce Chemical Co, Rockford, IL 




CCD imaging system  Compix Inc, Cranberry, PA 
Cell counter    Invitrogen, Carlsbad, CA 
Centrifuge IEC Multi RF, Thermo Electron Corporation, 
Waltham, MA 
 
Cholesterol/cholesteryl ester  BioVision, Mountain View, CA 
quantification kit    
 
Chow     Harlan Teklad Global Diets, Madison, WI 
Confocal system   Zeiss, Thornwood, NY, USA 
Cyto Tox-ONE Homogenous Promega, Madison, WI 
membrane integrity assay kit  
 
Dichlorofluorescein diacetate Sigma Aldrich, St Louis, MO 
DMEM/F12 Glutamax media  Gibco Laboratories, Grand Island, NY 
DMSO    Sigma Aldrich, St Louis, MO 
Dounce glass homogenizer  Wheaton, Millville, NJ 
Dual luciferase assay  Promega, Madison, WI  
Dulbecco's PBS   Invitrogen, Carlsbad, CA 
Enhanced chemiluminescence Bio-Rad, Hercules, CA 
Western blotting substrate    
 
ER reporter, LXR reporter  SABioscience, Frederick, MD, USA 
Ethanol 200 proof, anhydrous Sigma Aldrich, St Louis, MO 
FBS     Atlanta Biologicals, Norcross, GA 
Fura-2AM    Calbiochem, La Jolla, CA 
Gel electrophoresis system  Bio-Rad, Hercules, CA 
Glycine    Bio-Rad, Hercules, CA 
GSH- Glo assay Kit   Promega, Madison, WI  




CO2 incubator   Shell Lab, Sheldon Manufacturing, USA 
JC-1 assay    Biotium, Hayward, CA 
Laemmli sample buffer  Bio-Rad, Hercules, CA 
Laminar flow cabinet Labgard classII, typeA2, NuAire, Inc., 
Plymouth, MN 
 
Lipofectamine LTX and PLUS  Invitrogen, Carlsbad, CA 
MPER     Promega, Madison, WI 
Methanol    BDH Chemicals, Poole, England 
Microplate reader   Molecular Devices, Menlo Park, CA 
Microscope Zeiss Invertoskop 40C, Carl Zeiss, Thornwood, 
NY 
 
Milk     Bio-Rad, Hercules, CA 
Ms TNF-α ELISA   Invitrogen, Carlsbad, CA 
NE-PER extraction kit  Thermo Scientific, Rockford, IL 
NEXT GEL Solution  Amresco, Solon, OH 
Opti-MEM serum free media Invitrogen, Carlsbad, CA 
Orka imaging camera  Hamamatsu Photonics, Hamamatsu, Japan 
PCI software    Compix Inc, Cranberry, PA 
Paraffin    McCormick Scientific, St. Louis, MO 
Penicillin, Streptomycin  Sigma Aldrich, St Louis, MO 
pH meter    SympHony, VWR Scientific Products, USA 
PowerPac Basic Power Supply Bio-Rad, Hercules, CA 
Protease and phosphatase  Thermo Scientific, Rockford, IL 
PVDF membrane   Bio-Rad, Hercules, CA  




TEMED    Bio-Rad, Hercules, CA 
Tris     Bio-Rad, Hercules, CA 
Trypsin    Invitrogen, Carlsbad, CA 
T-PER extraction kit  Thermo Scientific, Rockford, IL 
TUNEL assay   Promega, Madison, WI 
ARPE-19 cell culture 
ARPE-19 (human retinal pigment epithelial cells – ATCC-CRL-2302) are 
spontaneously arising retinal pigment epithelial cells derived from the normal 
eyes of a 19-year-old male who died from head trauma in a motor vehicle 
accident. It was established in 1986 by Amy Aotaki-Keen and is the only human 
RPE cell line available for research. These cells form stable monolayer, which 
display morphological and functional polarity. ARPE-19 cells express the RPE-
specific markers cellular retinaldehyde-binding protein (CRALBP) and retinal 
pigment epithelium-specific 65 kDa protein (RPE-65) (Dunn, 1996). Cells were 
grown in Dulbecco's modified eagle medium: Nutrient mixture F-12 (DMEM/F-
12) glutamax media with 10 % fetal bovine serum (FBS) and standard antibiotics 
(100 IU/mL penicillin, and 100 μg/mL streptomycin in a 5 % CO2, 37 °C 
incubator. Media containing FBS and antibiotics was changed twice weekly. Cell 
cultures were routinely subcultivated in the ratio of 1:3 by trypsinization followed 
by phosphate buffered saline (PBS) wash (NaCl-137 mmol/L, KCl-2.7 mmol/L, 
Na2HPO4 2 H2O-10 mmol/L, KH2PO4-2.0mmol/L; pH-7.4). Complete growth 
media was added to detached cells to inactivate trypsin. After centrifuging at 125 




were transferred to 75 cm2 flasks for propagating, 6-well plates or 96-well plates 
for various assays.  
ARPE-19 cell culture treatments 
Stock solutions of 27-OHC, 25-OHC and 7-KC were prepared in 100 % 
ethanol or dimethyl sulfoxide (DMSO) and stored at -80 °C. Working 
concentrations were prepared by dissolving stock solutions in complete growth 
media. When cells reached confluency, they were treated with 0, 10 or 25 μM 27-
OHC in culture media at 37 °C for 24 h. The concentrations of the 27-OHC used 
in the present study are the same as those demonstrated to cause AD-like 
pathology in human neuroblastoma cells and in organotypic slices (Prasanthi, 
2009; Sharma, 2008). Joffre and colleagues have used concentrations up to 50 
μM of 7-KC, 24-OHC, and 25-OHC (Joffre, 2007). For experiments involving ER 
and LXR ligands cells were treated with 10 μM 25-OHC, 10 μM 25-OHC+10nM 
E2, 10 μM 25-OHC+1 μM ICI182780, 10 μM 25-OHC+1 μM GW3965, 10 μM 25-
OHC+1 μM ECHS; 10 μM 27-OHC, 10 μM 27-OHC+10nM E2, 10 μM 27-OHC+1 
μM ICI 182780, 10 μM 27-OHC+1 μM GW3965, 10 μM 27-OHC+1 μM ECHS; 25 
μM 7-KC, 25 μM 7-KC+10nM E2, 25 μM 7-KC+1 μM ICI182780, 25 μM 7-KC+1 
μM GW3965, 25 μM 7-KC+1 μM ECHS, 10nM E2, 1 μM ICI182780, 1 μM 
GW3965, 1 μM ECHS in complete growth media for 24 h at 37 °C. Antagonists 
were added 2 h before agonists’ addition. 
Animals and treatments 
Male New Zealand white rabbits (1.5-2 years old, 3-5 kg), housed 
separately in cages in a room with 12 h dark/light cycle, were randomly assigned 




supplemented with 2 % cholesterol. Rabbits fed with cholesterol-enriched diet 
and their matched controls were euthanized with pentobarbital after 12 weeks. At 
necropsy, rabbits were perfused with Dulbecco's phosphate-buffered saline and 
the eyes were promptly enucleated. Retinal homogenates were made from one 
eye of each animal, and the other was immediately placed in a fixative solution 
for paraffin embedding. Retinal homogenates were used for Western blotting, 
ELISA, DCFH-DA, Amplex Red, and mass spectrometry studies. All animal 
procedures were carried out in accordance with the U.S. Public Health Service 
Policy on Humane Care and Use of Laboratory Animals and were approved by the 
Institutional Animal Care and Use Committee.  
Paraffin embedding of eyes  
At necropsy, rabbits were perfused with Dulbecco's PBS and the eyes were 
promptly enucleated, and kept in alcoholic Z-fixative, then embedded in paraffin. 
7 μm eye cross sections were made from paraffin embedded eyes. Sections were 
placed on slides, and used for immunohistochemistry.  
Total cholesterol quantification 
Total cholesterol levels in the control and cholesterol-fed rabbit retina 
samples were quantified by colorimetric detection using cholesterol/cholesteryl 
ester quantification kit as per the manufacturer's instructions. Cholesterol was 
extracted from the retina samples in a solution containing a mixture of 
chloroform: isopropanol: NP-40 (7:11:0.1). The extract was centrifuged at 15,000 
× g for 10 min and the organic phase was transferred to a new tube. The organic 
phase liquid was air dried at 50 °C to remove chloroform and subjected to 




dissolved in 200 μL of cholesterol assay buffer provided with the kit until the 
samples were homogeneous by either sonicating or vortexing. Standards were 
prepared as per the manufacturer's instructions. 1 μL of the extracted sample 
adjusted to 50 μL/ well with cholesterol assay buffer was used per assay. 50 μL of 
the reaction mix (containing 44 μL of cholesterol assay buffer, 2 μL of cholesterol 
probe, 2 μL of cholesterol enzyme mix and 2 μL of cholesterol esterase all 
provided in the kit) was added to each well containing standards and samples. 
After 1 h reaction at 37 °C the absorbance was read at 570 nm. The concentration 
of cholesterol in each sample was calculated using the standard curve and 
expressed as mg/g tissue. 
Oxysterol levels measurement 
Extracted retinas were shipped to Dr. David Russell’s laboratory, the 
University of Texas Southwestern Medical Center at Dallas, TX, USA. Oxysterols 
were quantified in retinas from control (n = 3) and cholesterol-fed (n = 3) rabbits 
using a 4000 QTRAP liquid chromatography mass spectrometer (Applied 
Biosystems) as described in (McDonald, 2007).  
Protein extraction  
After treatment with indicated concentrations and times, cells were 
washed with Dulbecco’s PBS, then harvested on ice with a mammalian protein 
extraction reagent (M-PER). Whereas tissue protein extraction reagent (T-PER) 
was used for extracting proteins from cholesterol-fed and control rabbit retinas. 
M-PER and T-PER were supplemented with protease and phosphatase 
inhibitors. Nuclear extracts were prepared by using NE-PER extraction kit. 




Equal amount of Laemmli sample buffer with 2-mercaptoethanol was added to 
the samples and were boiled for 10 min at 100 oC. 
SDS-PAGE and Western blotting 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
was used to separate proteins according to their electrophoretic mobility (a 
function of the length of a polypeptide chain and its charge). SDS binds to amino 
acids of the reduced protein and provides negative charge. Separation of the 
proteins by PAGE is mainly by size or molecular weight as they pass through 
acrylamide gel. 
The Bio-Rad Mini-PROTEAN Tetra 4-gel vertical electrophoresis system 
was used for SDS-PAGE. A ready-to-pour SDS-PAGE acrylamide solution 
without a stacking gel was used. Various percentages of New Electrophoresis 
X'PRESS Technology (NEXT) gels were used for various molecular weight 
protein separations, described in the following table.  
NEXT GEL 5 % Solution 30-500 kDa 
NEXT GEL 7.5 % Solution 20-300 kDa 
NEXT GEL 10 % Solution 10-200 kDa 
NEXT GEL 12 % Solution 3.5-100 kDa 
Ammonium persulfate (APS) and Tetramethylethylenediamine (TEMED) 
were added to catalyze the polymerization of acrylamide solutions into gel 
matrices. 10 μg samples and protein molecular weight marker were separated on 
SDS-PAGE gels at a constant voltage of 150V. 20X SDS-PAGE running buffer 
provided by the manufacturer was diluted to 1X in distilled water and used for 




transfer buffer (25 mM Tris, 192 mM glycine) for 5 min. Polyvinylidene difluoride 
(PVDF) membranes are activated by methanol. Then gels were electrotransferred 
at constant voltage of 80 V for 2 h onto a PVDF membrane by using transfer 
buffer. After transfer, to block non-specific binding sites on the membrane 
surface, PVDF membranes were incubated in 5 % (5 g in 100 mL) non-fat milk 
solution in 1x T-TBS (25 mM Tris, 192 mM glycine, 0.5 % Tween-20) for 1 h at 
room temperature. After blocking, membranes were incubated overnight at 4 oC 
with primary antibodies at indicated concentrations. 
Primary Antibodies used for Western blotting 
Antibody Dilution  Manufacturer 
Mouse anti-ABCA-1 1:100 Neuromics, Edina, MN 
Mouse Anti-BACE-1 1:1000 Millipore, Bedford, MD 
Mouse anti-Bax 1:100 Santa Cruz Biotechnology, Santa 
Cruz, CA 
 
Mouse anti-Bcl-2 1:100 Santa Cruz Biotechnology, Santa 
Cruz, CA 
 
Mouse Anti-GADD153 1:1000 Abcam, Cambridge, MA 
Mouse Anti-HO-1 1:500 Assay Designs, Ann Arbor, MI 
Mouse Anti-NF-κB 1:100 Santa Cruz Biotechnology, Santa 
Cruz, CA 
 
Mouse β-actin 1:5000 Santa Cruz Biotechnology, Santa 
Cruz, CA 
 
Rabbit anti-CYP27A1 1:800 Protein Tech Group, Chicago, IL 
Rabbit anti-IDE 1:5000 Millipore, Bedford, MD 






Rat Anti-caspase 12 1:1000 Abcam, Cambridge, MA 
Rat anti-GFAP 1:200 Abcam, Cambridge, MA 
Rabbit anti-ERα 1:500 Abcam, Cambridge, MA 
Rabbit anti-ERβ  1:200 Upstate, Lake Placid, NY, USA 
Rabbit anti-LXRα 1:500 Abcam, Cambridge, MA 
Mouse anti-LXRβ 1:500 Abcam, Cambridge, MA 
After overnight incubation at 4 oC with primary antibodies, membranes 
were washed for 6 times for 10 min with T-TBS. Membranes were incubated with 
secondary antibody conjugated with horseradish peroxidase (HRP) for 1 h. 
Secondary Antibodies used for Western blotting 
Antibody Dilution  Manufacturer 
Goat anti-mouse HRP 1:5000 Bio-Rad, Herculus, CA 
Goat anti-rabbit HRP 1:5000 Bio-Rad, Herculus, CA 
Goat anti-rat HRP 1:2500 Santa Cruz Biotechnology, Santa 
Cruz, CA 
 
After incubation, membranes were washed for 6 times for 10 min with T-
TBS. Then the blots were developed with enhanced chemiluminescence Western 
blotting substrate immun-star HRP chemiluminescent kit. Bands were visualized 
on bioimaging system and analyzed by LabWorks 4.5 software (Upland, CA). 
Results were quantified by densitometry normalized to β-actin for cytosolic 
fractions or lamin A for nuclear fractions and analyzed as total integrated 






CytoTox-ONE Homogenous membrane integrity assay  
The CytoTox-ONE homogenous membrane integrity assay is a 
homogenous, fluorometric method for assessing the number of non-viable cells. 
This test quantifies released lactate dehydrogenase (LDH) from cells with a 
damaged membrane. LDH in the cell culture media was measured with a 10 min 
coupled enzymatic assay that results in the conversion of resazurin into resorfun. 
30,000 ARPE-19 cells were seeded in 96 well plates. After confluency, cells were 
treated as described in ARPE-19 cell culture treatments for 24 h. After 
incubation, plates were allowed to equilibrate at room temperature for 20 min. 2 
μL Triton X-100 provided with the kit was added to positive control wells. 
CytoTox-ONE reagent was added to all samples and incubated for 10 min. The 
reaction was stopped with stop solution, included in the kit. The plate was read 
using a plate reader at an excitation wavelength of 560 nm and an emission 
wavelength of 590 nm. The percentage of cytotoxicity was calculated by the 
following equation. 
               (Experimental-Culture medium background) 
Percent cytotoxicity= 100 x------------------------------------------------------------ 
         (Maximum LDH release-Culture medium background) 
Enzyme-Linked Immunosorbent Assay 
After treatments, conditioned media was collected. Protease and 
phosphatase inhibitors cocktail was added. The conditioned media was 
centrifuged at 16,000 × g for 5 min at 4 °C. 100 μL of supernatant was used for 
Aβ1-42 and Aβ1-40 quantification by colorimetric sandwich ELISA according to 




Aβ1-42 and Aβ1-40 levels were expressed in pg/mL. Aβ levels (Aβ1-40 and Aβ1-
42) were quantified in the retina of control and cholesterol-fed rabbits with an 
ELISA kit according to the manufacturer's protocol. Briefly, to measure the 
amount of Aβ1-40 and Aβ1-42, the wet mass of the retina was homogenized 
thoroughly with 8 × mass of cold 5 M guanidine HCl/50 mM Tris-HCl (pH=7.2). 
The homogenates were mixed for 3-4 h at room temperature and samples were 
diluted with cold reaction buffer (Dulbecco's phosphate-buffered saline with 5 % 
BSA and 0.03 % Tween-20 supplemented with 1 × protease inhibitor cocktail) 
and centrifuged at 16,000 × g for 20 min at 4 °C. The supernatant was decanted, 
stored on ice until use, diluted 1:2 with standard diluent buffer, and quantified by 
colorimetric sandwich ELISA kits. The quantity of Aβ in each sample was 
measured in duplicates. Protein concentrations of all samples were determined 
by standard BCA assay (Smith, 1985). Aβ levels were normalized to total protein 
content in the samples. 
DCFH-DA assay for measuring reactive oxygen species 
DCFH-DA, a nonfluorescent dye, is cleaved by esterase activity to yield 
DCFH, which is subsequently oxidized by a variety of ROS to form 
dichlorofluorescein (DCF), which is fluorescent. Because DCFH can be oxidized 
by various ROS, the increase of intracellular DCF fluorescence reflects an overall 
oxygen species index in cells. 30,000 ARPE-19 cells were seeded in 96 well 
plates. After confluency, cells were treated as described in ARPE-19 cell culture 
treatments for 24 h. After treatment, complete growth medium was removed and 
cells were washed with PBS. 5 μM DCFH-DA dissolved in the complete growth 




Fluorescence was read at excitation and emission wavelengths of 488 nm and 525 
nm, respectively at 0 min, 15 min, 30 min, and 60 min.  
ROS generation was measured in retinal tissue homogenates using DCFH-
DA as previously described (Bejma, 2000; Bejma and Ji, 1999; Rush, 2007). 
Retinas were homogenized in T-PER using a glass homogenizer. Samples 
containing 25 μg proteins diluted in Dulbecco’s PBS were incubated with 5 μM 
DCFH-DA. Fluorescence was measured at 0 min and every 15 min for 1 h at 
excitation and emission wavelengths of 488 nm and 525 nm, respectively, using a 
microplate reader. Values were expressed as relative fluorescence units (RFU) 
normalized per mg of protein. 
Amplex Red Hydrogen Peroxide/Peroxidase Assay 
The Amplex Red hydrogen peroxide/peroxidase assay uses the Amplex 
Red reagent (10-acetyl-3,7-dihydroxyphenoxazine) to detect H2O2 or peroxidase 
activity (Zhou, 1997). In the presence of peroxidase, the Amplex Red reagent 
reacts with H2O2 in a 1:1 stoichiometry and produces the red-fluorescent 
oxidation product, resorufin.  
Retinal homogenates of control and cholesterol-fed rabbits are diluted in 
reaction buffer and added into 96 well plates. For each well 50 μL of working 
solution containing 100 μM Amplex Red reagent and 0.2 U/mL HRP was added 
and after 30 min incubation in dark, fluorescence was measured. H2O2 standard 
curve was generated from 0 μM to 5 μM and H2O2 concentrations of retina 
samples were calculated from the standard curve. 
Similarly, for peroxidase activity determination, 100 μM Amplex Red 




incubation fluorescence was measured. Peroxidase standard curve was generated 
in the range from 0 to 2 mU/mL. Peroxidase activity of retinal samples was 
calculated from standard curve. Resorufin fluorescence was measured using a 
microplate reader with excitation at 530-560 nm and emission at 590 nm. 
JC-1 Mitochondrial Membrane Potential Detection 
Apoptosis involves genetically programmed series of events leading to cell 
death. During this process several key events occur in mitochondria including the 
loss of mitochondrial membrane potential (Green and Reed, 1998) which is an 
early event preceding phosphatidylserine externalization and coinciding with 
caspase activation. Studies have shown that apoptotic cells are present in the RPE 
of eyes with AMD, indicating that apoptosis of RPE cells could contribute to AMD 
(Cai, 1999; Ishibashi, 1986b). Fluorescent cationic dye, JC-1 was used to measure 
the loss of mitochondrial membrane potential (Smiley, 1991).  
In non-apoptotic cells, JC-1 accumulates as aggregates in the 
mitochondrial membranes, resulting in red fluorescence (590 nm) (Cossarizza, 
1993). In apoptotic cells, JC-1 exists in the green fluorescent (529 nm) 
monomeric form because of decreased mitochondrial membrane potential. JC-1 
is more specific for mitochondrial versus plasma membrane potential, and more 
consistent in its response to depolarization, than other cationic dyes such as 
DiOC6 (3) and rhodamine 123 (Salvioli, 1997).  
30,000 ARPE-19 cells were plated in 96 well plates. After confluency, cells 
were treated as described in ARPE-19 cell culture treatments for 24 h. After 
incubation, media was aspirated and cells were washed with Dulbecco’s PBS. 100 




incubation, cells were washed with PBS. 100 μL PBS was added to cells. Red 
fluorescence (excitation 550 nm, emission 600 nm) and green fluorescence 
(excitation 485 nm, emission 535 nm) was measured by a microplate reader. The 
ratio of red fluorescence divided by green fluorescence was determined. The ratio 
of red to green is decreased in dead cells and in cells undergoing apoptosis 
compared to healthy cells. 
The DeadEnd Fluorometric TUNEL System for apoptotic cell 
Detection 
 
The DeadEnd fluorometric TUNEL system was used for detection of 
apoptotic cells. Nuclear DNA fragmentation is an important biochemical 
hallmark of apoptosis. Endogenous nucleases breakdown DNA into fragments 
(Oberhammer, 1993; Schwartzman and Cidlowski, 1993). The TUNEL system 
measures fragmented DNA of apoptotic cells by catalytically incorporating 
fluorescein-12-dUTP at 3´-OH DNA ends using the enzyme terminal 
deoxynucleotidyl transferase (TdT), which forms a polymeric tail using the 
principle of the TUNEL assay.  
ARPE-19 cells were grown and treatments were carried out. After 
treatments, cells were fixed with 4 % paraformaldehyde in Dulbecco’s PBS at 
room temperature. Whereas retinal sections were deparaffinized, rehydrated and 
washed with PBS. Slides were permeabilized with 0.1 % Triton X-100, and then 
washed with PBS. Equilibration buffer was added and covered with plastic 
coverslip. Incubation buffer containing equilibration buffer, nucleotide mix and 
rTdT enzyme were added and incubated at 37 oC for 1 h. After incubation, slides 




Dulbecco’s PBS, and stained with Propidium iodide. The fluorescein-12-dUTP-
labeled DNA was visualized by confocal microscope coupled to a Zeiss Axiophot 
200 inverted epifluorescence microscope. 
GSH-Glo Glutathione Assay  
GSH is a tripeptide (L-γ-glutamyl-L-cysteinyl-glycine) antioxidant found 
in eukaryotic cells (Griffith, 1999; Pompella, 2003; Sies, 1999). A drop in GSH 
levels either by oxidation or reaction with thiol group can be caused by reactive 
chemical species. A change in GSH levels potentially leads to apoptosis and cell 
death (Townsend, 2003). For detection and quantification of GSH, the GSH-Glo 
glutathione assay was used. It is a luminescence-based assay. In the presence of 
GSH, a luciferin derivative is converted into luciferin by glutathione S-transferase 
(GST). The signal produced in a coupled reaction with firefly luciferase is relative 
to the amount of glutathione present in the sample.  
30,000 ARPE-19 cells were plated in 96 well plates. After confluency, cells 
were treated as described in ARPE-19 cell culture treatments for 24 h. After 
incubation the media was removed. GSH-Glo reagent was added and the plate 
was incubated for 30 min at room temperature. Reconstituted luciferin detection 
reagent was added to the plate, which was again incubated for another 15 min at 
room temperature. A microplate reader was used to read luminescence, which is 
proportional to the amount of GSH present in the sample. GSH standard curve 
was generated by diluting 5 mM stock. 0 μM to 5 μM range standards were used 







ARPE-19 cells were cultured on 35 mm glass bottom culture dishes and 
incubated with 0, 10 or 25 μM of 27-OHC for 24 h. To measure intracellular Ca2+ 
concentration, cells were loaded with 2 μM fura-2AM for 45 min at 37 °C under 
an atmosphere of 5 % CO2-95 % air, washed three times with Ca2+-free SES buffer 
(Panini and Sinensky, 2001). For fluorescence measurements, the fluorescence 
intensity of Fura-2AM -loaded cells were monitored using a charge-coupled 
device (CCD) camera-based imaging system mounted on an Olympus XL70 
inverted microscope equipped with an Olympus 40× (1.3 NA) fluor objective. A 
monochrometer dual wavelength enabled alternative excitation at 340 and 380 
nm, whereas the emission fluorescence was monitored at 510 nm with an Orka 
imaging camera. The images of multiple cells collected at each excitation 
wavelength were processed using the Ca2+ imaging, PCI software to provide ratios 
of Fura-2 fluorescence from excitation at 340 nm to that of excitation at 380 nm 
(F340/F380). 
Immunocytochemistry, Immunohistochemistry and H&E Staining 
ARPE-19 cells were grown on collagen coated coverslips. After confluency, 
cells were treated as described in ARPE-19 cell culture treatments for 24 h. After 
incubation cells were washed with PBS, fixed in 4 % paraformaldehyde, blocked 
with 5 % normal goat serum and incubated overnight at 4 °C with monoclonal 
mouse antibodies to GADD153 or NF-κB p65. Cells were washed with PBS, 
incubated with secondary antibodies conjugated to Alexa fluor-488 for 1 h at 




visualized with a Zeiss LSM 510 META confocal system coupled to a Zeiss 
Axiophot 200 inverted epifluorescence microscope.  
7 μm paraffin sections of eyes were deparaffinized with xylene and rehydrated 
with series of percentages of ethanol. Slides were kept in a rack and performed 
following washes. 
1: 4 times, each 2 min with Xylene 
2: 2 times, each 3 min with 100 % Ethanol 
3: 3 min with 95 % Ethanol 
4: 3 min with 70 % Ethanol 
5: 3 min with 50 % Ethanol 
6: Running cold tap water to rinse 
After that slides were washed with PBS, incubated with trypsin enzymatic 
antigen retrieval solution, then blocked with 10 % normal goat serum solution for 
1 h. This was followed by an overnight incubation at 4 °C with primary 
antibodies. Slides were washed with PBS 3 times for 5 min each. Secondary 
antibodies were incubated in PBS for 1 h at room temperature. Slides were 
washed with PBS 3 times for 5 min each. DAPI or propidium iodide was used as a 
counter stain for visualizing nuclei. Routine H&E staining was carried out after 
deparaffinization and rehydration of retinal sections with xylene, ethanol and 
deionized H2O. Antibodies and dyes used for experiments are listed below. 
Antibodies/Dyes 
Antibody / Dye Dilution Manufacturer 




Mouse NF-κB p65 1:250 Santa Cruz Biotechnology, Santa Cruz, 
CA 
 
Mouse anti-β amyloid, 
1-16(6E10) 
1:100 Signet laboratories Inc., Dedham, MA 
 











Abcam, Cambridge, MA 
Mouse anti-CYP27A1 1:200 Novus Biologicals, Littleton, CO 
Alexa Fluor 594 goat 
anti—rat IgG 
1:500 Molecular Probes 
 
Trypsin enzymatic 




Abcam, Cambridge, MA 
 
Vectashield mounting 





Vector laboratories, Inc., Burlingame, 
CA 
 
Vectashield mounting  
Medium Propidium Iodide  NA   Vector laboratories, Inc., Burlingame, 
CA 
Transfection and Dual-Luciferase Reporter Assays 
ARPE-19 cells were plated in 96 well plates. Estrogen transcriptional 
response element (ERE) reporter (a mixture of ERE-responsive firefly luciferase 
construct and renilla luciferase construct, 40:1), a negative control (a mixture of 
non-inducible firefly luciferase construct and constitutively expressing renilla 
luciferase construct, 40:1), and a positive control (a mixture of constitutively 
expressing green fluorescent protein (GFP), constitutively expressing firefly 
luciferase, and constitutively expressing renilla luciferase constructs, 40:1:1) were 




For testing LXR activity, liver X receptor response element (LXRE) 
reporter (a mixture of inducible LXR-responsive firefly luciferase construct and 
constitutively expressing renilla luciferase construct, 40:1), a negative control (a 
mixture of non-inducible firefly luciferase construct and constitutively expressing 
renilla luciferase construct, 40:1), a positive control (a mixture of constitutively 
expressing GFP, constitutively expressing firefly luciferase, and constitutively 
expressing renilla luciferase constructs, 40:1:1) were diluted in OptiMEM serum 
free media.  
Lipofectamine LTX and PLUS reagents were used for transfection, and 
was carried out according to the manufacturer’s protocol. After 24 h, media was 
replaced with DMEM/F12 media, and transfected ARPE-19 cells were treated 
with E2, 27-OHC, 25-OHC and 7-KC for ER activity and GW3965, 27-OHC, 25-
OHC and 7-KC for LXR activity determination. After 24 h treatment at 37 °C, 
cells were harvested into cell lysis buffer. Firefly and renilla luciferase activities 
were determined by using Dual-Luciferase assay system and microplate reader. 
Promoter activity values are expressed as arbitrary units using a renilla reporter 
for internal normalization. 
Statistical Analysis 
GraphPad Prism software 4.01 was used for statistical analysis. Quantitative data 
are presented as mean values ± SEM. The significance of differences between the 
control and cholesterol-treated group was assessed by unpaired Student's t test, 
with P < 0.05 considered statistically significant. The significance of differences 
among the treatments was assessed by one-way analysis of variance (one-way 




different experiments were expressed as mean value ± SEM. p < 0.05 was 








Aβ levels were increased in retinas of cholesterol-fed rabbits 
Aβ is found in drusen, the extracellular deposits that are the earliest sign 
of AMD. Drusen accumulates between the basal surface of RPE and Bruch’s 
membrane. Aβ deposition could be an important element in local inflammatory 
outcome that contribute to deterioration of photoreceptors and pathogenesis of 
AMD. Drusen deposition is accompanied with degeneration of photoreceptor 
cells. Immunohistochemical analysis in the present study with laser scanning 
confocal microscopy showed increased immunoreactivity to Aβ peptide in retinas 
from the cholesterol-fed rabbits compared to control rabbits as determined with 
4G8 antibody (Figure 12A). Aβ monoclonal antibody 4G8 is reactive to amino 
acid residues 17-24 of Aβ and also reacts with APP. The increase in Aβ staining is 
observed in the photoreceptor outer segments, outer nuclear layer, inner nuclear 
layer and also in the ganglion cell layers. 
Aβ quantitation by ELISA (Figure 12B, C) also showed a significant 
increase in both Aβ1-40 (Figure 12B) and Aβ1-42 (Figure 12C) forms in the 
retinal samples of cholesterol-fed rabbits when compared to controls. Aβ levels 
are regulated by generation from APP upon initial cleavage by BACE-1 and 





Figure 12: 4G8 immunoreactivity and Aβ levels were increased in cholesterol-fed 
rabbit retina 
A. Immunohistochemical analysis of retinal sections with 4G8 (green), an antibody that 
detects Aβ, showed increased immunoreactivity in the cholesterol-fed rabbits compared 
to control. DAPI (blue) is a nuclear counter stain. Bar = 20 μm. OS, ONL, INL, GCL are 
outer segments, outer nuclear layer, inner nuclear layer and ganglion cell layers 
respectively. B, C. Aβ quantification by ELISA showed an increase in levels of Aβ1-40 
and 1-42 in the retinal samples of cholesterol-fed rabbits compared to normal rabbits. D. 
BACE-1 and E. IDE levels are increased in retinas from cholesterol-fed rabbits, 




demonstrate that BACE-1 and IDE levels were significantly increased in 
cholesterol-fed rabbit retinas, compared to their respective controls (Figure 12D, 
E). 
These results suggest that both formation and degradation of Aβ are 
enhanced by the cholesterol enriched diet and that the increase in generation by 
beta-secretase 1 exceeds the degradation rate of Aβ peptide by Insulin-degrading 
enzyme. 
Cholesterol-fed rabbit retinas show increased oxidative stress 
As Aβ is a neurotoxic peptide and its accumulation in the retina may 
promote oxidative damage and cell death, the extent to which accumulation of Aβ 
peptide is associated with increased ROS and apoptotic cell death was 
determined. In 1954 Science paper, Gershman’s free radical theory of oxygen 
toxicity for the first time showed harmful side of oxygen (Gerschman, 2001). 
Oxidative stress has been implicated in many degenerating diseases including AD 
and AMD (Crabb, 2002; Hawkins, 1999; Markesbery, 1997; Shen, 2007; Zarbin, 
2004).  
The cholesterol-enriched diet significantly increased ROS levels in retinas 
(n=6) compared to control rabbits (Figure 13A). Fluorometric detection of H2O2 
and peroxidase by amplex red assay showed significant increases in H2O2 levels 
and decreases in peroxidase activity in retinas from cholesterol-fed rabbits 
compared to retinas from control rabbits (Figure 13B, C). Levels of the oxidative 
stress sensor HO-1 were determined by Western blotting. The levels of HO-1 were 




chow-fed rabbits (Figure 13D). All together, these results show that retinas from 
cholesterol-fed rabbits were subjected to oxidative stress. 
 
Figure 13: Retinas of cholesterol-fed animal exhibit an increase in oxidative 
stress. 
A. The cholesterol-enriched diet significantly increased ROS levels in the retinas as 
demonstrated by DCFH-DA. B, C. Fluorometric detection of H2O2 and peroxidase 
activity by Amplex Red assay showed an increase in H2O2 levels in cholesterol-fed rabbit 
retinas and decreased peroxidase activity. D. HO-1 levels were increased in the retinas of 
cholesterol-fed rabbits as shown by Western blotting. *p < 0.05;**p < 0.01; ***p < 0.001 
vs control. 
Cholesterol-enriched diet caused retinal morphological changes 
Astrogliosis is one of the remarkable characteristics of astrocytes to respond to 
oxidative stress insults. Confocal microscopy analysis show significant 




protein (GFAP) in retinas from cholesterol-fed rabbits compared to control 
rabbits (Figure 14A). The increase in the number of astrocytes occurred in the 
outer nuclear, and the ganglion cell layers. Western blot analyses also show that 
levels of GFAP are dramatically increased in retinas from cholesterol-fed rabbits 
compared to control rabbits (Figure 14B). 
.  
Figure 14: Cholesterol-enriched diet increased GFAP expression in retina. 
A. Cholesterol-fed rabbit retinal sections showed an increase in the expression of GFAP 
(Red). DAPI (blue) is a nuclear counter stain. B. Western blot (n=3 each) results also 
showed elevated GFAP levels. ONL=outer nuclear layer, INL= inner nuclear layer GCL= 





Figure 15: Cholesterol-enriched diet caused retinal morphological changes 
A. Confocal microscopy showed an increase in immunoreactivity of vitronectin antibody 
(green) in the retinas of rabbits fed with cholesterol-enriched diet compared to rabbits 
fed with normal chow. B. Drusen like debris was detected under the retinal pigment 
epithelium (arrow) of cholesterol-fed rabbits. GCL=Ganglion cell layer; INL=Inner 
nuclear layer; ONL=Outer nuclear layer; PR=Photoreceptors; RPE=Retinal pigment 
epithelium. Bar = 20 μm 
Vitronectin, an adhesive glycoprotein, is a common component of 




(Hageman, 1999) and is expressed in retina. Confocal microscopy showed an 
increase in immunoreactivity for vitronectin antibody in the retinas of rabbits fed 
with cholesterol-enriched diet compared to rabbits fed with normal chow (Figure 
15A). H&E staining analyzed by light microscopy, showed necrotic debris 
suggestive of drusen-like debris in retinas from cholesterol-fed rabbits (Figure 
15B). These drusen-like debris are localized under the RPE. 
Cholesterol-enriched diet caused apoptotic cell death 
Western blot results show that levels of the anti-apoptotic protein 
Apoptosis regulator Bcl-2 were decreased and levels of the pro-apoptotic protein 
apoptosis regulator BAX were increased in retinas of cholesterol-fed rabbits in 
comparison to levels of these proteins in retinas of control rabbits. Bcl-2 to Bax 
ratio of cholesterol fed rabbits is significantly reduced when compared to control 
rabbits (Figure 16A). In addition to Bcl-2 and Bax, levels of GADD153 were 
significantly increased in cholesterol-fed rabbits (Figure 16B). Growth arrest and 
DNA damage-inducible protein GADD153 (also called CHOP), a transcription 
factor that is activated by stress to the endoplasmic reticulum, triggers cell death 
by mechanisms that may include generation of ROS, downregulation of Bcl-2, 
and upregulation of Bax (Oyadomari and Mori, 2004). 
These results indicate that stress to the endoplasmic reticulum is involved 
in the deleterious effects of cholesterol-enriched diet in retinas of rabbits. TUNEL 
assay detects the fragmented DNA of apoptotic cells by catalytically incorporating 







Figure 16: Cholesterol-enriched diet caused apoptotic cell death in rabbit 
retina. A. Western blot results showed a decrease in the levels of the anti-apoptotic 
protein Bcl-2 and an increase in levels of the pro-apoptotic protein Bax levels in the 
retinas of rabbits fed with cholesterol-enriched diet compared to control rabbits. B. 
Levels of the endoplasmic reticulum stress marker GADD153 were increased in 
cholesterol-fed rabbits as shown by Western blotting. C. While no TUNEL-positive cells 
were detected in retinas from control rabbits, a large number of TUNEL-positive cells 
were observed in retinas of cholesterol-fed rabbits. Propidium iodide (red) was used as a 




TUNEL staining showed no apoptotic cells in the control retinas, whereas an 
extensive staining was observed in the retinas of cholesterol-fed rabbits (Figure 
16C). Propidium iodide was used as nuclear counter stain. Yellow color is the 
merge of green color which indicates fragmented DNA and red color which 
indicates nucleus. 
Cholesterol-enriched diet disturbed cholesterol homeostasis in the 
retina 
 
The extent to which cholesterol-enriched diet increases the accumulation 
of cholesterol and major oxysterols were determined in rabbit retinas (Table 1). 
Total cholesterol levels were increased in cholesterol-fed rabbit retinas compared 
to control retina. The amount of cholesterol in control retinas was 0.1024 ± 
0.028 mg/g of tissue, whereas in cholesterol-fed rabbit retina the concentration 
of cholesterol increased to 0.8427 ± 0.002 mg/g of tissue. Cholesterol is also 
eliminated through enzymatic conversion to polar oxysterols that include 27-
OHC, 24-OHC, and 22-hydroxycholesterol (22-OHC) by sterol 26-hydroxylase, 
mitochondrial (CYP27A1), Cytochrome P450, family 46, subfamily A, polypeptide 
1 (CYP46A1), and cholesterol side-chain cleavage enzyme, mitochondrial 
(CYP11A1) respectively. All these enzymes were found to be expressed in the 
retina (Rodriguez and Larrayoz, 2010). Mass spectrometry analysis showed a 
significant increase in the levels of oxysterols 27-OHC, 24-OHC, and 22-OHC in 
cholesterol-fed rabbit retinas (Table-1).  
Other enzymatically-generated oxysterols, 7α-hydroxycholesterol (7α-
OHC), 4β-hydroxycholesterol (4β-OHC) and 25-OHC were also measured and 




(Table-1). CYP27A1, the enzyme that converts cholesterol to 27-OHC, levels were 
investigated by Western blotting and immunohistochemistry (Figure 17).  
 
Figure 17: Cholesterol-enriched diet disturbed cholesterol homeostasis in 
the retina. 
A. Cholesterol-fed rabbit retinal sections showed an increase in the expression of 
CYP27A1 (green). DAPI (blue) is a nuclear counter stain. ONL, INL, GCL are outer 
nuclear layer, inner nuclear layer and ganglion cell layers respectively. B. Western 
blotting further confirmed an increase in CYP27A1 expression. C. Western blotting 
results showed that ABCA-1 levels were increased in the retinas of cholesterol-fed 
rabbits. *p < 0.05, **p < 0.01 vs control. Bar 20 μm. 




cholesterol-fed rabbits compared to control rabbits (Figure 17A). 
Table 1 - Total cholesterol and oxysterol levels in control (n=3) and 
cholesterol-fed rabbit retina (n=3) 
    Control retina Cholesterol-fed retina 
 
 
Total cholesterol  0.1024 ± 0.028  0.8427 ± 0.002 *** 
mg/g tissue 
4β-hydroxycholesterol 2491 ± 236   9046 ± 1015** 
ng/g tissue 
7α-hydroxycholesterol 344.1 ± 49.51              14378± 1504 ** 
ng/g tissue 
22-hydroxycholesterol 7.893 ± 1.59   105.6 ± 24.71 * 
ng/g tissue 
24-hydroxycholesterol 405.3 ± 173.9             1815.32 ± 313.5 * 
ng/g tissue 
25-hydroxycholesterol 24.39 ± 0.20   835.5 ± 29.77*** 
ng/g tissue 
27-hydroxycholesterol 29.38 ± 8.4   697.2 ± 161.4 * 
ng/g tissue 
 
Values are expressed as mean ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001 vs control. 
Western blotting also showed a significant increase in CYP27A1 levels in 
retinas from cholesterol-fed rabbits compared to those in retinas of control 
rabbits (n=3 each; Figure 17B). The cholesterol transporter ATP-binding cassette 
sub-family A member 1 (ABCA-1) shuttles cholesterol between various cells. 
Levels of ABCA-1 were dramatically increased in retinas of cholesterol-fed rabbits 
in comparison to levels in retinas of control rabbits (n=3 each; Figure 17C). All 
together, these results demonstrate accumulation of cholesterol and increased 




Previous research from our laboratory has shown that 27-OHC can cause 
AD like pathology in organotypic slices of rabbit brain and neuroblastoma cell 
line SHSY-5Y (Prasanthi, 2009; Sharma, 2008). Whether the oxysterol 27-OHC 
can cause pathological hallmark features related to AMD in retinal pigment 
epithelial cell line was investigated here. 27-OHC can increase Aβ levels in 
organotypic slices of rabbit brain and SHSY-5Y cells. If 27-OHC has similar effect 
on Aβ, a major component of drusen, in retinal pigment epithelial cells was 
investigated by using ARPE-19 cells. 
27-OHC increased Aβ production  
RPE cells secrete a variety of extracellular matrix proteins, complement 
factors, and protease inhibitors that have been reported to be major constituents 
of drusen (Farkas, 1971). APP immunoreactivity present in the RPE cytoplasm, 
anti-Aβ labeled structures identified in RPE cells and cultured human RPE cells 
labeled with APP and Aβ antibodies strongly suggest an RPE origin of amyloid. 
RPE has the ability to synthesize significant quantities of APP and generate Aβ. 
Amyloid vesicles in drusen are derived from degenerate RPE cells that contain Aβ 
and other molecules.  
 Beta-secretase 1 (BACE-1) is responsible for proteolytic processing of APP. 
BACE-1 is necessary for Aβ production in vivo and is the rate limiting step in the 
production of Aβ (Luo, 2001). Aβ is a primary component of amyloid plaques. 
Amyloid plaques and neurofibrillary tangles are two defining pathological 
hallmarks of AD. AMD hallmark component drusen comprises of Aβ (Anderson, 
2004; Dentchev, 2003; Johnson, 2002). After 27-OHC treatment, spent media of 





Figure 18: 27-OHC increased Aβ production in ARPE-19 cells 
A. Treatment of ARPE-19 cells with 10 μM and 25 μM 27-OHC for 24 h increased Aβ1-42 
but not Aβ1-40 levels. B. Levels of BACE-1, the enzyme that initiates the generation of 
Aβ, are also increased following treatment with 27-OHC. C. Immunocytochemistry with 
6E10, an antibody that detects Aβ, shows increased staining with 27-OHC (green); DAPI 





Treatment with 27-OHC at 10 μM and 25 μM for 24 h significantly 
increased Aβ1-42 but not Aβ1-40 levels in these cells. The magnitude of increase 
in Aβ1-42 levels is similar with 10 μM and 25 μM of 27-OHC (Figure 18A). Both 
10 μM and 25 μM 27-OHC significantly increased BACE-1 expression levels 
(Figure 18B), suggesting that the increased levels of Aβ1-42 derive, at least in 
part, from an increase in the rate of production of this peptide through the 
processing of APP by BACE-1. The immunocytochemistry using 6E10 antibody 
that detects Aβ peptides also showed an increase in the Aβ immunoreactivity with 
both 10 μM and 25 μM of 27-OHC compared to untreated cells (Figure 18C). The 
Aβ staining appeared to be mostly perinuclear. Increased Aβ1-42 peptide levels in 
the ARPE-19 cells could cause oxidative damage to these cells, as high levels of 
this peptide either soluble or insoluble form is toxic to cells. 
27-OHC disturbed Ca2+ homeostasis and affected endoplasmic 
reticulum stress 
 
Ca2+ is essential for cell functioning, and cell survival depends on the 
maintenance of Ca2+ homeostasis (Selvaraj, 2009). Disruptions of Ca2+ 
homeostasis result in the development of the endoplasmic reticulum stress 
response which can compromise cell survival.  
The addition of thapsigargin (Tg, 2 μM), which initiates release of Ca2+ 
from the internal endoplasmic reticulum stores (in Ca2+ free media) caused a 
significant decrease in endoplasmic reticulum Ca2+ content in cells treated with 
either 10 or 25 μM of 27-OHC. Importantly, addition of 1 mM Ca2+ externally 





Figure 19: Ca2+ homeostasis is disturbed by 27-OHC in ARPE-19 cells 
A. Ca2+ imaging was performed in the presence of thapsigargin (Tg; 2 μM in a Ca2+-free 
media) in control ARPE-19 cells or B. cells treated with 10 μM or C. 25 μM 27-OHC. D. 
Ca2+ influx was measured by the addition of 1 mM Ca2+ externally and traces shown here 
are averages of 30-40 cells in each condition. Bar graph indicates the mean values of the 
first peak (endoplasmic reticulum calcium release) and second peak (calcium entry). *p 




However, cells treated with 10 or 25 μM 27-OHC showed a gradual 
decrease in Ca2+ entry (40-50 % decrease) (Figure 19A, B, C). Mean Ca2+ influxes 
from 90-120 individual cells are shown as bar graph (Figure 19D). Basal 
Ca2+ influx (measured upon addition of external Ca2+ without Tg stimulation) was 
not altered. Overall, these data demonstrate that treatment of the cells with 27-
OHC leads to a decrease in intracellular Ca2+ entry and thus decreased 
endoplasmic reticulum Ca2+. This could lead to endoplasmic reticulum stress, 
since Ca2+ entry through the plasma membrane is essential for the refilling of the 
endoplasmic reticulum store. As a result of endoplasmic reticulum stress, 
caspase-12 is activated and can lead to apoptosis (Cordeiro, 2010). Western blot 
results showed that 27-OHC treatment increased the levels of caspase-12 (Figure 
20A). 
Caspase-12 is a initiator caspase and is activated by endoplasmic reticulum 
stress (Nakagawa, 2000). Once activated, it induces the cleavage of caspase-3 in a 
cytochrome c-independent manner. Activation of caspase-12 during apoptosis 
has been reported in mouse, rat, rabbit, cow, and human cells (Szegezdi, 2003). 
Sustained endoplasmic reticulum stress leads to activation of GADD153 which 
can cause cell-cycle arrest and/or apoptosis. GADD153 is a proapoptotic 
transcription factor, ubiquitously expressed at low levels (Fornace, 1988; Park, 
1992; Ron and Habener, 1992). GADD153 is present in the cytosol under normal 
conditions, and cellular stress leads to accumulation in the nucleus (Ron and 
Habener, 1992). Various physiological and pathological stimuli results in 
accumulation of misfolded proteins in the endoplasmic reticulum lumen 




endoplasmic reticulum stress can result in apoptosis (Momoi, 2004). GADD153 is 
one of the highest inducible genes during endoplasmic reticulum stress (Bartlett, 
1992; Okada, 2002; Oyadomari, 2001; Tang and Lane, 2000; Yang, 2005; 
Yoshida, 2000). Deficiency of GADD153 could protect cells from endoplasmic 
reticulum stress-induced apoptosis and overexpression of GADD153 can cause 
cell-cycle arrest and/or apoptosis, which indicates GADD153 plays an important 
role in the induction of endoplasmic reticulum stress-related apoptosis (van der 
Sanden, 2003).  
Induction of GADD153 was shown to upset the cellular redox state by 
depletion of cellular GSH and exaggerated production of ROS (McCullough, 
2001). Endoplasmic reticulum stress and disturbed calcium homeostasis is 
implicated in AD (Katayama, 2004; LaFerla, 2002; Verkhratsky, 2005). 
Oxidative stress, which may lead to endoplasmic reticular stress and eventually 
compromised endoplasmic reticulum stress response resulting RPE dysfunction 
are implicated in AMD (Ambati, 2005; Beatty, 2009; de Jong, 2006; Donoso, 
2003). GADD153 induction correlates with the onset of apoptosis (Eymin, 1997; 
Friedman, 1996). 
27-OHC significantly increased levels of GADD153 at both 10 μM and 25 
μM concentrations (Figure 20B). The confocal microscopy imaging revealed an 
increase in the number of nuclei that are GADD153-positive on treatment with 25 
μM 27-OHC treatment (Figure 20C). The immunocytochemistry results 







Figure 20: Endoplasmic reticulum stress induced by 27-OHC  
A. Western blots showing an increase in levels of caspase 12 and B. GADD153, two 
specific markers of endoplasmic reticulum stress stress. C. Immunocytochemistry shows 
that GADD153 immunoreactivity (green) is localized in nucleus (DAPI, blue) following 
treatment with 27-OHC (arrows). *p < 0.05, **p < 0.01 vs control; Bar, 20 μm. 
NFкB-p65 subunit is a transcription factor, expressed in almost all cell 
types and is involved in processes such as inflammation, immunity, 
differentiation, cell growth, tumorigenesis and apoptosis. In normal conditions, 
NF-κB is sequestered in the cytoplasm by inhibitor of kappa light polypeptide 




response pathways involves activation of NF-κB, for mediating immune and 
antiapoptotic responses. The stress leads to Ca2+ release from endoplasmic 
reticulum and reactive oxygen intermediates, which activate NF-κB by 
degradation of IκB. Free NF-κB is transported into the nucleus, and induces 
transcription of target genes (Sen and Baltimore, 1986). Reactive oxygen 
intermediates (ROIs) can function as second messengers in NF-κB activation 
(Meyer, 1993; Schmidt, 1995; Schreck, 1991). In neurons and astroglia of brain 
sections from AD patients, activation of NF-κB was observed (Kaltschmidt, 1997). 
Aberrant activation of NFĸB is associated with macular degeneration along with 
many other diseases. NF-κB can be activated by endoplasmic reticulum stress 
and can exert either cytoprotective or cytotoxic effects depending on the type of 
stimulus and duration (Pahl and Baeuerle, 1996).  
In the present study, NF-κB levels in the nucleus are significantly 
increased in the 27-OHC treated ARPE-19 cells (Figure 21B). The 
immunocytochemistry with antibody to NF-κB further showed an emergence of 
nuclear staining for NF-κB with 27-OHC treatment (Figure 21C). TNF-α is a 
multifunctional pro-inflammatory cytokine and is viewed as a classic regulator of 
cell death and is also activated by endoplasmic reticulum stress (Li, 2005). TNF-
α is also an activator of NF-κB. 27-OHC, at 25 μM but not at 10 μM, induces a 






Figure 21: TNF-α and NF-κB levels are increased by 27-OHC treatment  
A. Treatment with 27-OHC increases TNF-α levels, as shown by ELISA and B. increased 
NF-κB levels in the nucleus as shown by Western blot. C. Immunocytochemistry for NF-
κB shows increased immunoreactivity (green) and translocation into the nucleus (DAPI, 
blue) of this protein in the 27-OHC-treated cells (arrows, c). *p < 0.05 vs control; Bar, 20 
μm. 
27-OHC-induced oxidative damage 
Whether 27-OHC causes any oxidative stress on ARPE-19 cells was 
explored. The mechanistic basis of AMD disease is not clearly understood but 
may involve oxidative injury to retinal pigment epithelium. GSH, a tripeptide is 




1999; Kaplowitz, 1985; Meister and Anderson, 1983; Pompella, 2003; Sies, 1999). 
The GSH system, includes reduced GSH, GSSG and a number of related enzymes, 
is the main redox control system of the cell. GSH and its precursor amino acids 
protect against oxidative injury in cultured human RPE cells (Sternberg, 1993).  
It is known that glutathione levels of a person with AMD are lower than of 
a person the same age with healthy eyes. An alteration in GSH levels gives 
assessment of toxicological responses and is an indicator of oxidative stress, 
potentially leading to apoptosis (Townsend, 2003). In this study oxysterol 27-
OHC effect on glutathione levels in ARPE-19 cells was examined. Total GSH 
levels (reduced GSH plus GSSG) were quantified. GSH levels are significantly 
decreased in concentration dependent manner. 10 μM and 25 μM 27-OHC caused 
a significant reduction in glutathione (Figure 22A). These results suggest that 27-
OHC reduced the anti-oxidant potential of cells, thereby increasing cell 
susceptibility to oxidative damage. Excessive production of ROS is known to lead 
to oxidative stress, loss of cell function, and ultimately to cell death.  
This study showed that 27-OHC significantly increased heme oxygenase 1 
(HO-1) levels in ARPE-19 cells (Figure 22C). HO-1 catalyzes the rate-limiting step 
in the oxidative degradation of heme to biliverdin, iron, and carbon monoxide 
(Tenhunen, 1968). HO-1 is mainly located in the endoplasmic reticulum, 
anchored by a single transmembrane domain. HO-1 is ubiquitously distributed 
and strongly induced by oxidative, endoplasmic reticulum, nitrosative, osmotic, 
and hemodynamic stress (Durante, 1997; Keyse, 1990; Liu, 2005; Motterlini, 





Figure 22: 27-OHC altered glutathione, ROS and HO-1 levels in ARPE-19 
cells. A. Treatment with 27-OHC causes a decrease in glutathione concentrations. B. an 
increase in ROS generation as measured by DCFH-DA assay C. an increase in HO-1 




Induction of HO-1 by these biochemical stimuli provides an important 
cellular defense mechanism against tissue injury (Abrescia, 1979; Amersi, 1999; 
Clark, 2000; Foresti, 1999; Motterlini, 1996; Tian, 2001; Yet, 2001). HO-1 
elevation is regarded as a general indicator of oxidative stress in cells and tissues 
(Applegate, 1991; Keyse, 1990; Stocker, 1990). GSH depletion may lead to 
enhanced HO-1 gene expression (Lautier, 1992). HO-1 immunoreactivity is 
significantly more in neurons of the AD patients temporal cortex and 
hippocampus than corresponding tissues derived from nondemented controls 
matched for age and postmortem interval (Schipper, 1995). HO-1 induction is a 
relatively early event in the pathogenesis of sporadic AD (Schipper, 2006). HO-1 
presence at high levels is considered evidence that such stress is present. HO -1 
and -2 are increased in RPE of AMD-affected maculas (Frank, 1998).  
27-OHC triggered cell death in ARPE-19 cells 
LDH is released into the surrounding medium from cells when they lose 
membrane integrity. After 24 h treatment with 27-OHC, cell viability was 
quantitatively determined by the measurement of lactate dehydrogenase (LDH) 
released from cells into the medium by using the CytoTox-ONE homogeneous 
membrane integrity assay. This fluorometric assay estimates the number of 
nonviable cells by measuring the release of LDH from cells with a damaged 
membrane. The amount of fluorescence produced is proportional to the number 
of lysed cells. 27-OHC treatment leads to a significant increase in the number of 
dead cells (Figure 23A). Cell death involves various events including the loss of 




The fluorescent cationic dye JC-1 was used, which signals the loss of 
mitochondrial membrane potential (Smiley, 1991). The ratio of red (monomeric 
form of JC-1) to green fluorescence (aggregates of JC-1) was determined. 10 μM 
and 25 μM 27-OHC reduced the red: green fluorescence ratio, indicating a 
significant decrease in the mitochondrial membrane potential (Figure 23B).  
 
Figure 23: 27-OHC is deleterious to ARPE-19 cells. 
A. Cyto Tox-ONE homogenous membrane integrity assay shows that 27-OHC is cytotoxic 
to cells B. and decreases the mitochondrial membrane potential as measured by a 
reduction in red (non-apoptotic cells)/green (apoptotic cells) fluorescence. C. TUNEL 
assay shows that 27-OHC increases the number of apoptotic cells (arrow) with 25 μM 27-
OHC. Apoptosis is evidenced by DNA fragmentation labeled with fluorescein (green); 




TUNEL assay, used to detect apoptotic cell death, showed no apoptotic 
cells in untreated cells; in the 27-OHC-treated cells, TUNEL-positive cells were 
observed with a number that is higher with 25 μM than 10 μM 27-OHC (Figure 
23C). All together, these results demonstrate that 27-OHC compromises cell 
survival. 25-OHC and 7-KC is shown to be cytotoxic to cultured RPE and retinal 
cells (Ong, 2003). Presence of 7-KC in lipid deposits from primate retina 
suggested oxysterol involvement in AMD development (Moreira, 2009). 7-KC 
treated ARPE-19 cells showed some of the characteristics of apoptosis (Luthra, 
2006). Cytotoxicity of oxLDL on RPE cells was shown to be dependent on 7-KC 
formation (Rodriguez, 2004). 7-KC and 25-OHC have been demonstrated to have 
cytotoxic, pro-oxidative, and/or angiogenic activities on ARPE-19 cells. 
27-OHC is ligand for both ER and LXR. 27-OHC has both agonist and 
antagonist activities depending on cell type. For example 27-OHC displays 
agonist activity in breast cancer cells and antagonistic activity in cardiovascular 
system. 25-OHC is also a ligand for both ER and LXR. 7-KC has been described 
as an LXR agonist (Janowski, 1999). LXR involvement is suggested in 7-KC 
mediated induction of VEGFexpression (Moreira, 2009). 
ERα and ERβ, are expressed in ARPE-19 cells  
The ER α and β are ligand-inducible transcription factors and belong to 
the nuclear receptor superfamily. The two estrogen receptor subtypes-ERα and 
ERβ are shown to be expressed in the male and female retina (Munaut, 2001; 
Ogueta, 1999). ERs existence in ARPE-19 cells was probed by Western blotting 
(Figure 24). Triplicate cell lysates were resolved by SDS-PAGE and investigated 




and ERβ band was detected at approximately at 53 kDa. Both cytosolic and 
nuclear fractions were used for probing of ERα and ERβ. For cytosolic fractions, 
β-actin was used as loading control, and for nuclear fractions, lamin A was used 
as loading control. ERα and ERβ expression in these cells was proven by this 
study.  
 
Figure 24: ARPE-19 cells express ERα and ERβ 
Western blots showing ERα and ERβ receptor protein expression in ARPE-19 cells. 
Triplicate cell lysates were resolved by SDS-PAGE and probed for ERα and ERβ. β-actin 
and lamin were used as loading controls for cytosolic and nuclear fractions respectively. 
ERE-luciferase activity is increased by ER agonist E2  
The binding of E2 to ERs induce receptor activation, which lead to 
interaction with specific EREs located within the regulatory regions of target 
genes. Transfection of ERE-luciferase construct and luciferase activity measured 
by dual luciferase assay elucidated functional activity of ER. 10nM E2, an ER 
agonist caused an increase in ERE-luciferase activity denoted by ERE-relative 






Figure 25: E2 increased ERE-luciferase activity 
ARPE-19 cells were transfected in parallel with ERE-reporter and negative control. 
Transfected cells were subjected to 10 nM E2 treatment for 24 h. Cells were lysed and 
dual luciferase assay was performed, and reporter activity values are expressed as 
arbitrary units; ***p<0.001 vs control 
LXRα and LXRβ are expressed in ARPE-19 cells  
mRNA for LXRs were detected in ARPE-19 cell culture, primary RPE 
culture and freshly isolated RPE cells (Dwyer, 2011; Ishida, 2004). Unpublished 
observations by Rodriguez group noted LXRs expression in retina (Rodriguez 
and Larrayoz, 2010). There were no published studies showing LXRα and LXRβ 
expression. Expression of LXRs in ARPE-19 cells was researched in this study. 
Triplicate cell lysates were resolved by SDS-PAGE and probed for LXRα and 
LXRβ (Figure 26). LXRα band was detected approximately at 50 kDa, and LXRβ 
band was detected at approximately at 55 kDa. Both cytosolic and nuclear 
fractions were used for probing of LXRα and LXRβ. For cytosolic fractions, β-




loading control. Western blot analysis of cytoplasmic and nuclear extracts 
showed LXRα and LXRβ expression (Figure 26).  
 
Figure 26: ARPE-19 cells express LXRα and LXRβ 
Western blots showing LXRα and LXRβ receptor protein expression in ARPE-19 cells. 
Triplicate cell lysates were resolved by SDS-PAGE and probed for LXRα and LXRβ. β-
actin and lamin were used as loading controls for cytosolic and nuclear fractions 
respectively. 
LXRE-luciferase activity is increased by LXR agonist GW3965  
Western blot results confirmed the existence of LXRα and LXRβ receptors. 
However, whether these receptors are transcriptionally active in ARPE-19 cells is 
unknown. Transfection of LXRE-luciferase construct in parallel with negative 
control construct and dual luciferase assay upon treatment with LXR agonist 
GW3965 elucidated functional activity of LXR. GW3965 caused an increase in 
LXRE-luciferase activity denoted by LXRE-relative luciferase units, when 
compared to vehicle treatment confirming LXR functionality (Figure 27). There is 
endogenous LXR transcriptional activity in these cells, as shown by control cells 





Figure 27: GW3965 increased LXRE-luciferase activity 
ARPE-19 cells were transfected in parallel with LXRE reporter and negative control. 
Transfected cells were subjected to LXR agonist GW3965 treatment. After 24 h Dual 
luciferase assay was performed, and reporter activity values are expressed as arbitrary 
units. GW3965 increased LXRE-luciferase activity indicating that LXR are functional. 
**p<0.01 
25-OHC, 27-OHC and 7-KC inhibited ER mediated transcriptional 
activity 
 
It is unknown whether oxysterols, 27-OHC, 25-OHC and 7-KC have any 
effect on ER mediated transcription in ARPE-19 cells. Therefore in the present 
study 27-OHC, 25-OHC and 7-KC influence, if there is any, on ER mediated 
transcriptional activity in retinal pigment epithelial cells was investigated.  
ERE-luciferase reporter transfected ARPE-19 cells were treated with 27-
OHC, 25-OHC and 7-KC for 24 h. Dual luciferase assay upon treatment revealed 
that all three oxysterols significantly reduced ERE-luciferase activity, indicating 
suppressive effects of oxysterols on estrogen transcriptional response element 





Figure 28: 27-OHC, 25-OHC and 7-KC decreased ERE-luciferase activity 
ARPE-19 cells were transfected in parallel with ERE reporter, which is a mixture of 
inducible ERE-responsive firefly luciferase construct and constitutively expressing 
renilla luciferase construct and negative control, which is a mixture of non-inducible 
firefly luciferase construct and constitutively expressing renilla luciferase construct. 
Transfected cells were subjected to oxysterol treatments for 24 h. Dual luciferase assay 
was performed, and reporter activity values are expressed as arbitrary units. 27-OHC, 
25-OHC and 7-KC decreased ERE-luciferase activity. *p<0.05; **p<0.01;***p<0.001  
25-OHC and 27-OHC increased LXR mediated transcriptional activity  
25-OHC and 27-OHC were shown to be natural endogenous ligands for 
LXRs in several cell types. It is unknown whether these oxysterols have any 
influence on LXR-mediated transcriptional activity in RPE cells. LXR-mediated 
transcriptional activity was examined in ARPE-19 cells upon treatment with 27-




luciferase activity measured by dual luciferase assay upon oxysterols 27-OHC, 25-
OHC and 7-KC treatments elucidated LXR activation in presence of 25-OHC and 
27-OHC. 7-KC did not cause any significant change in LXRE-luciferase activity 
when compared with vehicle treatment. 
 
Figure 29: 25-OHC and 27-OHC increased LXR mediated transcriptional 
activity. ARPE-19 cells were transfected in parallel with LXRE reporter, which is a 
mixture of inducible LXRE-responsive firefly luciferase construct and constitutively 
expressing renilla luciferase construct and negative control, which is a mixture of non-
inducible firefly luciferase construct and constitutively expressing renilla luciferase 
construct. Transfected cells were subjected to oxysterol treatments for 24 h. Dual 
luciferase assay was performed, and reporter activity values are expressed as arbitrary 







ER agonist E2 protected cells from 25-OHC and 27-OHC induced 
cytotoxicity 
27-OHC is shown to be cytotoxic to ARPE-19 cells (Dasari, 2010). 25-OHC 
and 7-KC were also shown to be cytotoxic oxysterols in ARPE-19 cells and other 
cell types (Luthra, 2006; Rodriguez, 2004; Dugas, 2010). E2 has been suggested 
as a potential therapeutic agent in the management of several neurodegenerative 
disorders. E2 rescued undifferentiated neuroblastoma cells from 24-OHC 
induced neurotoxicity (Kolsch, 2001). E2 treatment was reported to attenuate 
release of cytokines, reactive oxygen species, and complement proteins (Bruce-
Keller, 2000; Drew and Chavis, 2000). 
Whether preincubation with E2 offers any cytoprotection in 25-OHC, 27-
OHC and 7-KC induced cytotoxicity in ARPE-19 cells was examined (Figure 30). 
ARPE-19 cells were treated with oxysterols for 24 h in the presence or absence of 
10 nM E2, an ER agonist and 1 μM ICI, an antagonist. After 24 h incubation, cell 
viability was quantitatively determined by the measurement of LDH released 
from cells into the medium by using the CytoTox-ONE homogeneous membrane 
integrity assay. 10 μM 25-OHC, 10 μM 27-OHC and 25 μM 7-KC significantly 
induced cytotoxicity. 25-OHC and 27-OHC induced cytotoxicity was significantly 
reduced in cells treated with E2 (Figure 30A, B). But 7-KC induced cytotoxicity 
was not reversed by E2 (Figure 30 C). ER antagonist ICI did not offer any 
cytoprotection. E2 and ICI treatments alone are comparable with control cells. 
ICI was added 30 min before the addition of E2, and E2 was added 2 h before 






Figure 30: E2 protected cells from 25-OHC and 27-OHC induced cytotoxicity 
CytoTox-ONE homogenous membrane integrity assay was used for measuring 
cytotoxicity. A. 27-OHC is cytotoxic to cells, when cells were treated with E2, cytotoxicity 
induced by 27-OHC is reduced. ICI did not protect cells from 27-OHC induced 
cytotoxicity. B. 25-OHC is also cytotoxic to cells. When cells were treated with E2, 25-
OHC induced cytotoxicity was reduced, whereas ICI is not protective. C. 7-KC is cytotoxic 
to cells and neither E2 nor ICI protected cells from 7-KC induced cytotoxicity. *p < 0.05, 
***p < 0.001 vs control; # p < 0.05 vs oxysterol. 
Since 25-OHC, 27-OHC and 7-KC were shown to be ligands of LXRs in 
various cell types, whether LXR agonist GW3965 or antagonist ECHS offer any 
beneficial role in oxysterol induced cytotoxicity was then investigated.  
After 24 h incubation with 10 μM 25-OHC, 10 μM 27-OHC and 25 μM 7-
KC in the presence or absence of 1μM GW3965 and 1μM ECHS, cell viability was 
quantitatively determined by the measurement of LDH released from cells into 
the medium by using the CytoTox-ONE homogeneous membrane integrity assay. 




OHC, 25-OHC and 7-KC induced cytotoxicity in ARPE-19 cells. LXR agonist 
GW3965 and LXR antagonist ECHS themselves did not cause cytotoxicity. 
        A                               B                                  C 
 
Figure 31: GW and ECHS did not offer cytoprotection against 25-OHC and 
27-OHC induced cytotoxicity 
CytoTox-ONE homogenous membrane integrity assay was used for measuring 
cytotoxicity. A. Treatment of GW3965 or ECHS along with 27-OHC did not offer any 
protection against 27-OHC induced cytotoxicity. B. Treatment of GW3965 or ECHS 
along with 25-OHC did not offer any protection against 25-OHC induced cytotoxicity. C. 
Treatment of GW3965 or ECHS along with 7-KC did not offer any protection against 7-
KC induced cytotoxicity. *p < 0.05, ***p < 0.001 vs control 
E2 counteracted 27-OHC and 25-OHC induced mitochondrial 
membrane potential decline 
Cell death comprises several events including the loss of mitochondrial 
membrane potential (Green and Reed, 1998). 27-OHC is shown to significantly 
decrease mitochondrial membrane potential in ARPE-19 cells (Figure 23B, 32A). 
25-OHC and 7-KC also significantly reduced the red to green fluorescence ratio, 




ARPE-19 cells were treated with 10 μM 25-OHC, 10 μM 27-OHC and 25 μM 7-KC 
for 24 h in the presence or absence of 10 nM E2, an ER agonist and 1 μM ICI, an 
antagonist of ER. Treating cells with E2 counteracted 27-OHC and 25-OHC 
induced mitochondrial membrane potential decline (Figure 32A, B), whereas E2 
treatment could not protect cells from 7-KC induced mitochondrial membrane 
potential decline (Figure 32C). Treating cells with ER antagonist ICI did not offer 
any protection against mitochondrial membrane potential decline (Figure 32A, B, 
C). 
 
Figure 32: E2 counteracted 27-OHC and 25-OHC induced mitochondrial 
membrane potential 
Mitochondrial membrane potential was measured by JC-1 assay. A. 27-OHC decreases 
the mitochondrial membrane potential as shown by a reduction in red (non-apoptotic 
cells)/green (apoptotic cells) fluorescence. E2 counteracted the mitochondrial 
membrane potential decline, whereas ICI did not. B. 25-OHC caused a decrease in 
mitochondrial membrane potential decrease, which is counteracted by E2 but not by ICI. 
C. 7-KC induced mitochondrial membrane potential decline was not counteracted by E2 




And then, whether LXR agonist GW3965 and antagonist ECHS has any 
protective role in mitochondrial membrane potential was investigated in ARPE-
19 cells. After 24 h incubation with 10 μM 25-OHC, 10 μM 27-OHC and 25 μM 7-
KC in the presence or absence of 1μM GW3965 and 1μM ECHS, mitochondrial 
membrane potential was measured by JC-1 assay. Neither GW3965 nor ECHS 
protected cells from oxysterols 27-OHC, 25-OHC and 7-KC induced 
mitochondrial membrane potential decline. Either GW3965 or ECHS alone did 
not significantly change mitochondrial membrane potential.  
         A                                             B                                           C                                     
 
Figure 33: GW3965 and ECHS did not offer any protection against 25-OHC, 
27-OHC and 7-KC induced mitochondrial membrane potential decline 
Mitochondrial membrane potential was measured by JC-1 assay. 25-OHC, 27-OHC and 
7-KC reduced mitochondrial membrane potential. A. Neither GW3965, nor ECHS 
counteracted 27-OHC induced mitochondrial membrane potential decline. B. Neither 
GW3965, nor ECHS counteracted 25-OHC induced mitochondrial membrane potential 
decline. C. Neither GW3965, nor ECHS counteracted 7-KC induced mitochondrial 





E2 treatment protected cells from 27-OHC and 25-OHC induced 
Apoptosis 
The pathogenesis involves apoptosis of the RPE followed by death of the 
underlying photoreceptors (Hinton, 1998; Xu, 1996). Due to RPE’s unique 
location and role, it is an ideal environment for the accumulation of reactive ROIs 
(Beatty, 2009) which in turn leads to RPE death (Liang and Godley, 2003). 27-
OHC reported to cause apoptosis in ARPE-19 cells (Figure 23C).  
ARPE-19 cells were treated with 10 μM 25-OHC, 10 μM 27-OHC and 25 
μM 7-KC for 24 h in the presence or absence of 10 nM E2, an ER agonist and 1 
μM ICI, an antagonist of ER. and in the presence or absence of 1μM GW3965, an 
LXR agonist and 1μM ECHS, an LXR antagonist. ICI was added 30 min before 
the addition of E2, and E2 was added 2 h before oxysterols addition to cells. 
ECHS was added 30 min before the addition of GW3965, and GW3965 was 
added to 2 h before oxysterol addition to cells. After 24 h of incubation, apoptosis 
was detected in ARPE-19 cells by TUNEL assay, which detects fragmented DNA. 
TUNEL staining showed no apoptotic cells in the control cells whereas 27-OHC, 
25-OHC and 7-KC induced apoptotic cell death which was shown by green 
staining. Red color is a counterstain for showing nucleus. Treating cells with E2 
counteracted from oxysterol induced apoptosis. ICI, GW3965 and ECHS did not 
offer any protection against apoptosis induced by oxysterols. E2, ICI, GW3965 
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Figure 34: E2 treatment protected cells from 27-OHC and 25-OHC induced 
apoptosis 
TUNEL assay shows that 27-OHC, 25-OHC and 7-KC increases the number of apoptotic 
cells. E2 treatment reduced apoptosis induced by 25-OHC and 27-OHC. E2 did not 
rescue cells from 7-KC induced cytotoxicity. ICI, GW3965 and ECHS did not offer any 
protection against oxysterol induced apoptosis. Apoptosis is evidenced by DNA 













Cholesterol dyshomeostasis has been implicated in the pathogenesis of AD 
(Wellington, 2004) and high-fat diet rich in saturated fatty acids and cholesterol 
is suggested to be associated with AMD (Mares-Perlman, 1995). Epidemiological 
studies showed that increased plasma cholesterol levels are associated with 
atherosclerosis and increased risk of dementia, including AD (Kivipelto and 
Solomon, 2006; Solomon, 2009). Although, there is no consensus on the 
association of plasma lipid levels and AMD, two recent genome wide association 
studies implicated cholesterol metabolism involvement in AMD (Chen, 2010; 
Neale, 2010). 
Strong evidence linking AD and retinal degeneration (Guo, 2010) incited 
this study. The retina is an extension of the brain, and has the potential to reflect 
AD brain pathology. Extracellular Aβ deposition, oxidative stress, and 
inflammation are implicated in both AD and AMD (Butterfield, 2002; Ding, 
2009). Ganglion cell death has been recently documented in retinas of AD mouse 
models (Cordeiro, 2010). AMD is characterized by the abnormal, extracellular 
deposits of cellular debris called drusen that are located between Bruch’s 
membrane and the RPE. Drusen contain various components including Aβ 
(Bressler, 1990; Dentchev, 2003). Amyloid misfolding-inducing inflammation 




extent to which the cholesterol-fed rabbit model for AD also exhibits retinal 
pathology relevant to AMD was investigated. Cholesterol-enriched diet increased 
Aβ levels and oxidative stress, induces apoptotic cell death and morphological 
changes, and alters cholesterol metabolism in rabbit retinas. Aβ steady state 
levels are determined by the balance between its production and removal levels. 
Aβ is generated from APP and degraded by several enzymes. Initial cleavage of 
APP involves BACE-1 enzyme to yield Aβ. Aβ1-40 and Aβ1-42 are then degraded 
by various enzymes including IDE.  
Feeding rabbits a diet rich in cholesterol increased Aβ peptide levels as 
well as levels of BACE-1. These results suggest that increased Aβ levels in rabbit 
retinas are derived from an increased APP processing by BACE-1. It may also be 
possible that increased Aβ transport from the circulation to retinas contributes to 
the elevated levels of Aβ peptide in retinas. While some studies showed an 
increase in IDE in AD patients (Caccamo, 2005; Dorfman, 2010; Miners, 2009; 
Vepsalainen, 2008), others have showed reduction in enzyme levels (Cook, 2003; 
Perez, 2000). In one of these studies, it was suggested that the reduction in IDE 
activity is not the primary cause of Aβ accumulation but rather is a late stage 
phenomenon secondary to neurodegeneration (Caccamo, 2005). 
Retinal IDE levels were increased in the cholesterol-fed rabbits. The 
increase in IDE levels may have been a mechanism for coping up with the Aβ 
overload. As Aβ is a neurotoxic peptide and its accumulation in the retina may 
promote oxidative damage and cell death, the extent to which accumulation of Aβ 




Cholesterol-enriched diet-induced Aβ accumulation is associated with 
increased oxidative stress. Proteins, carbohydrates, membrane lipids and nucleic 
acids are all vulnerable to ROS damage, and this damage is believed to contribute 
to the pathogenesis of many diseases. Oxidative injury to cells is associated with 
several diseases, including AD (Aksenov, 2001) and AMD (AREDS report 9, 
2001). DCFH-DA assay indicated that there is an increase in ROS in the retinas of 
cholesterol-fed rabbits. Hydrogen peroxide, which is also considered as reactive 
oxygen species, was increased and peroxidase activity is decreased in cholesterol-
fed rabbit retinas. 
HO-1 is a sensor of oxidative stress that degrades heme, leading to 
formation of biliverdin and carbon monoxide (Maines, 1988; Tenhunen, 1968). 
HO-1 has been shown to be increased in RPE of AMD-affected maculas (Frank, 
1998). HO-1 induction is suggested to be an early event in the pathogenesis of 
sporadic AD (Schipper, 2006) and has been demonstrated to be closely 
associated with neurofibrillary pathology in AD (Smith, 1994). We have 
previously shown that cholesterol-fed rabbits exhibit increased levels of ROS and 
HO-1 in addition to increased Aβ in the brain (Ghribi, 2006). This study showed 
that HO-1 levels are also increased in the retinas of cholesterol-fed rabbits.  
Pathogenesis of many retinal and ocular diseases involves apoptosis. 
Histopathological studies suggest that the retinal pigment epithelium damage 
occurs first, followed by death of photoreceptors (Sarks, 1988), with rod 
photoreceptor cell loss preceding that of cone photoreceptor cells (Curcio, 1996; 
Curcio, 2001). Characteristic DNA fragmentation of apoptosis was detected in 




is the cause of photoreceptor cell death in three mouse models of Retinitis 
pigmentosa (Portera-Cailliau, 1994). It was also shown that photic exposure 
triggers apoptosis of photoreceptor cells (Abler, 1996). Retinal ganglion cells also 
undergo apoptosis in glaucoma (Kerrigan, 1997; Quigley, 1995). As apoptosis may 
be involved in AMD and other retinal diseases and cholesterol-enriched diet has 
been shown to induce apoptosis in rabbit brains (Ghribi, 2006), the extent to 
which cholesterol induces apoptotic cell death in retinas was inspected here.  
The Bcl-2 family of proteins includes both pro- and anti-apoptotic 
members. Bcl-2 is the most prominent anti-apoptotic member and is an 
important regulator of photoreceptor cell death in retinal degenerations (Chen, 
1996). Bcl-2 has been shown to reduce apoptosis by facilitating recovery of 
mitochondrial DNA damage (Deng, 1999). Anti-apoptotic protein Bcl-2 levels 
were decreased and the levels of pro-apoptotic protein Bax were increased in 
retinas of cholesterol-fed rabbits. Cholesterol-enriched diet also increased levels 
of GADD153. a protein that induces cell death and upsets the cellular redox state 
by depleting cellular glutathione and exaggerating the production of ROS 
(McCullough, 2001). 
Development of drusen is one of the earliest clinical features of AMD. 
Drusen are extracellular deposits of lipids, proteins, glycoproteins, and cellular 
debris that accumulate between collagenous layer of Bruch’s membrane and 
basal lamina of the RPE. Recent studies found many drusen constituents which 
include cholesterol, apolipoproteins, and complement components (Crabb, 2002; 
Malek, 2003). In this study, debris-like material between RPE and choroid 




material known as drusen is regarded as a hallmark feature of AMD. In addition, 
GFAP is strongly upregulated in glial cells in response to neuronal damage and is 
best known marker for gliosis. Retinal macroglial cells (astrocytes and Müller 
cells) have an active role in normal retinal function (Newman and Reichenbach, 
1996) as well as in pathology (Dyer and Cepko, 2000). Upregulation of GFAP 
expression, an indicator of reactive gliosis, has been demonstrated in response to 
various retinal pathologies including mechanical injury (Dyer and Cepko, 2000), 
retinal detachment (Okada, 1990), diabetic retinopathy (Mizutani, 1998), 
glaucoma (Wang, 2000), retinal ischaemia (Nishiyama, 2000), and 
photoreceptor degeneration (Eisenfeld, 1984). Increased GFAP expression in 
macroglia has also been described in retinas with AMD (Guidry, 2002; Madigan, 
1994; Ramirez, 2001). The present study shows astrogliosis in the retinas of 
cholesterol-fed rabbits as shown by GFAP immunostaining.  
Vitronectin has regulatory roles in inflammation and phagocytosis 
(Preissner and Seiffert, 1998). Increased vitronectin deposition in retina is 
suggested to participate in the pathogenesis of AMD (Hageman, 1999). A marked 
increase in vitronectin immunoreactivity in retinas from cholesterol-fed rabbits 
was observed. All together, the data revealed that cholesterol-enriched diets 
cause structural and morphological changes relevant to AMD. However, the 
mechanisms by which dietary cholesterol cause these changes in retinas are not 
well known. Recent genome wide association studies implicated cholesterol 
metabolism involvement in AMD (Chen, 2010; Neale, 2010). Cholesterol is 
constantly taken up by retina via LDL receptors from the circulation in addition 




Cholesterol-enriched diet caused an accumulation of cholesterol in the 
retina. As excess cholesterol in cells is detrimental, various mechanisms are 
necessary for cholesterol efflux from cells. These mechanisms include passive 
diffusion, oxysterols formation, and reverse cholesterol transport. ABCA-1 has 
been shown to play a role in the transport of cholesterol, and was detected in the 
retina of various organisms (Duncan, 2009; Tserentsoodol, 2006a). 
ABCA-1 levels are increased in the cholesterol-fed rabbits, implying an 
increase in the cholesterol content in cells and efflux through ABCA-1. 
Cholesterol can be oxidized by enzymatic and non-enzymatic pathways. One of 
the most important enzymatically generated side-chain oxysterols is 27-OHC. 
This oxysterol is formed from cholesterol by CYP27A1 (Bjorkhem, 2009). 
CYP27A1 expression was increased in retinas of cholesterol-fed rabbits as shown 
by laser scanning confocal microscopy and Western blotting. 27-OHC and other 
oxysterols concentrations were measured in retinas by mass spectrometry. 27-
OHC, 22-OHC and 24-OHC levels were increased in cholesterol-fed rabbit retinas 
providing evidence that elimination of excess cholesterol to oxysterols takes place 
in the retina. In contrast to these results in rabbit, a recent study could not detect 
27-OHC in the bovine and human retinas, but found that its oxidation product, 5-
cholestenoic acid is the most abundant oxysterol (Mast, 2011). 5-cholestenoic 
acid was not measured in the present study. 
Other enzymatically generated oxysterols including 7α-OHC, 4β-OHC and 
25-OHC catalyzed by CYP7A1, CYP3A4 and cholesterol 25-hydroxylase 
respectively were also measured. These enzymes oxidize cholesterol for various 




were reported to be expressed in the retina, their oxysterol products were found 
in retinas, most probably coming from blood circulation as retina has access to 
blood borne lipids (Fliesler and Bretillon, 2010). These finding suggest an 
increase in cholesterol in retinas as well as an increase in cholesterol metabolites. 
Numerous studies suggested cytotoxic effects of oxysterols are associated with 
human diseases including AD and AMD (Vejux, 2008). Increased oxysterol 
concentrations subsequently to increased cholesterol levels may contribute to the 
generation of AMD-like pathological hallmarks. 
It is known that deficiency in 7-α-hydroxylase, an enzyme needed to 
prevent 27-OHC accumulation, causes severe neonatal cholestatic liver disease, 
where 27-OHC concentrations in the plasma could reach up to 800 μM (Setchell, 
1998). Similar abnormal accumulation of these metabolites in the retina may put 
this tissue in danger of degeneration. Of these oxysterols, 7-KC has been 
suggested to play a key role in the pathogenesis of AMD and has been recently 
shown to induce DNA damage in human RPE cells (Gramajo, 2010). Other 
oxysterols such as 24-OHC, 25-OHC, 27-OHC, and 7β-OHC triggered 
inflammation, induced oxidative stress and apoptotic cell death in various cells 
(Ares, 2000; Riendeau and Garenc, 2009; Zhang, 1997; Zhou, 1995; Zhou and 
Kummerow, 1997).  
Previous research showed 27-OHC causes AD-like pathology by increasing 
Aβ production and triggering apoptotic cell death in human neuroblastoma SH-
SY5Y cells (Prasanthi, 2009; Rantham Prabhakara, 2008) and in organotypic 
slices from rabbit hippocampus (Ghribi, 2009; Sharma, 2008). As 27-OHC 




apoptotic cell death in human neuroblastoma SH-SY5Y cells and in organotypic 
slices from rabbit hippocampus, this dissertation work focused on 27-OHC 
impact on pathological hallmarks that are common to both AMD and AD by 
using human RPE cell line, ARPE-19.  
Mounting evidence demonstrates that oxysterols have deleterious effects 
that may contribute to the pathogenesis of AD and AMD. However, the 
intracellular mechanisms underlying oxysterols toxicity are not well known. A 
common pathological feature that accumulates both in AD and AMD is Aβ 
(Dentchev, 2003; Johnson, 2002), a peptide that is considered to play a central 
role in the neurodegenerative processes by increasing oxidative stress and cell 
damage. The present study demonstrated for the first time that 27-OHC increases 
the levels of Aβ in RPE cells. Aβ deposition could be an important element in the 
local inflammatory and oxidative processes that contribute to the deterioration of 
photoreceptors and pathogenesis of AMD. The APP protein is present in the RPE 
cytoplasm and Aβ-labeled structures were also identified in RPE cells (Johnson, 
2002), suggesting that RPE cells have the ability to generate Aβ. Aβ accumulation 
observed in this study at least in part is due to increased generation of Aβ peptide 
by the action of BACE-1, the enzyme that initiates the cleavage of APP. 
Accumulation of Aβ and oxidative damage are intrinsically related. 
Oxidative damage in cells can be caused by a variety of factors including 
endoplasmic reticulum stress, ROS generation, GSH depletion and inflammation. 
Endoplasmic reticulum stress has been implicated in both AD (Ghribi, 2006) and 
AMD (Sauer, 2008). The endoplasmic reticulum is the cell compartment where 




depletion of endoplasmic reticulum Ca2+ stores, activation of specific 
endoplasmic reticulum stress proteins such as caspase-12, GADD153 and 
apoptotic cell death (Oyadomari, 2002). 27-OHC-induced endoplasmic reticulum 
stress may be due to the loss of Ca2+ influx and a decrease in endoplasmic 
reticulum Ca2+ levels in these RPE cells. This was consistent since 27-OHC 
showed activation of the endoplasmic reticulum specific apoptotic proteins 
caspase-12 and GADD153. GADD153 is present in the cytosol under normal 
conditions and translocate to the nucleus following sustained endoplasmic 
reticulum stress (Ron and Habener, 1992). Induction of GADD153 was shown to 
upset the cellular redox state by depleting cellular GSH and exaggerating the 
production of ROS (McCullough, 2001). 27-OHC-induced GADD153 activation is 
accompanied by increased levels of ROS and depleted glutathione. 
HO-1 is mainly located in the ER and stimulates the oxidation of 
cholesterol to oxysterols. It is regarded as a sensitive marker of oxidative stress in 
cells and tissues (Hascalovici, 2009; Vaya, 2007). Its induction is suggested to be 
an early event in the pathogenesis of sporadic AD (Schipper, 2006). HO-1 levels 
were also increased in RPE of AMD-affected maculas (Frank, 1998). HO-1 gene 
expression is stimulated by endoplasmic reticulum stress (Liu, 2005). 
Endoplasmic reticulum stress can also cause apoptosis via NF-κB activation (Pahl 
and Baeuerle, 1996). Activation of NF-κB was observed in AD (Kaltschmidt, 1997) 
as well as in AMD (Kaarniranta and Salminen, 2009). 27-OHC increased levels of 
HO-1 and activated NF-κB. This suggests the potential role of 27-OHC as a pro-
oxidant that can cause oxidative damage to retinal cells and in the 




Increased levels of Aβ, endoplasmic reticulum stress, HO-1 and NF-κB are 
accompanied by glutathione depletion as well as elevated levels of ROS. These 
results demonstrate the potential oxidative effects of 27-OHC. Increased levels of 
TNF-α suggest that 27-OHC-induced oxidative stress is associated with triggering 
of inflammatory processes. All together, oxidative stress and inflammation may 
ultimately lead to cell death. This study further demonstrates that 27-OHC is 
cytotoxic, induces the loss of mitochondrial membrane potential and causes 
apoptotic cell death. 
Freshly isolated human retinal pigment epithelial cells and ARPE-19 cells 
also shown to express ERα and ERβ (Giddabasappa, 2010; Marin-Castano, 
2003). In one recent study, ERα gene expression was observed in freshly isolated 
RPE cells but not in ARPE-19 cell culture and primary RPE culture (Dwyer, 
2011). In another study, ERα mRNA but not ERβ mRNA, was detected in ARPE-
19 cells (Paimela, 2010). As cell line establishment and different growth 
conditions may be responsible for these variances in ER expression, ERs 
existence was probed in the ARPE-19 cell line used for this work. 
In this study, the existence of ERα, ERβ, LXRα and LXRβ in both 
cytoplasmic and nuclear fractions of ARPE-19 cells was confirmed by Western 
blotting. Transfection with ERE-luciferase constructs and LXRE-luciferase 
constructs and dual luciferase assays upon treatments with ER agonist E2 and 
LXR agonist GW3965 confirmed ER and LXR transcriptional activity. 
CYP27A1 catalyzes the conversion of cholesterol to 27-OHC. A strong 
stoichiometric correlation has been recognized between circulating levels of 27-




25-OHC is produced from cholesterol primarily by the action of cholesterol 25-
hydroxylase. The ability to produce 25-OHC from cholesterol was also reported 
for sterol 27-hydroxylase and cholesterol 24-hydroxylase (Lund, 1993; Lund, 
1999). 25-OHC has also long been recognized as a cholesterol autoxidation 
product. 7-KC is commonly found in oxLDL associated with atherosclerotic 
plaques. The light is involved in mediating the oxidation of cholesterol to 7-KC in 
retina (Rodriguez and Larrayoz, 2010)  
Whether oxysterols, 27-OHC, 25-OHC and 7-KC have any impact on ER 
and LXR mediated transcriptional activity were explored. 27-OHC, 25-OHC and 
7-KC inhibited the ERE-luciferase activity. 27-OHC, 25-OHC activated LXRE-
luciferase activity, whereas 7-KC did not alter LXRE-luciferase activity. 
Numerous studies suggested that cytotoxic effects of oxysterols are associated 
with human diseases including AMD (Vejux, 2008). Increased oxysterol 
concentrations subsequently to increased cholesterol levels may contribute to the 
generation of AMD-like pathological hallmarks. 27-OHC, 25-OHC and 7-KC were 
shown to be cytotoxic to RPE cells by us and others (Dasari, 2010; Luthra, 2006; 
Ong, 2003). Since these oxysterols also function as ligands of ER and LXR, any 
potential protective or deteriorating effects of ER and LXR ligands in 
combination with 27-OHC, 25-OHC and 7-KC were studied.  
Epidemiologic studies suggest that the risk for AMD is increased in women 
undergoing menopause and that women on hormone-replacement therapy have a 
reduced risk of having the disease (Feskanich, 2008; Friedman, 2004). A 
relationship between use of postmenopausal exogenous E2 and a lower risk of 




Castano, 2003). ERs were shown to be expressed in the male and female retina 
(Munaut, 2001; Ogueta, 1999). Both ER subtypes are expressed in human RPE 
cells and regulated in a dose-dependent fashion by E2 (Marin-Castano, 2003). E2 
has been suggested as a potential therapeutic agent in the management of several 
neurodegenerative disorders because of its actions as an anti-oxidant, anti-
apoptotic and anti-inflammatory agent (Dimayuga, 2005; Moosmann and Behl, 
1999). E2 treatment was reported to attenuate release of cytokines, reactive 
oxygen species, and complement proteins (Bruce-Keller, 2000; Drew and Chavis, 
2000). These protective effects of E2 prompted us to investigate whether E2 is 
protective against the oxysterol induced cytotoxicity in ARPE-19 cells.  
Our study demonstrate that 27-OHC, 25-OHC and 7-KC were cytotoxic to 
ARPE-19 cells and treatment with E2 protected against 25-OHC and 27-OHC 
induced cytotoxicity, whereas ER antagonist ICI 182780 treatment did not offer 
any protection. However 7-KC induced cytotoxicity was not affected by either E2 
or ICI 182780. Then, mitochondrial membrane potential as a marker of 
mitochondrial stress was examined. 25-OHC, 27-OHC and 7-KC caused 
mitochondrial membrane potential decline, which is usually observed during 
apoptosis. E2 treatment counteracted against mitochondrial potential decline in 
cells incubated with 27-OHC and 25-OHC, but not in cells incubated with 7-KC.  
Estrogens inhibit cellular apoptosis through several mechanisms, 
including acting as nonspecific antioxidants, modulation of gene expression 
(Strehlow, 2003) and activation of nongenomic signaling pathways (Fernando 
and Wimalasena, 2004; Urata, 2006; Vasconsuelo, 2008). These mechanisms 




Several in vitro studies have shown that E2 prevents oxidative stress–induced 
apoptosis of retinal neurons (Simpkins, 2005), RPE cells (Giddabasappa, 2010) 
and human lens epithelial cells (HLECs) (Flynn, 2008). Apoptosis induction 
upon oxysterols, 27-OHC, 25-OHC and 7-KC treatment was examined by TUNEL 
method. 27-OHC, 25-OHC and 7-KC all caused apoptosis. E2 protected against 
apoptosis in 27-OHC and 25-OHC treated cells, whereas E2 did not offer any 
protection in 7-KC treated cells. LXR agonist GW3965, antagonist ECHS has not 
offered any protection against cytotoxicity, mitochondrial membrane potential in 
oxysterols 27-OHC, 25-OHC and 7-KC treated cells. 
Estrogen effects are mostly mediated by ER. Classic ER signaling involves 
E2 binding to EREs in the promoter regions of target genes. ERs can also 
modulate non-ERE-containing genes by interacting with the DNA-bound 
transcription factors. A number of studies have advocated that membrane-bound 
estrogen receptors cause rapid nongenomic signaling that modify cellular 
physiology in bone, brain, cardiovascular system, and mammary gland (Levin, 
2001). These rapid effects of estrogens are facilitated by the stimulation of 
signaling cascades such as nitric oxide, receptor tyrosine kinases, G-protein 
coupled receptors, phosphatidylinositol-3-kinase, serene threonine kinase Akt, 
mitogen activated protein kinase family members, protein kinase A and protein 
kinase c (Castoria, 2001; Migliaccio, 1996; Simoncini, 2000). It needs to be 
determined that the protection of E2 occurs through whether ERα, ERβ or non-
genomic signaling pathways. Under normal conditions and when oxysterol levels 
are low, ER function is preserved, whereas conditions which increase these 




levels, ER function could be inhibited by oxysterols. This ER function 
compromise could explain AMD in conditions related to low levels of E2. These 
results emphasize importance of potential estrogen receptor agonists for 
counteracting oxysterol induced toxicity, which could lead to AMD. 
All together, this study showed retinal modifications that are relevant to 
AMD in cholesterol-fed rabbits, a model for AD. Increased levels of Aβ, decreased 
levels of the anti-apoptotic protein Bcl-2, increased levels of the pro-apoptotic 
Bax and GADD153 proteins, emergence of apoptotic cells, and increased 
generation of reactive oxygen species were found in retinas from cholesterol-fed 
compared to normal chow-fed rabbits. Additionally, astrogliosis, drusen-like 
debris and cholesterol accumulations in retinas from cholesterol-fed rabbits were 
observed. Oxysterol levels in retinas from cholesterol-fed rabbits were increased.  
27-OHC dose-dependently increased Aβ peptide production, increased 
levels of endoplasmic reticulum stress specific markers caspase 12 and GADD153, 
reduced mitochondrial membrane potential, triggered Ca2+ dyshomeostasis, and 
increased levels of the NF-κB and HO-1, two proteins activated by oxidative 
stress. Additionally, 27-OHC caused glutathione depletion, ROS generation, 
inflammation and apoptotic-mediated cell death in ARPE-19 cells, a model for 
retinal pigment epithelial cells. ARPE-19 cells express ERα, ERβ, LXRα and 
LXRβ. ERE-luciferase activity is increased by ER agonist E2, and LXRE-
luciferase activity is increased by LXR agonist GW3965 confirming ER and LXR 
transcriptional activity in ARPE-19 cells. ER agonist E2 protected cells from 25-




induced mitochondrial membrane potential decline. E2 treatment protected cells 
from 27-OHC and 25-OHC induced apoptosis. 
Taken together, data demonstrates that cholesterol-enriched diets induce 
pathological hallmarks suggestive of AMD in rabbit retinas. The cholesterol diet 
substantially increased concentrations of the major oxysterols, accumulation of 
which is toxic to retinal cells. Incubation of cells with oxysterols also reproduced 
the majors effects observed in vivo with the diet rich in cholesterol. These results 
strongly suggest that hypercholesterolemia and subsequent increase in oxysterol 
formation may contribute to the pathogenesis of AMD. The data also shows that 
ER modulation may play an important role in the cholesterol and oxysterol 
effects. Specifically, ER agonists may provide protection against oxysterol 
deleterious effects on retinas. As well, reduction of cholesterol plasma levels may 
prevent excess conversion of cholesterol to oxysterols and precludes the 






22-OHC   22-hydroxycholesterol  
24-OHC    24-hydroxycholesterol  
25-OHC   25-hydroxycholesterol 
27-OHC   27- hydroxycholesterol 
4β-OHC   4β-hydroxycholesterol 
7-KC    7-ketocholesterol 
7α-OHC   7α-hydroxycholesterol 
7β-OHC   7β-hydroxycholesterol 
ABCA-1   ATP-binding cassette sub-family A member 1 
AC    Amacrine cells 
AD    Alzheimer's disease  
AMD    Age related macular degeneration 
ANOVA    Analysis of variance 
APP    Amyloid precursor protein 
APS    Ammonium persulfate 
ARM    Age related maculopathy 
ARPE-19    Arising retinal pigment epithelia 
Aβ    Amyloid beta peptide 
BACE-1   Beta-secretase 1 




BCA    Bicinchoninic acid 
Bcl-2     B-cell lymphoma 2 
BM    Bruch's membrane 
BP    Bipolar cells 
BSA    Bovine serum albumin 
CCD    Charge-coupled device 
CNV    Choroidal neovascularization 
CRALBP   Cellular retinal-binding protein 
CRP    C-reactive protein 
CYP11A1  Cholesterol side-chain cleavage enzyme, 
mitochondrial 
 
CYP27A1   Sterol 26-hydroxylase, mitochondrial 
CYP3A4    Cytochrome P450 family 3 subfamily A polypeptide 4 
CYP46A1   Cholesterol 24-hydroxylase 
CYP7A1   Cholesterol 7-alpha-monooxygenase 
DAPI    Diamidino-2-phenylindole 
DCFH-DA   Dichlorofluorescein diacetate 
DMEM   Dulbecco's modified eagle medium 
DMSO   Dimethyl sulfoxide 
DR    Diabetic retinopathy 
E2    Estrogen 
EC    Esterified cholesterol 
ECHS    5α-6α-epoxycholesterol-3-sulfate 




ER    Endoplasmic reticulum 
ERE    Estrogen response element 
ERα    Estrogen receptor α 
ERβ    Estrogen receptor β 
FBS    Fetal bovine serum 
GADD153   Growth arrest and DNA damage inducible gene 153 
GC    Ganglion cells 
GCL    Ganglion cell layer  
GFP    Green fluorescent protein 
GFAP     Glial Fibrillary Acidic Protein 
GSH    Glutathione  
GSSG    Oxidized glutathione 
GST    Glutathione S-transferase 
GW3965   3-[3-[N-(2-Chloro-3-trifluoromethylbenzyl)- 
    (2,2-diphenylethyl)amino] 
propyloxy]phenylacetic acid hydrochloride 
H&E    Hematoxylin and eosin 
H2O2    Hydrogen peroxide  
HC    Horizontal cells 
HDL    High-density lipoprotein 
HO-1    Heme-oxygenase 1 








INL    Inner nuclear layer 
IPL    Inner plexiform layer 
IκB    Nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor 
 
JC-1  5, 5’, 6, 6’-tetrachloro-1,1’,3,3’- 
 tetraethylbenzimidazolylcarbocyanine iodide 
LDH    Lactate dehydrogenase 
LDL    Low-density Lipoprotein   
LXRE    Liver X receptor response elemenr 
LXRα    Liver X receptor alpha 
LXRβ    Liver X receptor beta 
M-PER   Mammalian protein extraction reagent 
NF-κB   Nuclear factor kappa-light-chain-enhancer of 
activated B cells 
NOS    Nitric oxide synthase 
NP-40 Tergitol-type nonyl phenoxypolyethoxylethanol 
NSAIDs   Nonsteroidal anti-inflammatory drugs 
OD     Optical density 
ONL    Outer nuclear layer 
OPL    Outer plexiform layer 
OS    Outer segments  
oxLDL   Oxidized LDL 
PAGE    Polyacrylamide gel electrophoresis 
PBS    Phosphate buffered saline 




POS    Photoreceptor outer segments 
PRL    Photoreceptor layer 
PVDF    Polyvinylidene difluoride 
RGC    Retinal ganglion cells 
ROS    Reactive oxygen species 
RP    Retinitis pigmentosa 
RPE    Retinal pigment epithelium 
SDS    Sodium dodecyl sulfate 
SSC    Saline-sodium citrate 
TEMED   Tetramethylethylenediamine 
Tg    Thapsigargin 
TNF-α   Tumor necrosis factor-α  
T-PER   Tissue protein extraction reagent 
TdT  Terminal deoxynucleotidyl transferase  
 
TUNEL Terminal deoxynucleotidyl transferase mediated 
dUTP nick end labeling 
 
UC Unesterified cholesterol 










Abler, A. S., Chang, C. J., Ful, J., Tso, M. O., and Lam, T. T. (1996) Photic injury 
triggers apoptosis of photoreceptor cells. Research Communications in 
Molecular Pathology & Pharmacology. 92, 177-189. 
 
Abrescia, P., Guardiola, J., Foresti, M., Lamberti, A., and Iaccarino, M. (1979) 
Threonine deaminase: autogenous regulator of the ilv genes in Escherichia coli K-
12. Molecular Genetics and Genomics 171, 261-275. 
Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W., and 
Markesbery, W. R. (2001) Protein oxidation in the brain in Alzheimer's disease. 
Neuroscience 103, 373-383. 
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., and Adamis, A. P. (2005) Age-
related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. 
Survey of Ophthalmology 48, 257-293. 
Amersi, F., Buelow, R., Kato, H., Ke, B., Coito, A. J., Shen, X. D., Zhao, D., Zaky, 
J., Melinek, J., Lassman, C. R., Kolls, J. K., Alam, J., Ritter, T., Volk, H. D., 
Farmer, D. G., Ghobrial, R. M., Busuttil, R. W., and Kupiec-Weglinski, J. W. 
(1999) Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers 
from ischemia/reperfusion injury. The Journal of Clinical Investigation 104, 
1631-1639. 
An, E., Lu, X., Flippin, J., Devaney, J. M., Halligan, B., Hoffman, E. P., 
Strunnikova, N., Csaky, K., and Hathout, Y. (2006) Secreted proteome profiling 
in human RPE cell cultures derived from donors with age related macular 
degeneration and age matched healthy donors. Journal of proteome research 5, 
2599-2610. 
Anderson, D. H., Talaga, K. C., Rivest, A. J., Barron, E., Hageman, G. S., and 
Johnson, L. V. (2004) Characterization of β amyloid assemblies in drusen: The 
deposits associated with aging and age-related macular degeneration. 
Experimental Eye Research 78, 243-256. 
Anderson, D. H., Mullins, R. F., Hageman, G. S., and Johnson, L. V. (2002) A role 
for local inflammation in the formation of drusen in the aging eye. American 




Applegate, L. A., Luscher, P., and Tyrrell, R. M. (1991) Induction of heme 
oxygenase: A general response to oxidant stress in cultured mammalian cells. 
Cancer Reserch 51, 974-978. 
AREDS report 9 (2001) A randomized, placebo-controlled, clinical trial of high-
dose supplementation with vitamins C and E and β-carotene for age-related 
cataract and vision loss: AREDS report no. 9. Archives of Ophthalmology 119, 
1439-1452. 
Ares, M. P., Porn-Ares, M. I., Moses, S., Thyberg, J., Juntti-Berggren, L., 
Berggren, P., Hultgardh-Nilsson, A., Kallin, B., and Nilsson, J. (2000) 7β-
hydroxycholesterol induces Ca2+ oscillations, MAP kinase activation and 
apoptosis in human aortic smooth muscle cells. Atherosclerosis 153, 23-35. 
Arnarsson, A., Sverrisson, T., Stefansson, E., Sigurdsson, H., Sasaki, H., Sasaki, 
K., and Jonasson, F. (2006) Risk factors for five-year incident age-related 
macular degeneration: the Reykjavik Eye Study. American Journal of 
Ophthalmology 142, 419-428. 
Augood, C. A., Vingerling, J. R., de Jong, P. T., Chakravarthy, U., Seland, J., 
Soubrane, G., Tomazzoli, L., Topouzis, F., Bentham, G., Rahu, M., Vioque, J., 
Young, I. S., and Fletcher, A. E. (2006) Prevalence of age-related maculopathy in 
older Europeans: the European Eye Study (EUREYE). Archives of 
Ophthalmology 124, 529-535. 
Bartlett, J. D., Luethy, J. D., Carlson, S. G., Sollott, S. J., and Holbrook, N. J. 
(1992) Calcium ionophore A23187 induces expression of the growth arrest and 
DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)-related gene, 
GADD153. Ca2+ increases transcriptional activity and mRNA stability. Journal of 
Biological Chemistry 267, 20465-20470. 
Beatty, S., Koh, H. H., Phil, M., Henson, D., and Boulton, M. (2009) The role of 
oxidative stress in the pathogenesis of age-related macular degeneration. Survey 
of Ophthalmology 45, 115-134. 
Bejma, J. and Ji, L. L. (1999) Aging and acute exercise enhance free radical 
generation in rat skeletal muscle. Journal of Applied Physiology 87, 465-470. 
Bejma, J., Ramires, P., and Ji, L. L. (2000) Free radical generation and oxidative 
stress with ageing and exercise: differential effects in the myocardium and liver. 
Acta Physiologica Scandinavica 169, 343-351. 
Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., and Schepens, C. L. (2007) 
Retinal abnormalities in early Alzheimer's disease. Investigative Ophthalmology 
and Visual Science 48, 2285-2289. 
Bjorkhem, I. (2002) Do oxysterols control cholesterol homeostasis? Journal of 




Bjorkhem, I., Heverin, M., Leoni, V., Meaney, S., and Diczfalusy, U. (2006) 
Oxysterols and Alzheimer's disease. ACTA Neurologica Scandinavica 
Supplementum 185, 43-49. 
Bjorkhem, I., Cedazo-Minguez, A., Leoni, V., and Meaney, S. (2009) Oxysterols 
and neurodegenerative diseases. Molecular Aspects of Medicine 30, 171-179. 
Bok, D. (1985) Retinal photoreceptor-pigment epithelium interactions. 
Friedenwald lecture. Investigative Ophthalmology and Visual Science 26, 1659-
1694. 
Bressler, N. M., Bressler, S. B., West, S. K., Fine, S. L., and Taylor, H. R. (1989) 
The grading and prevalence of macular degeneration in Chesapeake Bay 
watermen. Archives of Ophthalmology 107, 847-852. 
Bressler, S. B., Maguire, M. G., Bressler, N. M., Fine, S. L., and the Macular 
Photocoagulation Study Group (1990) Relationship of drusen and abnormalities 
of the retinal pigment epithelium to the prognosis of neovascular macular 
degeneration. Archives of Ophthalmology 108, 1442-1447. 
Bringmann, A., Pannicke, T., Grosche, J., Francke, M., Wiedemann, P., 
Skatchkov, S. N., Osborne, N. N., and Reichenbach, A. (2006) Müller cells in the 
healthy and diseased retina. Progress in Retinal and Eye Research 25, 397-424. 
Brown, A. J. and Jessup, W. (1999) Oxysterols and atherosclerosis. 
Atherosclerosis 142, 1-28. 
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, 
J. P., and Schneider, S. (2006) Ranibizumab versus Verteporfin for neovascular 
age-related macular degeneration. New England Journal of Medicine 355, 1432-
1444. 
Bruce-Keller, A. J., Keeling, J. L., Keller, J. N., Huang, F. F., Camondola, S., and 
Mattson, M. P. (2000) Antiinflammatory effects of estrogen on microglial 
activation. Endocrinology 141, 3646-3656. 
Buch, H., Nielsen, N. V., Vinding, T., Jensen, G. B., Prause, J. U., and la, C. M. 
(2005a) 14-year incidence, progression, and visual morbidity of age-related 
maculopathy: The Copenhagen City Eye Study. Ophthalmology 112, 787-798. 
Buch, H., Vinding, T., la, C. M., Jensen, G. B., Prause, J. U., and Nielsen, N. V. 
(2005b) Risk factors for age-related maculopathy in a 14-year follow-up study: 






Buch, H., Vinding, T., la, C. M., and Nielsen, N. V. (2001) The prevalence and 
causes of bilateral and unilateral blindness in an elderly urban Danish 
population. The Copenhagen City Eye Study. ACTA Ophthalmologica 
Scandinavica 79, 441-449. 
Burns, R. P. and Feeney-Burns, L. (1980) Clinico-morphologic correlations of 
drusen of Bruch's membrane. Transactions of the American Ophthalmological 
Society 78, 206-225. 
Butterfield, D. A., Griffin, S., Munch, G., and Pasinetti, G. M. (2002) Amyloid β-
peptide and amyloid pathology are central to the oxidative stress and 
inflammatory cascades under which Alzheimer's disease brain exists. Journal of 
Alzheimer’s Disease 4, 193-201. 
Caccamo, A., Oddo, S., Sugarman, M. C., Akbari, Y., and LaFerla, F. M. (2005) 
Age-and region-dependent alterations in Aβ-degrading enzymes: Implications for 
Aβ-induced disorders. Neurobiology of Aging 26, 645-654. 
Cai, J., Wu, M., Nelson, K. C., Sternberg, P., Jr., and Jones, D. P. (1999) Oxidant-
induced apoptosis in cultured human retinal pigment epithelial cells. 
Investigative Ophthalmology and Visual Science 40, 959-966. 
Castoria, G., Migliaccio, A., Bilancio, A., Di Domenico, M., de Falco, A., 
Lombardi, M., Fiorentino, R., Varricchio, L., Barone, M. V., and Auricchio, F. 
(2001) PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-
stimulated MCF-7 cells. EMBO Journal 20, 6050-6059. 
Cepko, C. (1993) Lineage versus environment in the embryonic retina. Trends in 
Neurosciences 16, 96-97. 
Chakravarthy, U., Augood, C., Bentham, G. C., de Jong, P. T., Rahu, M., Seland, 
J., Soubrane, G., Tomazzoli, L., Topouzis, F., Vingerling, J. R., Vioque, J., Young, 
I. S., and Fletcher, A. E. (2007) Cigarette smoking and age-related macular 
degeneration in the EUREYE study. Ophthalmology 114, 1157-1163. 
Chang, J. Y. and Liu, L. Z. (1998) Toxicity of cholesterol oxides on cultured 
neuroretinal cells. Current Eye Research 17, 95-103. 
Chen, J., Flannery, J. G., LaVail, M. M., Steinberg, R. H., Xu, J., and Simon, M. I. 
(1996) Bcl-2 overexpression reduces apoptotic photoreceptor cell death in three 
different retinal degenerations. Proceedings of the National Academy of Sciences 
of the United States of America 93, 7042-7047. 
Chen, J. J., Lukyanenko, Y., and Hutson, J. C. (2002) 25-hydroxycholesterol is 
produced by testicular macrophages during the early postnatal period and 





Chen, W., Stambolian, D., Edwards, A. O., Branham, K. E., Othman, M., 
Jakobsdottir, J., Tosakulwong, N., Pericak-Vance, M. A., Campochiaro, P. A., 
Klein, M. L., Tan, P. L., Conley, Y. P., Kanda, A., Kopplin, L., Li, Y., Augustaitis, K. 
J., Karoukis, A. J., Scott, W. K., Agarwal, A., Kovach, J. L., Schwartz, S. G., Postel, 
E. A., Brooks, M., Baratz, K. H., Brown, W. L., Brucker, A. J., Orlin, A., Brown, G., 
Ho, A., Regillo, C., Donoso, L., Tian, L., Kaderli, B., Hadley, D., Hagstrom, S. A., 
Peachey, N. S., Klein, R., Klein, B. E. K., Gotoh, N., Yamashiro, K., Ferris, F., 
Fagerness, J. A., Reynolds, R., Farrer, L. A., Kim, I. K., Miller, J. W., Cortón, M., 
Carracedo, A., Sanchez-Salorio, M., Pugh, E. W., Doheny, K. F., Brion, M., 
DeAngelis, M. M., Weeks, D. E., Zack, D. J., Chew, E. Y., Heckenlively, J. R., 
Yoshimura, N., Iyengar, S. K., Francis, P. J., Katsanis, N., Seddon, J. M., Haines, 
J. L., Gorin, M. B., Abecasis, G. R., and Swaroop, A. (2010) Genetic variants near 
TIMP3 and high-density lipoprotein-associated loci influence susceptibility to 
age-related macular degeneration. Proceedings of the National Academy of 
Sciences of the United States of America 107, 7401-7406. 
Chen, W., Chen, G., Head, D. L., Mangelsdorf, D. J., and Russell, D. W. (2007) 
Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the 
livers of mice. Cell Metabolism 5, 73-79. 
Cheung, N., Liao, D., Islam, F. M., Klein, R., Wang, J. J., and Wong, T. Y. (2007) 
Is early age-related macular degeneration related to carotid artery stiffness? The 
Atherosclerosis Risk in Communities Study. British Journal of Ophthalmology 
91, 430-433. 
Clark, J. E., Foresti, R., Sarathchandra, P., Kaur, H., Green, C. J., and Motterlini, 
R. (2000) Heme oxygenase-1-derived bilirubin ameliorates postischemic 
myocardial dysfunction. American Journal of Physiology - Heart and Circular 
Physiology 278, H643-H651. 
Colles, S. M., Maxson, J. M., Carlson, S. G., and Chisolm, G. M. (2001) Oxidized 
LDL-induced injury and apoptosis in atherosclerosis. Potential roles for 
oxysterols. Trends in Cardiovascular Medicine 11, 131-138. 
Connell, P. P., Keane, P. A., O'Neill, E. C., Altaie, R. W., Loane, E., Neelam, K., 
Nolan, J. M., and Beatty, S. (2009) Risk factors for age-related maculopathy. 
Journal of Ophthalmology 2009, 360764. 
Cook, D. G., Leverenz, J. B., McMillan, P. J., Kulstad, J. J., Ericksen, S., Roth, R. 
A., Schellenberg, G. D., Jin, L. W., Kovacina, K. S., and Craft, S. (2003) Reduced 
hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease Is 
associated with the Apolipoprotein E-e4 allele. American Journal of Pathology 
162, 313-319. 
Cordeiro, M. F., Guo, L., Coxon, K. M., Duggan, J., Nizari, S., Normando, E. M., 
Sensi, S. L., Sillito, A. M., Fitzke, F. W., Salt, T. E., and Moss, S. E. (2010) 
Imaging multiple phases of neurodegeneration: A novel approach to assessing 




Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G., and Franceschi, C. (1993) 
A new method for the cytofluorimetric analysis of mitochondrial membrane 
potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-
1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochemical and 
Biophysical Research Communications 197, 40-45. 
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, 
M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., and Hollyfield, J. G. 
(2002) Drusen proteome analysis: An approach to the etiology of age-related 
macular degeneration. Proceedings of the National Academy of Sciences of the 
United States of America 99, 14682-14687. 
Curcio, C. A. (2001) Photoreceptor topography in ageing and age-related 
maculopathy. Eye 15, 376-383. 
Curcio, C. A., Medeiros, N. E., and Millican, C. L. (1996) Photoreceptor loss in 
age-related macular degeneration. Investigative Ophthalmology and Visual 
Science 37, 1236-1249. 
Curcio, C. A. and Millican, C. L. (1999) Basal linear deposit and large drusen are 
specific for early age-related maculopathy. Archives of Ophthalmology 117, 329-
339. 
Curcio, C. A., Presley, J. B., Millican, C. L., and Medeiros, N. E. (2005a) Basal 
deposits and drusen in eyes with age-related maculopathy: Evidence for solid 
lipid particles. Experimental Eye Research 80, 761-775. 
Curcio, C. A., Millican, C. L., Bailey, T., and Kruth, H. S. (2001) Accumulation of 
cholesterol with age in human Bruch's membrane. Investigative Ophthalmology 
and Visual Science 42, 265-274. 
Curcio, C. A., Presley, J. B., Malek, G., Medeiros, N. E., Avery, D. V., and Kruth, 
H. S. (2005b) Esterified and unesterified cholesterol in drusen and basal deposits 
of eyes with age-related maculopathy. Experimental Eye Research 81, 731-741. 
Dasari, B., Prasanthi, J., Marwarha, G., Singh, B., and Ghribi, O. (2010) The 
oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in 
retinal pigment epithelial cells. BMC Ophthalmology 10, 22. 
de Jong, P. T. V. M. (2006) Age-related macular degeneration. The New England 
Journal of Medicine 355, 1474-1485. 
Delcourt, C., Cristol, J. P., Tessier, F., Leger, C. L., Descomps, B., and Papoz, L. 
(1999) Age-related macular degeneration and antioxidant status in the POLA 
study. POLA Study Group. Pathologies Oculaires Liees a l'Age. Archives of 




Delcourt, C., Lacroux, A., and Carriere, I. (2005) The three-year incidence of age-
related macular degeneration: The "Pathologies Oculaires Liees a l'Age" (POLA) 
prospective study. American Journal of Ophthalmology 140, 924-926. 
Delcourt, C., Michel, F., Colvez, A., Lacroux, A., Delage, M., and Vernet, M. H. 
(2001) Associations of cardiovascular disease and its risk factors with age-related 
macular degeneration: The POLA study. Ophthalmic Epidemiology 8, 237-249. 
Deng, G., Su, J. H., Ivins, K. J., Van Houten, B., and Cotman, C. W. (1999) Bcl-2 
facilitates recovery from DNA damage after oxidative stress. Experimental 
Neurology 159, 309-318. 
Dentchev, T., Milam, A. H., Lee, V. M., Trojanowski, J. Q., and Dunaief, J. L. 
(2003) Amyloid-β is found in drusen from some age-related macular 
degeneration retinas, but not in drusen from normal retinas. Molecular Vision 9, 
184-190. 
Dimayuga, F. O., Reed, J. L., Carnero, G. A., Wang, C., Dimayuga, E. R., 
Dimayuga, V. M., Perger, A., Wilson, M. E., Keller, J. N., and Bruce-Keller, A. J. 
(2005) Estrogen and brain inflammation: Effects on microglial expression of 
MHC, costimulatory molecules and cytokines. Journal of Neuroimmunology 
161, 123-136. 
Ding, J. D., Lin, J., Mace, B. E., Herrmann, R., Sullivan, P., and Bowes, R. C. 
(2008) Targeting age-related macular degeneration with Alzheimer's disease 
based immunotherapies: Anti-amyloid-β antibody attenuates pathologies in an 
age-related macular degeneration mouse model. Vision Research 48, 339-345. 
Ding, J. D., Johnson, L. V., Herrmann, R., Farsiu, S., Smith, S. G., Groelle, M., 
Mace, B. E., Sullivan, P., Jamison, J. A., Kelly, U., Harrabi, O., Bollini, S. S., 
Dilley, J., Kobayashi, D., Kuang, B., Li, W., Pons, J., Lin, J. C., and Rickman, C. B. 
(2011) Anti-amyloid therapy protects against retinal pigmented epithelium 
damage and vision loss in a model of age-related macular degeneration. 
Proceedings of the National Academy of Sciences of the United States of 
America 108 (28) 11307–11308 
Ding, X., Patel, M., and Chan, C. C. (2009) Molecular pathology of age-related 
macular degeneration. Progress in Retinal and Eye Research 28, 1-18. 
Donoso, L. A., Kim, D., Frost, A., Callahan, A., and Hageman, G. (2003) The role 
of inflammation in the pathogenesis of age-related macular degeneration. Survey 
of Ophthalmology 51, 137-152. 
Dorfman, V. B., Pasquini, L., Riudavets, M., Lopez-Costa, J. J., Villegas, A., 
Troncoso, J. C., Lopera, F., Castano, E. M., and Morelli, L. (2010) Differential 
cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease. 




Drew, P. D. and Chavis, J. A. (2000) Female sex steroids: Effects upon microglial 
cell activation. Journal of Neuroimmunology 111, 77-85. 
Dugas, B., Charbonnier, S., Baarine, M., Ragot, K., Delmas, D., Ménétrier, F., 
Lherminier, J., Malvitte, L., Khalfaoui, T., Bron, A., Creuzot-Garcher, C., Latruffe, 
N., and Lizard, G. (2010) Effects of oxysterols on cell viability, inflammatory 
cytokines, VEGF, and reactive oxygen species production on human retinal cells: 
Cytoprotective effects and prevention of VEGF secretion by resveratrol. 
European Journal of Nutrition 49, 435-446. 
Duncan, K. G., Hosseini, K., Bailey, K. R., Yang, H., Lowe, R. J., Matthes, M. T., 
Kane, J. P., LaVail, M. M., Schwartz, D. M., and Duncan, J. L. (2009) Expression 
of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and 
scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. 
British Journal of Ophthalmology 93, 1116-1120. 
Dunn, K. C., Otaki-Keen, A. E., Putkey, F. R., and H Jelmeland, L. M. (1996) 
ARPE-19, a human retinal pigment epithelial cell line with differentiated 
properties. Experimental Eye Research 62, 155-170. 
Durante, W., Kroll, M. H., Christodoulides, N., Peyton, K. J., and Schafer, A. I. 
(1997) Nitric oxide induces heme oxygenase-1 gene expression and carbon 
monoxide production in vascular smooth muscle cells. Circulation Research 80, 
557-564. 
Dwyer, M. A., Kazmin, D., Hu, P., McDonnell, D. P., and Malek, G. (2011) 
Research resource: nuclear receptor atlas of human retinal pigment epithelial 
cells: Potential relevance to age-related macular degeneration. Molecular 
Endocrinology 25, 360-372. 
Dyer, M. A. and Cepko, C. L. (2000) Control of Muller glial cell proliferation and 
activation following retinal injury. Nature Neuroscience 3, 873-880. 
Eisenfeld, A. J., Bunt-Milam, A. H., and Sarthy, P. V. (1984) Muller cell 
expression of glial fibrillary acidic protein after genetic and experimental 
photoreceptor degeneration in the rat retina. Investigative Ophthalmology and 
Visual Science 25, 1321-1328. 
Evans, J. and Wormald, R. (1996) Is the incidence of registrable age-related 
macular degeneration increasing? British Journal of Ophthalmology 80, 9-14. 
Evans, J. R. (2001) Risk factors for age-related macular degeneration. Progress 
in Retina and Eye Research 20, 227-253. 
Eymin, B., Dubrez, L., Allouche, M., and Solary, E. (1997) Increased GADD153 
messenger RNA level is associated with apoptosis in human leukemic cells 




Fang, M., Kearns, B. G., Gedvilaite, A., Kagiwada, S., Kearns, M., Fung, M. K., 
and Bankaitis, V. A. (1996) Kes1p shares homology with human oxysterol binding 
protein and participates in a novel regulatory pathway for yeast Golgi-derived 
transport vesicle biogenesis. EMBO Journal 15, 6447-6459. 
Farkas, T. G., Sylvester, V., and Archer, D. (1971) The ultrastructure of drusen. 
American Journal of Ophthalmology 71, 1196-1205. 
Feng, B., Yao, P. M., Li, Y., Devlin, C. M., Zhang, D., Harding, H. P., Sweeney, M., 
Rong, J. X., Kuriakose, G., Fisher, E. A., Marks, A. R., Ron, D., and Tabas, I. 
(2003) The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity 
in macrophages. Nature Cell Biology. 5, 781-792. 
Fernando, R. I. and Wimalasena, J. (2004) Estradiol abrogates apoptosis in 
breast cancer cells through inactivation of BAD: Ras-dependent nongenomic 
pathways requiring signaling through ERK and Akt. Molecular Biology of the Cell 
15, 3266-3284. 
Feskanich, D., Cho, E., Schaumberg, D. A., Colditz, G. A., and Hankinson, S. E. 
(2008) Menopausal and reproductive factors and risk of age-related macular 
degeneration. Archives of Ophthalmology 126, 519-524. 
Finking, G. and Hanke, H. (1997) Nikolaj Nikolajewitsch Anitschkow (1885-1964) 
established the cholesterol-fed rabbit as a model for atherosclerosis research. 
Atherosclerosis 135, 1-7. 
Fliesler, S. J., Florman, R., Rapp, L. M., Pittler, S. J., and Keller, R. K. (1993) In 
vivo biosynthesis of cholesterol in the rat retina. FEBS Letters 335, 234-238. 
Fliesler, S. J. and Keller, R. K. (1997) Isoprenoid metabolism in the vertebrate 
retina. International Journal of Biochemistry and Cell Biology 29, 877-894. 
Fliesler, S. J. and Bretillon, L. (2010) The ins and outs of cholesterol in the 
vertebrate retina. Journal of Lipid Research 51, 3399-3413. 
Flynn, J. M., Dimitrijevich, S. D., Younes, M., Skliris, G., Murphy, L. C., and 
Cammarata, P. R. (2008) Role of wild-type estrogen receptor-β in mitochondrial 
cytoprotection of cultured normal male and female human lens epithelial cells. 
American Journal of Physiology, Endocrinology and Metabolism 295, E637-
E647. 
Foresti, R., Sarathchandra, P., Clark, J. E., Green, C. J., and Motterlini, R. (1999) 
Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: A link to 





Fornace, A. J., Alamo, I., and Hollander, M. C. (1988) DNA damage-inducible 
transcripts in mammalian cells. Proceedings of the National Academy of 
Sciences of the United States of America of the United States of America 85, 
8800-8804. 
Frank, R. N. (1998) "Oxidative protector" enzymes in the macular retinal pigment 
epithelium of aging eyes and eyes with age-related macular degeneration. 
Transactions of the American Ophthalmological Society 96, 635-689. 
Friedman, A. D. (1996) GADD153/CHOP, a DNA damage-inducible protein, 
reduced CAAT/enhancer binding protein activities and increased apoptosis in 
32D cl3 myeloid cells. Cancer Research 56, 3250-3256. 
Friedman, D. S., O'Colmain, B. J., Munoz, B., Tomany, S. C., McCarty, C., de 
Jong, P. T., Nemesure, B., Mitchell, P., and Kempen, J. (2004) Prevalence of age-
related macular degeneration in the United States. Archives of Ophthalmology 
122, 564-572. 
Fu, X., Menke, J. G., Chen, Y., Zhou, G., MacNaul, K. L., Wright, S. D., Sparrow, 
C. P., and Lund, E. G. (2001) 27-hydroxycholesterol is an endogenous ligand for 
liver X receptor in cholesterol-loaded cells. Journal of Biological Chemistry 276, 
38378-38387. 
Gehrs, K. M., Anderson, D. H., Johnson, L. V., and Hageman, G. S. (2006) Age- 
related macular degeneration-emerging pathogenetic and therapeutic concepts. 
Annals of Medicine 38, 450-471. 
Gerschman, R., Gilbert, D., Nye, S. W., Dwyer, P., and Fenn, W. O. (2001) 
Oxygen poisoning and X-irradiation: A mechanism in common. 1954. Nutrition 
17, 162. 
Ghribi, O. (2006) The role of the endoplasmic reticulum in the accumulation of 
β-amyloid peptide in Alzheimer's disease. Current Molecular Medicine 6, 119-
133. 
Ghribi, O. (2008) Potential mechanisms linking cholesterol to Alzheimer's 
disease-like pathology in rabbit brain, hippocampal organotypic slices, and 
skeletal muscle. Journal of Alzheimer's Disease 15, 673-684. 
Ghribi, O., Golovko, M. Y., Larsen, B., Schrag, M., and Murphy, E. J. (2006) 
Deposition of iron and β-Amyloid plaques is associated with cortical cellular 
damage in rabbits fed with long-term cholesterol-enriched diets. Journal of 
Neurochemistry 99, 438-449. 
Ghribi, O., Schommer, E., and Prasanthi, J. R. P. (2009) 27-hydroxycholestrol as 
the missing link between circulating cholesterol and AD-like pathology. 




Giddabasappa, A., Bauler, M., Yepuru, M., Chaum, E., Dalton, J. T., and 
Eswaraka, J. (2010) 17-β estradiol protects ARPE-19 cells from oxidative stress 
through estrogen receptor-β. Investigative Ophthalmology and Visual Science 
51, 5278-5287. 
Girao, H., Mota, M. C., Ramalho, J., and Pereira, P. (1998) Cholesterol oxides 
accumulate in human cataracts. Experimental Eye Research 66, 645-652. 
Goldberg, J., Flowerdew, G., Smith, E., Brody, J. A., and Tso, M. O. (1988) 
Factors associated with age-related macular degeneration. An analysis of data 
from the first National Health and Nutrition Examination Survey. American 
Journal of Epidemiology 128, 700-710. 
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., and Guyer, D. 
R. (2004) Pegaptanib for neovascular age-related macular degeneration. New 
England Journal of Medicine 351, 2805-2816. 
Gramajo, A. L., Zacharias, L. C., Neekhra, A., Luthra, S., Atilano, S. R., Chwa, M., 
Brown, D. J., Kuppermann, B. D., and Kenney, M. C. (2010) Mitochondrial DNA 
damage induced by 7-Ketocholesterol in human retinal pigment epithelial Cells 
In Vitro. Investigative Ophthalmology Visual Science 51, 1164-1170. 
Green, D. R. and Reed, J. C. (1998) Mitochondria and apoptosis. Science 281, 
1309-1312. 
Green, W. R. (1999) Histopathology of age-related macular degeneration. 
Molecular Vision 5, 27. 
Green, W. R. and Enger, C. (1993) Age-related macular degeneration 
histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. 
Ophthalmology 100, 1519-1535. 
Green, W. R. and Key, S. N., III (2005) Senile macular degeneration: A 
histopathologic study. 1977. Retina 25, 180-250. 
Griffith, O. W. (1999) Biologic and pharmacologic regulation of mammalian 
glutathione synthesis. Free Radical Biology and Medicine 27, 922-935. 
Grosso, A., Mosley, T. H., Klein, R., Couper, D. J., Tikellis, G., and Wong, T. Y. 
(2007) Is early age-related macular degeneration associated with cerebral MRI 
changes? The atherosclerosis risk in communities study. American Journal of 
Ophthalmology 143, 157-159. 
Guidry, C., Medeiros, N. E., and Curcio, C. A. (2002) Phenotypic variation of 
retinal pigment epithelium in age-related macular degeneration. Investigative 




Guo, L., Duggan, J., and Cordeiro, M. F. (2010) Alzheimer's disease and retinal 
neurodegeneration. Current Alzheimer Research 7, 3-14. 
Hageman, G. S. and Mullins, R. F. (1999) Molecular composition of drusen as 
related to substructural phenotype. Molecular Vision 5, 28. 
Hageman, G. S., Mullins, R. F., Russell, S. R., Johnson, L. V., and Anderson, D. 
H. (1999) Vitronectin is a constituent of ocular drusen and the vitronectin gene is 
expressed in human retinal pigmented epithelial cells. FASEB Journal 13, 477-
484. 
Haimovici, R., Gantz, D. L., Rumelt, S., Freddo, T. F., and Small, D. M. (2001) 
The lipid composition of drusen, Bruch's membrane, and sclera by hot stage 
polarizing light microscopy. Investigative Ophthalmology and Visual Science 
42, 1592-1599. 
Hanley, K., Ng, D. C., He, S. S., Lau, P., Min, K., Elias, P. M., Bikle, D. D., 
Mangelsdorf, D. J., Williams, M. L., and Feingold, K. R. (2000) Oxysterols induce 
differentiation in human keratinocytes and increase Ap-1-dependent involucrin 
transcription. Journal of Investigative Dermatology 114, 545-553. 
Harding, H. P., Zhang, Y., and Ron, D. (1999) Protein translation and folding are 
coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271-274. 
Hascalovici, J. R., Vaya, J., Khatib, S., Holcroft, C. A., Zukor, H., Song, W., 
Arvanitakis, Z., Bennett, D. A., and Schipper, H. M. (2009) Brain sterol 
dysregulation in sporadic AD and MCI: Relationship to heme oxygenase-1. 
Journal of Neurochemistry 110, 1241-1253. 
Hawkins, B. S., Bird, A., Klein, R., and West, S. K. (1999) Epidemiology of age-
related macular degeneration. Molecular Vision 5, 26. 
Hayden, J. M., Brachova, L., Higgins, K., Obermiller, L., Sevanian, A., Khandrika, 
S., and Reaven, P. D. (2002) Induction of monocyte differentiation and foam cell 
formation in vitro by 7-ketocholesterol. Journal of Lipid Research 43, 26-35. 
Heuberger, R. A., Fisher, A. I., Jacques, P. F., Klein, R., Klein, B. E., Palta, M., 
and Mares-Perlman, J. A. (2002) Relation of blood homocysteine and its 
nutritional determinants to age-related maculopathy in the third National Health 
and Nutrition Examination Survey. American Journal of Clinical Nutrition 76, 
897-902. 
Heuberger, R. A., Mares-Perlman, J. A., Klein, R., Klein, B. E., Millen, A. E., and 
Palta, M. (2001) Relationship of dietary fat to age-related maculopathy in the 
Third National Health and Nutrition Examination Survey. Archives of 




Hinton, D. R., He, S., and Lopez, P. F. (1998) Apoptosis in surgically excised 
choroidal neovascular membranes in age-related macular degeneration. Archives 
of Ophthalmology 116, 203-209. 
Hinton, D. R., Sadun, A. A., Blanks, J. C., and Miller, C. A. (1986) Optic-nerve 
degeneration in Alzheimer's disease. New England Journal of Medicine 315, 
485-487. 
Holz, F. G., Sheraidah, G., Pauleikhoff, D., and Bird, A. C. (1994) Analysis of lipid 
deposits extracted from human macular and peripheral Bruch's membrane. 
Archives of Ophthalmology 112, 402-406. 
Hooper, C. Y. and Guymer, R. H. (2003) New treatments in age-related macular 
degeneration. Clinical & Experimental Ophthalmology 31, 376-391. 
Hyman, L., Wu, S. Y., Connell, A. M., Schachat, A., Nemesure, B., Hennis, A., and 
Leske, M. C. (2001) Prevalence and causes of visual impairment in the Barbados 
eye study. Ophthalmology 108, 1751-1756. 
Iseri, P. K., Altinas, o., Tokay, T., and Yuksel, N. (2006) Relationship between 
Cognitive impairment and retinal morphological and visual functional 
abnormalities in Alzheimer disease. Journal of Neuro-Ophthalmology 26. 
Ishibashi, T., Patterson, R., Ohnishi, Y., Inomata, H., and Ryan, S. J. (1986a) 
Formation of drusen in the human eye. American Journal of Ophthalmology 
101, 342-353. 
Ishibashi, T., Sorgente, N., Patterson, R., and Ryan, S. J. (1986b) Pathogenesis of 
drusen in the primate. Investigative Ophthalmology and Visual Science 27, 184-
193. 
Ishida, B. Y., Bailey, K. R., Duncan, K. G., Chalkley, R. J., Burlingame, A. L., 
Kane, J. P., and Schwartz, D. M. (2004) Regulated expression of apolipoprotein E 
by human retinal pigment epithelial cells. Journal of Lipid Research 45, 263-
271. 
Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. 
J., and Mangelsdorf, D. J. (1999) Structural requirements of ligands for the 
oxysterol liver X receptors LXRα and LXRβ. Proceedings of the National 
Academy of Sciences of the United States of America 96, 266-271. 
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., and Mangelsdorf, D. J. 
(1996) An oxysterol signalling pathway mediated by the nuclear receptor LXRα. 
Nature 383, 728-731. 
Javitt, N. B. (2007) Oxysterols: Functional significance in fetal development and 





Javitt, N. B. (2008) Oxysterols: Novel biologic roles for the 21st century. Steroids 
73, 149-157. 
Javitt, N. B. and Javitt, J. C. (2009) The retinal oxysterol pathway: A unifying 
hypothesis for the cause of age-related macular degeneration. Current Opinion in 
Ophthalmology 20, 151-157. 
Joffre, C., Leclere, L., Buteau, B., Martine, L., Cabaret, S., Malvitte, L., Acar, N., 
Lizard, G., Bron, A., Creuzot-Garcher, C., and Bretillon, L. (2007) Oxysterols 
induced inflammation and oxidation in primary porcine retinal pigment 
epithelial cells. Current Eye Research 32, 271-280. 
Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., and 
Anderson, D. H. (2002) The Alzheimer's Aβ-peptide is deposited at sites of 
complement activation in pathologic deposits associated with aging and age-
related macular degeneration. Proceedings of the National Academy of Sciences 
of the United States of America 99, 11830-11835. 
Jonasson, F., Arnarsson, A., Peto, T., Sasaki, H., Sasaki, K., and Bird, A. C. (2005) 
5-year incidence of age-related maculopathy in the Reykjavik Eye Study. 
Ophthalmology 112, 132-138. 
Jonasson, F., Arnarsson, A., Sasaki, H., Peto, T., Sasaki, K., and Bird, A. C. (2003) 
The prevalence of age-related maculopathy in iceland: Reykjavik eye study. 
Archives of Ophthalmology 121, 379-385. 
Kaarniranta, K. and Salminen, A. (2009) NF-ĸB signaling as a putative target for 
omega-3 metabolites in the prevention of age-related macular degeneration 
(AMD). Experimental Gerontology 44, 685-688. 
Kaarniranta, K., Salminen, A., Haapasalo, A., Soininen, H., and Hiltunen, M. 
(2011) Age-related macular degeneration (AMD): Alzheimer's disease in the eye? 
Journal of Alzheimer's Disease 24(4):615-31 
Kahn, H. A., Leibowitz, H. M., Ganley, J. P., Kini, M. M., Colton, T., Nickerson, R. 
S., and Dawber, T. R. (1977a) The Framingham Eye Study. I. Outline and major 
prevalence findings. American Journal of Epidemiology 106, 17-32. 
Kahn, H. A., Leibowitz, H. M., Ganley, J. P., Kini, M. M., Colton, T., Nickerson, R. 
S., and Dawber, T. R. (1977b) The Framingham Eye Study. II. Association of 
ophthalmic pathology with single variables previously measured in the 
Framingham Heart Study. American Journal of Epidemiology 106, 33-41. 
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., and Kaltschmidt, C. (1997) 
Transcription factor NF-ĸB is activated in primary neurons by amyloid β peptides 
and in neurons surrounding early plaques from patients with Alzheimer disease. 
Proceedings of the National Academy of Sciences of the United States of 




Kaplowitz, N., Aw, T. Y., and Ookhtens, M. (1985) The regulation of hepatic 
glutathione. Annual Review of Pharmacology and Toxicology 25, 715-744. 
Karuna, R., Holleboom, A. G., Motazacker, M. M., Kuivenhoven, J. A., Frikke-
Schmidt, R., Tybjaerg-Hansen, A., Georgopoulos, S., van, E. M., van Berkel, T. J., 
von, E. A., and Rentsch, K. M. (2011) Plasma levels of 27-hydroxycholesterol in 
humans and mice with monogenic disturbances of high density lipoprotein 
metabolism. Atherosclerosis 214, 448-455. 
Katayama, T., Imaizumi, K., Manabe, T., Hitomi, J., Kudo, T., and Tohyama, M. 
(2004) Induction of neuronal death by ER stress in Alzheimer's disease. Journal 
of Chemical Neuroanatomy 28, 67-78. 
Katz, B. and Rimmer, S. (1989) Ophthalmologic manifestations of Alzheimer's 
disease. Survey of Ophthalmology 34, 31-43. 
Kawasaki, R., Yasuda, M., Song, S. J., Chen, S. J., Jonas, J. B., Wang, J. J., 
Mitchell, P., and Wong, T. Y. (2010) The prevalence of age-related macular 
degeneration in Asians: A systematic review and meta-analysis. Ophthalmology 
117, 921-927. 
Kerrigan, L. A., Zack, D. J., Quigley, H. A., Smith, S. D., and Pease, M. E. (1997) 
TUNEL-positive ganglion cells in human primary open-angle glaucoma. Archives 
of Ophthalmology 115, 1031-1035. 
Keyse, S. M., Applegate, L. A., Tromvoukis, Y., and Tyrrell, R. M. (1990) Oxidant 
stress leads to transcriptional activation of the human heme oxygenase gene in 
cultured skin fibroblasts. Molecular and Cellular Biology 10, 4967-4969. 
Kim, W. S., Chan, S. L., Hill, A. F., Guillemin, G. J., and Garner, B. (2009) Impact 
of 27-hydroxycholesterol on amyloid-β peptide production and ATP-binding 
cassette transporter expression in primary human neurons. Journal of 
Alzheimer's Disease 16, 121-131. 
Kivipelto, M. and Solomon, A. (2006) Cholesterol as a risk factor for Alzheimer's 
disease - epidemiological evidence. Acta Neurologica Scandinavica 
Supplementum 185, 50-57. 
Klaver, C. C., Assink, J. J., van, L. R., Wolfs, R. C., Vingerling, J. R., Stijnen, T., 
Hofman, A., and de Jong, P. T. (2001) Incidence and progression rates of age-
related maculopathy: The Rotterdam Study. Investigative Ophthalmology and 
Visual Science 42, 2237-2241. 
Klein, B. E., Klein, R., Lee, K. E., Moore, E. L., and Danforth, L. (2001) Risk of 
incident age-related eye diseases in people with an affected sibling : the Beaver 




Klein, M. L., Schultz, D. W., Edwards, A., Matise, T. C., Rust, K., Berselli, C. B., 
Trzupek, K., Weleber, R. G., Ott, J., Wirtz, M. K., and Acott, T. S. (1998) Age-
related macular degeneration: Clinical features in a large family and linkage to 
chromosome 1q. Archives of Ophthalmology 116, 1082-1088. 
Klein, R., Clegg, L., Cooper, L. S., Hubbard, L. D., Klein, B. E., King, W. N., and 
Folsom, A. R. (1999) Prevalence of age-related maculopathy in the 
atherosclerosis risk in communities study. Archives of Ophthalmology 117, 1203-
1210. 
Klein, R., Klein, B. E., Jensen, S. C., and Meuer, S. M. (1997) The five-year 
incidence and progression of age-related maculopathy: The Beaver Dam Eye 
Study. Ophthalmology 104, 7-21. 
Klein, R., Klein, B. E., Marino, E. K., Kuller, L. H., Furberg, C., Burke, G. L., and 
Hubbard, L. D. (2003a) Early age-related maculopathy in the cardiovascular 
health study. Ophthalmology 110, 25-33. 
Klein, R., Klein, B. E., Tomany, S. C., and Cruickshanks, K. J. (2003b) The 
association of cardiovascular disease with the long-term incidence of age-related 
maculopathy: The Beaver Dam eye study. Ophthalmology 110, 636-643. 
Klein, R., Klein, B. E., Tomany, S. C., Meuer, S. M., and Huang, G. H. (2002) Ten-
year incidence and progression of age-related maculopathy: The Beaver Dam eye 
study. Ophthalmology 109, 1767-1779. 
Klein, R., Knudtson, M. D., and Klein, B. E. K. (2007) Statin use and the five-year 
incidence and progression of age-related macular degeneration. American 
Journal of Ophthalmology 144, 1-6. 
Kliffen, M., van der Schaft, T. L., Mooy, C. M., and de Jong, P. T. V. M. (1997) 
Morphologic changes in age-related maculopathy. Microscopy Research and 
Technique 36, 106-122. 
Kolsch, H., Ludwig, M., Lutjohann, D., and Rao, M. L. (2001) Neurotoxicity of 
24-hydroxycholesterol, an important cholesterol elimination product of the 
brain, may be prevented by vitamin E and estradiol-17β. Journal of Neural 
Transmission 108, 475-488. 
Komuves, L. G., Schmuth, M., Fowler, A. J., Elias, P. M., Hanley, K., Man, M. Q., 
Moser, A. H., Lobaccaro, J. M., Williams, M. L., Mangelsdorf, D. J., and Feingold, 
K. R. (2002) Oxysterol stimulation of epidermal differentiation is mediated by 
liver X receptor-β in murine epidermis. Journal of Investigative Dermatology 
118, 25-34. 
Kopitz, J., Holz, F. G., Kaemmerer, E., and Schutt, F. (2004) Lipids and lipid 
peroxidation products in the pathogenesis of age-related macular degeneration. 




Krishnaiah, S., Das, T., Nirmalan, P. K., Nutheti, R., Shamanna, B. R., Rao, G. N., 
and Thomas, R. (2005) Risk factors for age-related macular degeneration: 
findings from the Andhra Pradesh eye disease study in South India. Investigative 
Ophthalmology and Visual Science 46, 4442-4449. 
LaFerla, F. M. (2002) Calcium dyshomeostasis and intracellular signalling in 
alzheimer's disease. Nature Review Neuroscience 3, 862-872. 
Lappano, R., Recchia, A. G., De Francesco, E. M., Angelone, T., Cerra, M. C., 
Picard, D., and Maggiolini, M. (2011) The cholesterol metabolite 25-
hydroxycholesterol activates estrogen receptor α mediated signaling in cancer 
cells and in cardiomyocytes. PLoS ONE 6, e16631. 
Lautier, D., Luscher, P., and Tyrrell, R. M. (1992) Endogenous glutathione levels 
modulate both constitutive and UVA radiation/hydrogen peroxide inducible 
expression of the human heme oxygenase gene. Carcinogenesis 13, 227-232. 
LeClaire, J. E. (1998) Relationship of ocular factors to the incidence of age-
related maculopathy. Archives of Ophthalmology 116, 1404-1405. 
Levin, E. R. (2001) Invited review: Cell localization, physiology, and nongenomic 
actions of estrogen receptors. Journal of Applied Physiology 91, 1860-1867. 
Li, C. M., Clark, M. E., Rudolf, M., and Curcio, C. A. (2007) Distribution and 
composition of esterified and unesterified cholesterol in extra-macular drusen. 
Experimental Eye Research. 85, 192-201. 
Li, Y., Schwabe, R. F., Vries-Seimon, T., Yao, P. M., Gerbod-Giannone, M. C., 
Tall, A. R., Davis, R. J., Flavell, R., Brenner, D. A., and Tabas, I. (2005) Free 
cholesterol-loaded macrophages are an abundant source of tumor necrosis 
factor-α and interleukin-6: Model of NFĸB- and map kinase-dependent 
inflammation in advanced atherosclerosis. Journal of Biological Chemistry 280, 
21763-21772. 
Liang, F. Q. and Godley, B. F. (2003) Oxidative stress-induced mitochondrial 
DNA damage in human retinal pigment epithelial cells: A possible mechanism for 
RPE aging and age-related macular degeneration. Experimental Eye Research 
76, 397-403. 
Liu, X. M., Peyton, K. J., Ensenat, D., Wang, H., Schafer, A. I., Alam, J., and 
Durante, W. (2005) Endoplasmic reticulum stress stimulates heme oxygenase-1 
gene expression in vascular smooth muscle. Role in cell survival. Journal of 
Biological Chemistry 280, 872-877. 
Luibl, V., Isas, J. M., Kayed, R., Glabe, C. G., Langen, R., and Chen, J. (2006) 
Drusen deposits associated with aging and age-related macular degeneration 





Lund, E., Bjorkhem, I., Furster, C., and Wikvall, K. (1993) 24-, 25- and 27-
hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig 
liver. Biochimica et Biophysica ACTA 1166, 177-182. 
Lund, E. G., Guileyardo, J. M., and Russell, D. W. (1999) cDNA cloning of 
cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. 
Proceedings of the National Academy of Sciences of the United States of 
America 96, 7238-7243. 
Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., 
Kha, H., Zhang, J., Gong, Y., Martin, L., Louis, J. C., Yan, Q., Richards, W. G., 
Citron, M., and Vassar, R. (2001) Mice deficient in BACE1, the Alzheimer's β-
secretase, have normal phenotype and abolished β-amyloid generation. Nature 
Neuroscience 4, 231-232. 
Luthra, S., Fardin, B., Dong, J., Hertzog, D., Kamjoo, S., Gebremariam, S., 
Butani, V., Narayanan, R., Mungcal, J. K., Kuppermann, B. D., and Kenney, M. C. 
(2006) Activation of caspase-8 and caspase-12 pathways by 7-ketocholesterol in 
human retinal pigment epithelial cells. Investigative Ophthalmology and Visual 
Science 47, 5569-5575. 
Lutjohann, D., Papassotiropoulos, A., Bjorkhem, I., Locatelli, S., Bagli, M., 
Oehring, R. D., Schlegel, U., Jessen, F., Rao, M. L., von, B. K., and Heun, R. 
(2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer 
and vascular demented patients. Journal of Lipid Research 41, 195-198. 
Madigan, M. C., Penfold, P. L., Provis, J. M., Balind, T. K., and Billson, F. A. 
(1994) Intermediate filament expression in human retinal macroglia. 
Histopathologic changes associated with age-related macular degeneration. 
Retina 14, 65-74. 
Maines, M. D. (1988) Heme oxygenase: Function, multiplicity, regulatory 
mechanisms, and clinical applications. FASEB Journal 2, 2557-2568. 
Malek, G., Johnson, L. V., Mace, B. E., Saloupis, P., Schmechel, D. E., Rickman, 
D. W., Toth, C. A., Sullivan, P. M., and Bowes, R. C. (2005) Apolipoprotein E 
allele-dependent pathogenesis: A model for age-related retinal degeneration. 
Proceedings of the National Academy of Sciences of the United States of 
America 102, 11900-11905. 
Malek, G., Li, C. M., Guidry, C., Medeiros, N. E., and Curcio, C. A. (2003) 
Apolipoprotein B in cholesterol-containing drusen and basal deposits of human 
eyes with age-related maculopathy. American Journal of Pathology 162, 413-
425. 
Mares-Perlman, J. A., Brady, W. E., Klein, R., VandenLangenberg, G. M., Klein, 
B. E., and Palta, M. (1995) Dietary fat and age-related maculopathy. Archives of 




Marin-Castano, M. E., Elliot, S. J., Potier, M., Karl, M., Striker, L. J., Striker, G. 
E., Csaky, K. G., and Cousins, S. W. (2003) Regulation of estrogen receptors and 
MMP-2 Expression by estrogens in human retinal pigment epithelium. 
Investigative Ophthalmology and Visual Science 44, 50-59. 
Markesbery, W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. 
Free Radical Biology and Medicine 23, 134-147. 
Mast, N., Reem, R., Bederman, I., Huang, S., Dipatre, P. L., Bjorkhem, I., and 
Pikuleva, I. A. (2011) Cholestenoic acid is an important elimination product of 
cholesterol in the retina: Comparison of retinal cholesterol metabolism with that 
in the brain. Investigative Ophthalmology and Visual Science 52, 594-603. 
Maxfield, F. R. and Tabas, I. (2005) Role of cholesterol and lipid organization in 
disease. Nature 438, 612-621. 
McCarty, C. A., Mukesh, B. N., Fu, C. L., Mitchell, P., Wang, J. J., and Taylor, H. 
R. (2001) Risk factors for age-related maculopathy: The visual impairment 
project. Archives of Ophthalmology 119, 1455-1462. 
McCullough, K. D., Martindale, J. L., Klotz, L. O., Aw, T. Y., and Holbrook, N. J. 
(2001) GADD153 sensitizes cells to endoplasmic reticulum stress by down-
regulating Bcl2 and perturbing the cellular redox state. Molecular and Cellular 
Biology 21, 1249-1259. 
McDonald, J. G., Thompson, B. M., McCrum, E. C., and Russell, D. W. (2007) 
Extraction and analysis of sterols in biological matrices by high performance 
liquid chromatography electrospray ionization mass spectrometry: Methods in 
enzymology lipidomics and bioactive lipids: Mass spectrometry-based lipid 
analysis, pp. 145-170. Ed H. A. Brown. Academic Press. 
Meister, A. and Anderson, M. E. (1983) Glutathione. Annual Review of 
Biochemistry 52, 711-760. 
Meyer, M., Schreck, R., and Baeuerle, P. A. (1993) H2O2 and antioxidants have 
opposite effects on activation of NFĸB and AP-1 in intact cells: AP-1 as secondary 
antioxidant-responsive factor. EMBO Journal 12, 2005-2015. 
Miceli, M. V., Newsome, D. A., Tate, D. J., Jr., and Sarphie, T. G. (2000) 
Pathologic changes in the retinal pigment epithelium and Bruch's membrane of 
fat-fed atherogenic mice. Current Eye Research 20, 8-16. 
Migliaccio, A., Di, D. M., Castoria, G., de, F. A., Bontempo, P., Nola, E., and 
Auricchio, F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by 




Miller, S. S. and Steinberg, R. H. (1979) Potassium modulation of taurine 
transport across the frog retinal pigment epithelium. The Journal of General 
Physiology 74, 237-259. 
Miners, J. S., Baig, S., Tayler, H., Kehoe, P. G., and Love, S. (2009) Neprilysin 
and insulin-degrading enzyme levels are increased in Alzheimer disease in 
relation to disease severity. Journal of Neuropathology and Experimental 
Neurology 68, 902-914. 
Mitchell, P., Smith, W., Attebo, K., and Wang, J. J. (1995) Prevalence of age-
related maculopathy in Australia. The Blue Mountains Eye Study. 
Ophthalmology 102, 1450-1460. 
Mitchell, P., Wang, J. J., Foran, S., and Smith, W. (2002) Five-year incidence of 
age-related maculopathy lesions: The Blue Mountains Eye Study. Ophthalmology 
109, 1092-1097. 
Miyazaki, M., Kiyohara, Y., Yoshida, A., Iida, M., Nose, Y., and Ishibashi, T. 
(2005) The 5-year incidence and risk factors for age-related maculopathy in a 
general Japanese population: The Hisayama study. Investigative Ophthalmology 
and Visual Science 46, 1907-1910. 
Miyazaki, M., Nakamura, H., Kubo, M., Kiyohara, Y., Oshima, Y., Ishibashi, T., 
and Nose, Y. (2003) Risk factors for age related maculopathy in a Japanese 
population: The Hisayama study. British Journal of Ophthalmology 87, 469-
472. 
Mizutani, M., Gerhardinger, C., and Lorenzi, M. (1998) Muller cell changes in 
human diabetic retinopathy. Diabetes 47, 445-449. 
Momoi, T. (2004) Caspases involved in ER stress-mediated cell death. Journal of 
Chemical Neuroanatomy 28, 101-105. 
Moosmann, B. and Behl, C. (1999) The antioxidant neuroprotective effects of 
estrogens and phenolic compounds are independent from their estrogenic 
properties. Proceedings of the National Academy of Sciences of the United States 
of America 96, 8867-8872. 
Mordenti, J., Cuthbertson, R. A., Ferrara, N., Thomsen, K., Berleau, L., Licko, V., 
Allen, P. C., Valverde, C. R., Meng, Y. G., Fei, D. T. W., Fourre, K. M., and Ryan, 
A. M. (1999) Comparisons of the intraocular tissue distribution, 
pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in 






Moreira, E. F., Larrayoz, I. M., Lee, J. W., and Rodriguez, I. R. (2009) 7-
ketocholesterol is present in lipid deposits in the primate retina: Potential 
implication in the induction of VEGF and CNV formation. Investigative 
Ophthalmology and Visual Science 50, 523-532. 
Motterlini, R., Foresti, R., Intaglietta, M., and Winslow, R. M. (1996) NO-
mediated activation of heme oxygenase: Endogenous cytoprotection against 
oxidative stress to endothelium. American Journal of Physiology - Heart and 
Circulatory Physiology 270, H107-H114. 
Mukesh, B. N., Dimitrov, P. N., Leikin, S., Wang, J. J., Mitchell, P., McCarty, C. 
A., and Taylor, H. R. (2004) Five-year incidence of age-related maculopathy: The 
visual impairment project. Ophthalmology 111, 1176-1182. 
Mullins, R. F., Aptsiauri, N., and Hageman, G. S. (2001) Structure and 
composition of drusen associated with glomerulonephritis: Implications for the 
role of complement activation in drusen biogenesis. Eye 15, 390-395. 
Munaut, C., Lambert, V., Noël, A., Frankenne, F., Deprez, M., Foidart, J. M., and 
Rakic, J. M. (2001) Presence of oestrogen receptor type β in human retina. 
British Journal of Ophthalmology 85, 877-882. 
Munoz, B., Klein, R., Rodriguez, J., Snyder, R., and West, S. K. (2005) Prevalence 
of age-related macular degeneration in a population-based sample of Hispanic 
people in Arizona: Proyecto VER. Archives of Ophthalmology 123, 1575-1580. 
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., and Yuan, J. 
(2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and 
cytotoxicity by amyloid-β. Nature 403, 98-103. 
Neale, B. M., Fagerness, J., Reynolds, R., Sobrin, L., Parker, M., Raychaudhuri, 
S., Tan, P. L., Oh, E. C., Merriam, J. E., Souied, E., Bernstein, P. S., Li, B., 
Frederick, J. M., Zhang, K., Brantley, M. A., Jr., Lee, A. Y., Zack, D. J., 
Campochiaro, B., Campochiaro, P., Ripke, S., Smith, R. T., Barile, G. R., Katsanis, 
N., Allikmets, R., Daly, M. J., and Seddon, J. M. (2010) Genome-wide association 
study of advanced age-related macular degeneration identifies a role of the 
hepatic lipase gene (LIPC). Proceedings of the National Academy of Sciences of 
the United States of America 107, 7395-7400. 
Newman, E. and Reichenbach, A. (1996) The Muller cell: A functional element of 
the retina. Trends in Neurosciences 19, 307-312. 
Ning, A., Cui, J., To, E., Ashe, K. H., and Matsubara, J. (2008) Amyloid-β 
deposits lead to retinal degeneration in a mouse model of Alzheimer disease. 





Nirmalan, P. K., Katz, J., Robin, A. L., Tielsch, J. M., Namperumalsamy, P., Kim, 
R., Narendran, V., Ramakrishnan, R., Krishnadas, R., Thulasiraj, R. D., and Suan, 
E. (2004) Prevalence of vitreoretinal disorders in a rural population of southern 
India: The Aravind Comprehensive Eye Study. Archives of Ophthalmology 122, 
581-586. 
Nishiyama, T., Nishukawa, S., Hiroshi, Tomita, and Tamai, M. (2000) Muller 
cells in the preconditioned retinal ischemic injury rat. The Tohoku Journal of 
Experimental Medicine 191, 221-232. 
Nowak, J. Z. (2006) Age-related macular degeneration (AMD): Pathogenesis and 
therapy. Pharmacological Reports Online 58, 353-363. 
Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, 
A. E., Walker, P. R., and Sikorska, M. (1993) Apoptotic death in epithelial cells: 
Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of 
internucleosomal fragmentation. EMBO Journal 12, 3679-3684. 
Ogueta, S. B., Schwartz, S. D., Yamashita, C. K., and Farber, D. B. (1999) 
Estrogen receptor in the human eye: Influence of gender and age on gene 
expression. Investigative Ophthalmology and Visual Science 40, 1906-1911. 
Ohno-Matsui, K. (2011) Parallel findings in age-related macular degeneration and 
Alzheimer's disease. Progress in Retinal and Eye Research 30, 217-238. 
Okada, M., Matsumura, M., Ogino, N., and Honda, Y. (1990) Muller cells in 
detached human retina express glial fibrillary acidic protein and vimentin. 
Graefe's Archive for Clinical and Experimental Ophthalmology 228, 467-474. 
Okada, T., Yoshida, H., Akazawa, R., Negishi, M., and Mori, K. (2002) Distinct 
roles of activating transcription factor 6 (ATF6) and double-stranded RNA-
activated protein kinase-like endoplasmic reticulum kinase (PERK) in 
transcription during the mammalian unfolded protein response. Biochemical 
Journal 366, 585-594. 
Ong, J. M., Aoki, A. M., Seigel, G. M., Sacerio, I., Castellon, R., Nesburn, A. B., 
and Kenney, M. C. (2003) Oxysterol-induced toxicity in R28 and ARPE-19 cells. 
Neurochemical Research 28, 883-891. 
Ong, J. M., Zorapapel, N. C., Rich, K. A., Wagstaff, R. E., Lambert, R. W., 
Rosenberg, S. E., Moghaddas, F., Pirouzmanesh, A., Aoki, A. M., and Kenney, M. 
C. (2001) Effects of cholesterol and apolipoprotein E on retinal abnormalities in 
ApoE-deficient mice. Investigative Ophthalmology & Visual Science 42, 1891-
1900. 
Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E., and Mori, 
M. (2002) Targeted disruption of the chop gene delays endoplasmic reticulum 




Oyadomari, S. and Mori, M. (2004) Roles of CHOP/GADD153 in endoplasmic 
reticulum stress. Cell Death and Differentiation 11, 381-389. 
Oyadomari, S., Takeda, K., Takiguchi, M., Gotoh, T., Matsumoto, M., Wada, I., 
Akira, S., Araki, E., and Mori, M. (2001) Nitric oxide-induced apoptosis in 
pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. 
Proceedings of the National Academy of Sciences of the United States of 
America 98, 10845-10850. 
Pahl, H. L. and Baeuerle, P. A. (1996) Activation of NFĸB by ER stress requires 
both Ca2+ and reactive oxygen intermediates as messengers. FEBS Letters 392, 
129-136. 
Paimela, T., Hyttinen, J. M., Viiri, J., Ryhanen, T., Karvonen, M. K., Unkila, M., 
Uusitalo, H., Salminen, A., and Kaarniranta, K. (2010) Influence of selective 
estrogen receptor modulators on interleukin-6 expression in human retinal 
pigment epithelial cells (ARPE-19). European Journal of Pharmacology 640, 
219-225. 
Panini, S. R. and Sinensky, M. S. (2001) Mechanisms of oxysterol-induced 
apoptosis. Current Opinion in Lipidology 12, 529-533. 
Paquet, C., Boissonnot, M., Roger, F., Dighiero, P., Gil, R., and Hugon, J. (2007) 
Abnormal retinal thickness in patients with mild cognitive impairment and 
Alzheimer's disease. Neuroscience Letters 420, 97-99. 
Parisi, V. (2003) Correlation between morphological and functional retinal 
impairment in patients affected by ocular hypertension, glaucoma, demyelinating 
optic neuritis and Alzheimer's disease. Seminars in Ophthalmology 18, 50-57. 
Parisi, V., Restuccia, R., Fattapposta, F., Mina, C., Bucci, M. G., and Pierelli, F. 
(2001) Morphological and functional retinal impairment in Alzheimer's disease 
patients. Clinical Neurophysiology 112, 1860-1867. 
Park, J. S., Luethy, J. D., Wang, M. G., Fargnoli, J., Fornace, A. J., Jr., McBride, 
O. W., and Holbrook, N. J. (1992) Isolation, characterization and chromosomal 
localization of the human GADD153 gene. Gene 116, 259-267. 
Perez, A., Morelli, L., Cresto, J. C., and Castano, E. M. (2000) Degradation of 
soluble Amyloid β-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin 
degrading enzyme from Alzheimer disease and control brains. Neurochemical 
Research 25, 247-255. 
Pompella, A., Visvikis, A., Paolicchi, A., De, T., V, and Casini, A. F. (2003) The 





Portera-Cailliau, C., Sung, C. H., Nathans, J., and Adler, R. (1994) Apoptotic 
photoreceptor cell death in mouse models of retinitis pigmentosa. Proceedings of 
the National Academy of Sciences of the United States of America 91, 974-978. 
Prasanthi, J. R., Huls, A., Thomasson, S., Thompson, A., Schommer, E., and 
Ghribi, O. (2009) Differential effects of 24-hydroxycholesterol and 27-
hydroxycholesterol on β-amyloid precursor protein levels and processing in 
human neuroblastoma SH-SY5Y cells. Molecular Neurodegeneration 4, 1. 
Preissner, K. T. and Seiffert, D. (1998) Role of vitronectin and its receptors in 
haemostasis and vascular remodeling. Thrombosis Research 89, 1-21. 
Querfurth, H. W. and LaFerla, F. M. (2010) Alzheimer's disease. New England 
Journal of Medicine 362, 329-344. 
Quigley, H. A., Nickells, R. W., Kerrigan, L. A., Pease, M. E., Thibault, D. J., and 
Zack, D. J. (1995) Retinal ganglion cell death in experimental glaucoma and after 
axotomy occurs by apoptosis. Investigative Ophthalmology and Visual Science 
36, 774-786. 
Ramirez, A. I., Salazar, J. J., de Hoz, R., Rojas, B., Ruiz, E., Tejerina, T., Ramírez, 
J. M., and Triviño, A. (2006) Macroglial and retinal changes in 
hypercholesterolemic rabbits after normalization of cholesterol levels. 
Experimental Eye Research 83, 1423-1438. 
Ramirez, J. M., Ramirez, A. I., Salazar, J. J., de, H. R., and Trivino, A. (2001) 
Changes of astrocytes in retinal ageing and age-related macular degeneration. 
Experimental Eye Research 73, 601-615. 
Rantham Prabhakara, J. P., Feist, G., Thomasson, S., Thompson, A., Schommer, 
E., and Ghribi, O. (2008) Differential effects of 24-hydroxycholesterol and 27-
hydroxycholesterol on tyrosine hydroxylase and α-synuclein in human 
neuroblastoma SH-SY5Y cells. Journal of Neurochemistry 107, 1722-1729. 
Raymond, S. M. and Jackson, I. J. (1995) The retinal pigmented epithelium is 
required for development and maintenance of the mouse neural retina. Current 
Biology 5, 1286-1295. 
Rein, D. B., Wittenborn, J. S., Zhang, X., Honeycutt, A. A., Lesesne, S. B., 
Saaddine, J., and for the vision health cost-effectiveness study group (2009) 
Forecasting age-related macular degeneration through the year 2050: the 
potential impact of new treatments. Archives of Ophthalmology 127, 533-540. 
Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, 
G. P., and Mariotti, S. P. (2004) Global data on visual impairment in the year 




Riendeau, V. and Garenc, C. (2009) Effect of 27-hydroxycholesterol on survival 
and death of human macrophages and vascular smooth muscle cells. Free 
Radical Research 43, 1019-1028. 
Robman, L., McNeil, J., Dimitrov, P., Dowrick, A., Tikellis, G., Nicolas, C., 
Cameron, J., Guymer, R., McGrath, B., and McCarty, C. (2004) Methodology of 
the cardiovascular health and age-related maculopathy (CHARM) study. 
Ophthalmic Epidemiology 11, 161-179. 
Rodriguez, I. R. and Fliesler, S. J. (2009) Photodamage generates 7-keto- and 7-
hydroxycholesterol in the rat retina via a free radical-mediated mechanism. 
Photochemistry and Photobiology 85, 1116-1125. 
Rodriguez, I. R. and Larrayoz, I. M. (2010) Cholesterol oxidation in the retina: 
Implications of 7KCh formation in chronic inflammation and age-related macular 
degeneration. The Journal of Lipid Research 51, 2847-2862. 
Rodriguez, I. R., Alam, S., and Lee, J. W. (2004) Cytotoxicity of oxidized low-
density lipoprotein in cultured RPE cells is dependent on the formation of 7-
ketocholesterol. Investigative Ophthalmology and Visual Science 45, 2830-
2837. 
Ron, D. and Habener, J. F. (1992) CHOP, a novel developmentally regulated 
nuclear protein that dimerizes with transcription factors C/EBP and LAP and 
functions as a dominant-negative inhibitor of gene transcription. Genes & 
Development 6, 439-453. 
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. 
Y., and Kim, R. Y. (2006) Ranibizumab for Neovascular Age-Related Macular 
Degeneration. New England Journal of Medicine 355, 1419-1431. 
Rudolf, M. and Curcio, C. A. (2009) Esterified cholesterol is highly localized to 
Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human 
choroid. Journalof Histochemistry and Cytochemistry 57, 731-739. 
Rush, J. W., Quadrilatero, J., Levy, A. S., and Ford, R. J. (2007) Chronic 
resveratrol enhances endothelium-dependent relaxation but does not alter eNOS 
levels in aorta of spontaneously hypertensive rats. Experimental Biology and 
Medicine 232, 814-822. 
Russell, S. R., Mullins, R. F., Schneider, B. L., and Hageman, G. S. (2000) 
Location, substructure, and composition of basal laminar drusen compared with 
drusen associated with aging and age-related macular degeneration. American 
Journal of Ophthalmology 129, 205-214. 
Sadun, A. A., Borchert, M., DeVita, E., Hinton, D. R., and Bassi, C. J. (1987) 
Assessment of visual impairment in patients with Alzheimer's disease. American 




Salazar, J. J., Ramirez, A. I., de Hoz, R., Rojas, B., Ruiz, E., Tejerina, T., Trivino, 
A., and Ramirez, J. M. (2007) Alterations in the choroid in hypercholesterolemic 
rabbits: Reversibility after normalization of cholesterol levels. Experimental Eye 
Research 84, 412-422. 
Salvioli, S., Ardizzoni, A., Franceschi, C., and Cossarizza, A. (1997) JC-1, but not 
DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi 
changes in intact cells: Implications for studies on mitochondrial functionality 
during apoptosis. FEBS Letters 411, 77-82. 
Sarks, J. P., Sarks, S. H., and Killingsworth, M. C. (1988) Evolution of geographic 
atrophy of the retinal pigment epithelium. Eye 2 552-577. 
Sarks, S. H. (1976) Ageing and degeneration in the macular region: A clinico-
pathological study. British Journal of Ophthalmology 60, 324-341. 
Sarks, S. H. (1980) Council Lecture. Drusen and their relationship to senile 
macular degeneration. Australian Journal of Ophthalmology 8, 117-130. 
Sarks, S. H., Arnold, J. J., Killingsworth, M. C., and Sarks, J. P. (1999) Early 
drusen formation in the normal and aging eye and their relation to age related 
maculopathy: a clinicopathological study. British Journal of Ophthalmology 83, 
358-368. 
Sarks, S., Cherepanoff, S., Killingsworth, M., and Sarks, J. (2007) Relationship of 
basal laminar deposit and membranous debris to the clinical presentation of 
early age-related macular degeneration. Investigative Ophthalmology & Visual 
Science 48, 968-977. 
Sauer, T., Patel, M., Chan, C. C., and Tuo, J. (2008) Unfolding the therapeutic 
potential of chemical chaperones for age-related macular degeneration. Expert 
Reviews of Ophthalmology 3, 29-42. 
Schipper, H. M., Bennett, D. A., Liberman, A., Bienias, J. L., Schneider, J. A., 
Kelly, J., and Arvanitakis, Z. (2006) Glial heme oxygenase-1 expression in 
Alzheimer disease and mild cognitive impairment. Neurobiology of Aging 27, 
252-261. 
Schipper, H. M., Cisse, S., and Stopa, E. G. (1995) Expression of heme oxygenase-
1 in the senescent and Alzheimer-diseased brain. Annals of Neurology 37, 758-
768. 
Schmidt, K. N., Amstad, P., Cerutti, P., and Baeuerle, P. A. (1995) The roles of 
hydrogen peroxide and superoxide as messengers in the activation of 




Schreck, R., Rieber, P., and Baeuerle, P. A. (1991) Reactive oxygen intermediates 
as apparently widely used messengers in the activation of the NFĸB transcription 
factor and HIV-1. EMBO Journal 10, 2247-2258. 
Schwartzman, R. A. and Cidlowski, J. A. (1993) Apoptosis: The biochemistry and 
molecular biology of programmed cell death. Endocrine Reviews 14, 133-151. 
Selvaraj, S., Sun, Y., and Singh, B. B. (2009) TRPC channels and their implication 
in neurological diseases. CNS & Neurological Disorders - Drug Targets 9 (1) 
94–104 
Sen, R. and Baltimore, D. (1986) Inducibility of ĸ immunoglobulin enhancer-
binding protein NfĸB by a posttranslational mechanism. Cell 47, 921-928. 
Setchell, K. D., Schwarz, M., O'Connell, N. C., Lund, E. G., Davis, D. L., Lathe, R., 
Thompson, H. R., Weslie, T. R., Sokol, R. J., and Russell, D. W. (1998) 
Identification of a new inborn error in bile acid synthesis: Mutation of the 
oxysterol 7α-hydroxylase gene causes severe neonatal liver disease. Journal of 
Clinical Investigation 102, 1690-1703. 
Sharma, S., Prasanthi, R. P., Schommer, E., Feist, G., and Ghribi, O. (2008) 
Hypercholesterolemia-induced Ab accumulation in rabbit brain is associated 
with alteration in IGF-1 signaling. Neurobiology of Disease 32, 426-432. 
Shen, J. K., Dong, A., Hackett, S. F., Bell, W. R., Green, W. R., and Campochiaro, 
P. A. (2007) Oxidative damage in age-related macular degeneration. Histology 
and Histopathology 22, 1301-1308. 
Shimazawa, M., Inokuchi, Y., Okuno, T., Nakajima, Y., Sakaguchi, G., Kato, A., 
Oku, H., Sugiyama, T., Kudo, T., Ikeda, T., Takeda, M., and Hara, H. (2008) 
Reduced retinal function in amyloid precursor protein-over-expressing 
transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor 
signaling. Journal of Neurochemistry 107, 279-290. 
Sies, H. (1999) Glutathione and its role in cellular functions. Free Radic. Biol. 
Med. 27, 916-921. 
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, 
J. K. (2000) Interaction of oestrogen receptor with the regulatory subunit of 
phosphatidylinositol-3-OH kinase. Nature 407, 538-541. 
Simpkins, J. W., Wang, J., Wang, X., Perez, E., Prokai, L., and Dykens, J. A. 
(2005) Mitochondria play a central role in estrogen-induced neuroprotection. 





Smiley, S. T., Reers, M., Mottola-Hartshorn, C., Lin, M., Chen, A., Smith, T. W., 
Steele, G. D., Jr., and Chen, L. B. (1991) Intracellular heterogeneity in 
mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic 
cation JC-1. Proceedings of the National Academy of Sciences of the United 
States of America 88, 3671-3675. 
Smith, L. L. and Johnson, B. H. (1989) Biological activities of oxysterols. Free 
Radical Biology and Medicine 7, 285-332. 
Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., 
Wiggert, B., Petersen, R. B., and Perry, G. (1994) Heme oxygenase-1 is associated 
with the neurofibrillary pathology of Alzheimer's disease. American Journal of 
Pathology 145, 42-47. 
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C., Klein, B. E., Hofman, 
A., Jensen, S., Wang, J. J., and de Jong, P. T. (2001) Risk factors for age-related 
macular degeneration: Pooled findings from three continents. Ophthalmology 
108, 697-704. 
Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., and Whitmer, R. A. (2009) 
Midlife serum cholesterol and increased risk of Alzheimer's and vascular 
dementia three decades later. Dementia and Geriatric Cognitive Disorders 28, 
75-80. 
Song, C. and Liao, S. (2000) Cholestenoic acid is a naturally occurring ligand for 
liver X receptor α. Endocrinology 141, 4180-4184. 
Sparks, D. L., Scheff, S. W., Hunsaker, J. C., III, Liu, H., Landers, T., and Gross, 
D. R. (1994) Induction of Alzheimer-like β-amyloid immunoreactivity in the 
brains of rabbits with dietary cholesterol. Experimental Neurology 126, 88-94. 
Sternberg, P., Jr., Davidson, P. C., Jones, D. P., Hagen, T. M., Reed, R. L., and 
Drews-Botsch, C. (1993) Protection of retinal pigment epithelium from oxidative 
injury by glutathione and precursors. Investigative Ophthalmology and Visual 
Science 34, 3661-3668. 
Stocker, R. (1990) Induction of haem oxygenase as a defence against oxidative 
stress. Free Radical Research Communication 9, 101-112. 
Strehlow, K., Rotter, S., Wassmann, S., Adam, O., Grohe, C., Laufs, K., Böhm, M., 
and Nickenig, G. (2003) Modulation of antioxidant enzyme expression and 
function by estrogen. Circulation Research 93, 170-177. 
Szegezdi, E., Fitzgerald, U., and Samali, A. (2003) Caspase-12 and ER-stress-
mediated apoptosis: The story so far. Annals of the New York Academy of 




Tabas, I. (2002) Consequences of cellular cholesterol accumulation: Basic 
concepts and physiological implications. Journal of Clinical Investigation 110, 
905-911. 
Tang, Q. Q. and Lane, M. D. (2000) Role of C/EBP homologous protein (CHOP-
10) in the programmed activation of CCAAT/enhancer-binding protein-β during 
adipogenesis. Proceedings of the National Academy of Sciences of the United 
States of America 97, 12446-12450. 
Tenhunen, R., Marver, H. S., and Schmid, R. (1968) The enzymatic conversion of 
heme to bilirubin by microsomal heme oxygenase. Proceedings of the National 
Academy of Sciences of the United States of America 61, 748-755. 
Tian, W., Bonkovsky, H. L., Shibahara, S., and Cohen, D. M. (2001) Urea and 
hypertonicity increase expression of heme oxygenase-1 in murine renal medullary 
cells. American Journal of Physiology- Renal Physiology 281, F983-F991. 
Tomany, S. C., Wang, J. J., van, L. R., Klein, R., Mitchell, P., Vingerling, J. R., 
Klein, B. E., Smith, W., and de Jong, P. T. (2004) Risk factors for incident age-
related macular degeneration: Pooled findings from 3 continents. 
Ophthalmology 111, 1280-1287. 
Townsend, D. M., Tew, K. D., and Tapiero, H. (2003) The importance of 
glutathione in human disease. Biomedicine and Pharmacotherapy 57, 145-155. 
Treatment of age-related macular degeneration with photodynamic therapy study 
group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in 
age-related macular degeneration with Verteporfin: One-year results of 2 
randomized clinical trials-TAP Report 1. Archives of Ophthalmology 117, 1329-
1345. 
Trivino, A., Ramirez, A. I., Salazar, J. J., de, H. R., Rojas, B., Padilla, E., Tejerina, 
T., and Ramírez, J. M. (2006) A cholesterol-enriched diet induces ultrastructural 
changes in retinal and macroglial rabbit cells. Experimental Eye Research. 83, 
357-366. 
Tserentsoodol, N., Gordiyenko, N. V., Pascual, I., Lee, J. W., Fliesler, S. J., and 
Rodriguez, I. R. (2006a) Intraretinal lipid transport is dependent on high density 
lipoprotein-like particles and class B scavenger receptors. Molecular Vision 12, 
1319-1333. 
Tserentsoodol, N., Sztein, J., Campos, M., Gordiyenko, N. V., Fariss, R. N., Lee, J. 
W., Fliesler, S. J., and Rodriguez, I. R. (2006b) Uptake of cholesterol by the 
retina occurs primarily via a low density lipoprotein receptor-mediated process. 





Tufail, A., Patel, P. J., Egan, C., Hykin, P., da, C. L., Gregor, Z., Dowler, J., Majid, 
M. A., Bailey, C., Mohamed, Q., Johnston, R., Bunce, C., and Xing, W. (2010) 
Bevacizumab for neovascular age related macular degeneration (ABC Trial): 
Multicentre randomised double masked study. British Medical Journal 340, 
c2459. 
Umetani, M., Domoto, H., Gormley, A. K., Yuhanna, I. S., Cummins, C. L., Javitt, 
N. B., Korach, K. S., Shaul, P. W., and Mangelsdorf, D. J. (2007) 27-
hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular 
effects of estrogen. Nature Medicine 13, 1185-1192. 
Urata, Y., Ihara, Y., Murata, H., Goto, S., Koji, T., Yodoi, J., Inoue, S., and Kondo, 
T. (2006) 17β-Estradiol protects against oxidative stress-induced cell death 
through the glutathione/glutaredoxin-dependent redox regulation of Akt in 
myocardiac H9c2 Cells. Journal of Biological Chemistry 281, 13092-13102. 
van den Kommer, T. N., Dik, M. G., Comijs, H. C., Fassbender, K., Lutjohann, D., 
and Jonker, C. (2009) Total cholesterol and oxysterols: Early markers for 
cognitive decline in elderly? Neurobiology of Aging 30, 534-545. 
van der Sanden, M. H., Houweling, M., van Golde, L. M., and Vaandrager, A. B. 
(2003) Inhibition of phosphatidylcholine synthesis induces expression of the 
endoplasmic reticulum stress and apoptosis-related protein CCAAT/enhancer-
binding protein-homologous protein (CHOP/GADD153). Biochemical Journal 
369, 643-650. 
van Leeuwen, R., Klaver, C. C. W., Vingerling, J. R., Hofman, A., and de Jong, P. 
T. V. M. (2003) The risk and natural course of age-related maculopathy: follow-
up at 6 1/2 years in the Rotterdam study. Archives of Ophthalmology 121, 519-
526. 
van, L. R., Klaver, C. C., Vingerling, J. R., Hofman, A., van Duijn, C. M., Stricker, 
B. H., and de Jong, P. T. (2004) Cholesterol and age-related macular 
degeneration: Is there a link? American Journal of Ophthalmology 137, 750-
752. 
van, L. R., Vingerling, J. R., Hofman, A., de Jong, P. T., and Stricker, B. H. (2003) 
Cholesterol lowering drugs and risk of age related maculopathy: Prospective 
cohort study with cumulative exposure measurement. British Medical Journal 
326, 255-256. 
VanNewkirk, M. R., Nanjan, M. B., Wang, J. J., Mitchell, P., Taylor, H. R., and 
McCarty, C. A. (2000) The prevalence of age-related maculopathy: The visual 
impairment project. Ophthalmology 107, 1593-1600. 
Varma, R., Fraser-Bell, S., Tan, S., Klein, R., and Azen, S. P. (2004) Prevalence of 
age-related macular degeneration in Latinos: The Los Angeles Latino eye study. 




Vasconsuelo, A., Milanesi, L., and Boland, R. (2008) 17β-Estradiol abrogates 
apoptosis in murine skeletal muscle cells through estrogen receptors: Role of the 
phosphatidylinositol 3-kinase/Akt pathway. Journal of Endocrinology 196, 385-
397. 
Vaya, J., Song, W., Khatib, S., Geng, G., and Schipper, H. M. (2007) Effects of 
heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radical 
Biology and Medicine 42, 864-871. 
Vejux, A., Malvitte, L., and Lizard, G. (2008) Side effects of oxysterols: 
cytotoxicity, oxidation, inflammation, and phospholipidosis. Brazillian Journal 
of Medical and Biological Research 41, 545-556. 
Vepsalainen, S., Hiltunen, M., Helisalmi, S., Wang, J., van Groen, T., Tanila, H., 
and Soininen, H. (2008) Increased expression of Aβ degrading enzyme IDE in 
the cortex of transgenic mice with Alzheimer's disease-like neuropathology. 
Neuroscience Letters 438, 216-220. 
Verkhratsky, A. (2005) Physiology and pathophysiology of the calcium store in 
the endoplasmic reticulum of neurons. Physiological Reviews 85, 201-279. 
Wagner, C. T., Durante, W., Christodoulides, N., Hellums, J. D., and Schafer, A. I. 
(1997) Hemodynamic forces induce the expression of heme oxygenase in cultured 
vascular smooth muscle cells. The Journal of Clinical Investigation 100, 589-
596. 
Wang, L., Clark, M. E., Crossman, D. K., Kojima, K., Messinger, J. D., Mobley, J. 
A., and Curcio, C. A. (2010) Abundant lipid and protein components of drusen. 
PLoS. ONE 5, e10329. 
Wang, X., Tay, S. S., and Ng, Y. K. (2000) An immunohistochemical study of 
neuronal and glial cell reactions in retinae of rats with experimental glaucoma. 
Experimental Brain Research 132, 476-484. 
Wellington, C. L. (2004) Cholesterol at the crossroads: Alzheimer's disease and 
lipid metabolism. Clinical Genetics 66, 1-16. 
Wolozin, B. (2004) Cholesterol and the biology of Alzheimer's disease. Neuron 
41, 7-10. 
Wolter, J. R. and Falls, H. F. (1962) Bilateral confluent drusen. Archives of 
Ophthalmology 68, 219-226. 
Xu, G. Z., Li, W. W., and Tso, M. O. (1996) Apoptosis in human retinal 





Xu, L., Li, Y., Zheng, Y., and Jonas, J. B. (2006) Associated factors for age related 
maculopathy in the adult population in China: The Beijing eye study. British 
Journal of Ophthalmology 90, 1087-1090. 
Xu, X. and London, E. (2000) The effect of sterol structure on membrane lipid 
domains reveals how cholesterol can induce lipid domain formation. 
Biochemistry 39, 843-849. 
Yang, L., Carlson, S. G., McBurney, D., and Horton, W. E. (2005) Multiple signals 
induce endoplasmic reticulum stress in both primary and immortalized 
chondrocytes resulting in loss of differentiation, impaired cell growth, and 
apoptosis. Journal of Biological Chemistry 280, 31156-31165. 
Yanni, A. E. (2004) The laboratory rabbit: An animal model of atherosclerosis 
research. Lab Animal 38, 246-256. 
Yet, S. F., Tian, R., Layne, M. D., Wang, Z. Y., Maemura, K., Solovyeva, M., Ith, 
B., Melo, L. G., Zhang, L., Ingwall, J. S., Dzau, V. J., Lee, M. E., and Perrella, M. 
A. (2001) Cardiac-specific expression of heme oxygenase-1 protects against 
ischemia and reperfusion injury in transgenic mice. Circulation Research 89, 
168-173. 
Yoshida, H., Okada, T., Haze, K., Yanagi, H., Yura, T., Negishi, M., and Mori, K. 
(2000) ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) 
directly to the cis-acting element responsible for the mammalian unfolded 
protein response. Molecular and Cellular Biology 20, 6755-6767. 
Yoshida, T., Ohno-Matsui, K., Ichinose, S., Sato, T., Iwata, N., Saido, T. C., 
Hisatomi, T., Mochizuki, M., and Morita, I. (2005) The potential role of amyloid 
β in the pathogenesis of age-related macular degeneration. The Journal of 
Clinical Investigation 115, 2793-2800. 
Young, R. W. (1987) Pathophysiology of age-related macular degeneration. 
Survey of Ophthalmology 31, 291-306. 
Zarbin, M. A. (2004) Current concepts in the pathogenesis of age-related macular 
degeneration. Archives of Ophthalmology 122, 598-614. 
Zhang, J., Xue, Y., Jondal, M., and Sjovall, J. (1997) 7-hydroxylation and 3-
dehydrogenation abolish the ability of 25-hydroxycholesterol and 27-
hydroxycholesterol to induce apoptosis in thymocytes. European Journal of 
Biochemistry 247, 129-135. 
Zhou, M., Diwu, Z., Panchuk-Voloshina, N., and Haugland, R. P. (1997) A stable 
nonfluorescent derivative of resorufin for the fluorometric determination of trace 
hydrogen peroxide: Applications in detecting the activity of phagocyte NADPH 




Zhou, Q. and Kummerow, F. A. (1997) Effect of 27-hydroxycholesterol on cellular 
sphingomyelin synthesis and Ca++ content in cultured smooth muscle cells. 
Biomedical and Environmental Sciences 10, 369-376. 
Zhou, Q., Wasowicz, E., and Kummerow, F. A. (1995) Failure of vitamin E to 
protect cultured human arterial smooth muscle cells against oxysterol-induced 
cytotoxicity. Journal of the American College of Nutrition 14, 169-175. 
 
